id	sid	tid	token	lemma	pos
bam-10833	1	1	intravenous	intravenous	ADJ
bam-10833	1	2	colistin	colistin	NOUN
bam-10833	1	3	monotherapy	monotherapy	NOUN
bam-10833	1	4	versus	versus	ADP
bam-10833	1	5	combination	combination	NOUN
bam-10833	1	6	therapy	therapy	NOUN
bam-10833	1	7	eur	eur	PROPN
bam-10833	1	8	j	j	PROPN
bam-10833	1	9	transl	transl	PROPN
bam-10833	1	10	myol	myol	ADV
bam-10833	1	11	32	32	NUM
bam-10833	1	12	(	(	PUNCT
bam-10833	1	13	4	4	NUM
bam-10833	1	14	):	):	PUNCT
bam-10833	1	15	10833	10833	NUM
bam-10833	1	16	,	,	PUNCT
bam-10833	1	17	2022	2022	NUM
bam-10833	1	18	doi	doi	NOUN
bam-10833	1	19	:	:	PUNCT
bam-10833	1	20	10.4081	10.4081	NUM
bam-10833	1	21	/	/	SYM
bam-10833	1	22	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	1	23	1	1	NUM
bam-10833	1	24	optimal	optimal	ADJ
bam-10833	1	25	dosing	dosing	NOUN
bam-10833	1	26	interval	interval	NOUN
bam-10833	1	27	of	of	ADP
bam-10833	1	28	intravenous	intravenous	ADJ
bam-10833	1	29	colistin	colistin	NOUN
bam-10833	1	30	monotherapy	monotherapy	NOUN
bam-10833	1	31	versus	versus	ADP
bam-10833	1	32	combination	combination	NOUN
bam-10833	1	33	therapy	therapy	NOUN
bam-10833	1	34	:	:	PUNCT
bam-10833	1	35	a	a	DET
bam-10833	1	36	systematic	systematic	ADJ
bam-10833	1	37	review	review	NOUN
bam-10833	1	38	and	and	CCONJ
bam-10833	1	39	meta	meta	ADJ
bam-10833	1	40	-	-	PUNCT
bam-10833	1	41	analysis	analysis	NOUN
bam-10833	1	42	forouzan	forouzan	NOUN
bam-10833	1	43	ahmadpour	ahmadpour	NOUN
bam-10833	1	44	(	(	PUNCT
bam-10833	1	45	1	1	NUM
bam-10833	1	46	)	)	PUNCT
bam-10833	1	47	,	,	PUNCT
bam-10833	1	48	elnaz	elnaz	ADJ
bam-10833	1	49	shaseb	shaseb	NOUN
bam-10833	1	50	(	(	PUNCT
bam-10833	1	51	2	2	NUM
bam-10833	1	52	)	)	PUNCT
bam-10833	1	53	,	,	PUNCT
bam-10833	1	54	mandana	mandana	PROPN
bam-10833	1	55	izadpanah	izadpanah	PROPN
bam-10833	1	56	(	(	PUNCT
bam-10833	1	57	3	3	NUM
bam-10833	1	58	)	)	PUNCT
bam-10833	1	59	,	,	PUNCT
bam-10833	1	60	amin	amin	NOUN
bam-10833	1	61	rakhshan	rakhshan	NOUN
bam-10833	1	62	(	(	PUNCT
bam-10833	1	63	4	4	NUM
bam-10833	1	64	)	)	PUNCT
bam-10833	1	65	,	,	PUNCT
bam-10833	1	66	farzaneh	farzaneh	NOUN
bam-10833	1	67	hematian	hematian	NOUN
bam-10833	1	68	(	(	PUNCT
bam-10833	1	69	3	3	NUM
bam-10833	1	70	)	)	PUNCT
bam-10833	1	71	(	(	PUNCT
bam-10833	1	72	1	1	X
bam-10833	1	73	)	)	PUNCT
bam-10833	1	74	department	department	NOUN
bam-10833	1	75	of	of	ADP
bam-10833	1	76	pharmacotherapy	pharmacotherapy	NOUN
bam-10833	1	77	,	,	PUNCT
bam-10833	1	78	school	school	NOUN
bam-10833	1	79	of	of	ADP
bam-10833	1	80	pharmacy	pharmacy	NOUN
bam-10833	1	81	,	,	PUNCT
bam-10833	1	82	lorestan	lorestan	PROPN
bam-10833	1	83	university	university	PROPN
bam-10833	1	84	of	of	ADP
bam-10833	1	85	medical	medical	ADJ
bam-10833	1	86	sciences	sciences	PROPN
bam-10833	1	87	,	,	PUNCT
bam-10833	1	88	khoramabad	khoramabad	PROPN
bam-10833	1	89	,	,	PUNCT
bam-10833	1	90	iran	iran	PROPN
bam-10833	1	91	;	;	PUNCT
bam-10833	1	92	(	(	PUNCT
bam-10833	1	93	2	2	X
bam-10833	1	94	)	)	PUNCT
bam-10833	1	95	faculty	faculty	NOUN
bam-10833	1	96	of	of	ADP
bam-10833	1	97	pharmacy	pharmacy	NOUN
bam-10833	1	98	,	,	PUNCT
bam-10833	1	99	tabriz	tabriz	PROPN
bam-10833	1	100	university	university	PROPN
bam-10833	1	101	of	of	ADP
bam-10833	1	102	medical	medical	ADJ
bam-10833	1	103	sciences	sciences	PROPN
bam-10833	1	104	,	,	PUNCT
bam-10833	1	105	tabriz	tabriz	NOUN
bam-10833	1	106	,	,	PUNCT
bam-10833	1	107	iran	iran	PROPN
bam-10833	1	108	;	;	PUNCT
bam-10833	1	109	(	(	PUNCT
bam-10833	1	110	3	3	X
bam-10833	1	111	)	)	PUNCT
bam-10833	1	112	department	department	NOUN
bam-10833	1	113	of	of	ADP
bam-10833	1	114	clinical	clinical	ADJ
bam-10833	1	115	pharmacy	pharmacy	NOUN
bam-10833	1	116	,	,	PUNCT
bam-10833	1	117	faculty	faculty	NOUN
bam-10833	1	118	of	of	ADP
bam-10833	1	119	pharmacy	pharmacy	NOUN
bam-10833	1	120	,	,	PUNCT
bam-10833	1	121	ahvaz	ahvaz	PROPN
bam-10833	1	122	jundishapur	jundishapur	PROPN
bam-10833	1	123	university	university	PROPN
bam-10833	1	124	of	of	ADP
bam-10833	1	125	medical	medical	ADJ
bam-10833	1	126	sciences	science	NOUN
bam-10833	1	127	,	,	PUNCT
bam-10833	1	128	ahvaz	ahvaz	PROPN
bam-10833	1	129	,	,	PUNCT
bam-10833	1	130	iran	iran	PROPN
bam-10833	1	131	;	;	PUNCT
bam-10833	1	132	(	(	PUNCT
bam-10833	1	133	4	4	X
bam-10833	1	134	)	)	PUNCT
bam-10833	1	135	department	department	NOUN
bam-10833	1	136	of	of	ADP
bam-10833	1	137	clinical	clinical	ADJ
bam-10833	1	138	pharmacy	pharmacy	NOUN
bam-10833	1	139	,	,	PUNCT
bam-10833	1	140	school	school	NOUN
bam-10833	1	141	of	of	ADP
bam-10833	1	142	pharmacy	pharmacy	NOUN
bam-10833	1	143	,	,	PUNCT
bam-10833	1	144	shahid	shahid	PROPN
bam-10833	1	145	beheshti	beheshti	VERB
bam-10833	1	146	university	university	PROPN
bam-10833	1	147	of	of	ADP
bam-10833	1	148	medical	medical	ADJ
bam-10833	1	149	sciences	sciences	PROPN
bam-10833	1	150	,	,	PUNCT
bam-10833	1	151	tehran	tehran	PROPN
bam-10833	1	152	,	,	PUNCT
bam-10833	1	153	iran	iran	PROPN
bam-10833	1	154	.	.	PUNCT
bam-10833	2	1	this	this	DET
bam-10833	2	2	article	article	NOUN
bam-10833	2	3	is	be	AUX
bam-10833	2	4	distributed	distribute	VERB
bam-10833	2	5	under	under	ADP
bam-10833	2	6	the	the	DET
bam-10833	2	7	terms	term	NOUN
bam-10833	2	8	of	of	ADP
bam-10833	2	9	the	the	DET
bam-10833	2	10	creative	creative	ADJ
bam-10833	2	11	commons	common	NOUN
bam-10833	2	12	attribution	attribution	NOUN
bam-10833	2	13	noncommercial	noncommercial	ADJ
bam-10833	2	14	license	license	NOUN
bam-10833	2	15	(	(	PUNCT
bam-10833	2	16	cc	cc	NOUN
bam-10833	2	17	by	by	ADP
bam-10833	2	18	-	-	PUNCT
bam-10833	2	19	nc	nc	PROPN
bam-10833	2	20	4.0	4.0	NUM
bam-10833	2	21	)	)	PUNCT
bam-10833	2	22	which	which	PRON
bam-10833	2	23	permits	permit	VERB
bam-10833	2	24	any	any	DET
bam-10833	2	25	noncommercial	noncommercial	ADJ
bam-10833	2	26	use	use	NOUN
bam-10833	2	27	,	,	PUNCT
bam-10833	2	28	distribution	distribution	NOUN
bam-10833	2	29	,	,	PUNCT
bam-10833	2	30	and	and	CCONJ
bam-10833	2	31	reproduction	reproduction	NOUN
bam-10833	2	32	in	in	ADP
bam-10833	2	33	any	any	DET
bam-10833	2	34	medium	medium	NOUN
bam-10833	2	35	,	,	PUNCT
bam-10833	2	36	provided	provide	VERB
bam-10833	2	37	the	the	DET
bam-10833	2	38	original	original	ADJ
bam-10833	2	39	author(s	author(s	NOUN
bam-10833	2	40	)	)	PUNCT
bam-10833	2	41	and	and	CCONJ
bam-10833	2	42	source	source	NOUN
bam-10833	2	43	are	be	AUX
bam-10833	2	44	credited	credit	VERB
bam-10833	2	45	.	.	PUNCT
bam-10833	3	1	abstract	abstract	ADV
bam-10833	3	2	we	we	PRON
bam-10833	3	3	aimed	aim	VERB
bam-10833	3	4	to	to	PART
bam-10833	3	5	maximize	maximize	VERB
bam-10833	3	6	the	the	DET
bam-10833	3	7	clinical	clinical	ADJ
bam-10833	3	8	response	response	NOUN
bam-10833	3	9	and	and	CCONJ
bam-10833	3	10	effectiveness	effectiveness	NOUN
bam-10833	3	11	of	of	ADP
bam-10833	3	12	colistin	colistin	NOUN
bam-10833	3	13	antibiotics	antibiotic	NOUN
bam-10833	3	14	in	in	ADP
bam-10833	3	15	patients	patient	NOUN
bam-10833	3	16	with	with	ADP
bam-10833	3	17	multi	multi	ADJ
bam-10833	3	18	-	-	ADJ
bam-10833	3	19	drug	drug	ADJ
bam-10833	3	20	(	(	PUNCT
bam-10833	3	21	mdr	mdr	NOUN
bam-10833	3	22	)	)	PUNCT
bam-10833	3	23	and	and	CCONJ
bam-10833	3	24	extensively	extensively	ADV
bam-10833	3	25	drug	drug	NOUN
bam-10833	3	26	-	-	PUNCT
bam-10833	3	27	resistant	resistant	ADJ
bam-10833	3	28	(	(	PUNCT
bam-10833	3	29	xdr	xdr	NOUN
bam-10833	3	30	)	)	PUNCT
bam-10833	3	31	gram	gram	PROPN
bam-10833	3	32	-	-	PUNCT
bam-10833	3	33	negative	negative	ADJ
bam-10833	3	34	bacteria	bacteria	NOUN
bam-10833	3	35	,	,	PUNCT
bam-10833	3	36	there	there	PRON
bam-10833	3	37	is	be	VERB
bam-10833	3	38	an	an	DET
bam-10833	3	39	increasing	increase	VERB
bam-10833	3	40	interest	interest	NOUN
bam-10833	3	41	in	in	ADP
bam-10833	3	42	colistin	colistin	NOUN
bam-10833	3	43	combination	combination	NOUN
bam-10833	3	44	therapy	therapy	NOUN
bam-10833	3	45	with	with	ADP
bam-10833	3	46	other	other	ADJ
bam-10833	3	47	antibiotics	antibiotic	NOUN
bam-10833	3	48	and	and	CCONJ
bam-10833	3	49	extended	extended	ADJ
bam-10833	3	50	interval	interval	NOUN
bam-10833	3	51	dosing	dose	VERB
bam-10833	3	52	regimens	regimen	NOUN
bam-10833	3	53	.	.	PUNCT
bam-10833	4	1	this	this	DET
bam-10833	4	2	systematic	systematic	ADJ
bam-10833	4	3	review	review	NOUN
bam-10833	4	4	and	and	CCONJ
bam-10833	4	5	meta	meta	ADJ
bam-10833	4	6	-	-	PUNCT
bam-10833	4	7	analysis	analysis	NOUN
bam-10833	4	8	aim	aim	NOUN
bam-10833	4	9	is	be	AUX
bam-10833	4	10	to	to	PART
bam-10833	4	11	evaluate	evaluate	VERB
bam-10833	4	12	if	if	SCONJ
bam-10833	4	13	the	the	DET
bam-10833	4	14	combination	combination	NOUN
bam-10833	4	15	therapy	therapy	NOUN
bam-10833	4	16	is	be	AUX
bam-10833	4	17	superior	superior	ADJ
bam-10833	4	18	to	to	ADP
bam-10833	4	19	monotherapy	monotherapy	NOUN
bam-10833	4	20	with	with	ADP
bam-10833	4	21	colistin	colistin	NOUN
bam-10833	4	22	regarding	regard	VERB
bam-10833	4	23	increased	increase	VERB
bam-10833	4	24	survival	survival	NOUN
bam-10833	4	25	and	and	CCONJ
bam-10833	4	26	also	also	ADV
bam-10833	4	27	which	which	DET
bam-10833	4	28	dose	dose	NOUN
bam-10833	4	29	interval	interval	NOUN
bam-10833	4	30	is	be	AUX
bam-10833	4	31	the	the	DET
bam-10833	4	32	most	most	ADV
bam-10833	4	33	effective	effective	ADJ
bam-10833	4	34	to	to	PART
bam-10833	4	35	utilize	utilize	VERB
bam-10833	4	36	.	.	PUNCT
bam-10833	5	1	english	english	ADJ
bam-10833	5	2	language	language	PROPN
bam-10833	5	3	,	,	PUNCT
bam-10833	5	4	peer	peer	NOUN
bam-10833	5	5	-	-	PUNCT
bam-10833	5	6	reviewed	review	VERB
bam-10833	5	7	journal	journal	NOUN
bam-10833	5	8	publications	publication	NOUN
bam-10833	5	9	from	from	ADP
bam-10833	5	10	the	the	DET
bam-10833	5	11	first	first	ADJ
bam-10833	5	12	date	date	NOUN
bam-10833	5	13	available	available	ADJ
bam-10833	5	14	to	to	ADP
bam-10833	5	15	25	25	NUM
bam-10833	5	16	january	january	PROPN
bam-10833	5	17	2022	2022	NUM
bam-10833	5	18	were	be	AUX
bam-10833	5	19	identified	identify	VERB
bam-10833	5	20	by	by	ADP
bam-10833	5	21	searching	search	VERB
bam-10833	5	22	the	the	DET
bam-10833	5	23	pubmed	pubmed	PROPN
bam-10833	5	24	and	and	CCONJ
bam-10833	5	25	web	web	NOUN
bam-10833	5	26	of	of	ADP
bam-10833	5	27	science	science	NOUN
bam-10833	5	28	databases	database	NOUN
bam-10833	5	29	.	.	PUNCT
bam-10833	6	1	forest	forest	NOUN
bam-10833	6	2	plots	plot	NOUN
bam-10833	6	3	for	for	ADP
bam-10833	6	4	overall	overall	ADJ
bam-10833	6	5	and	and	CCONJ
bam-10833	6	6	subgroups	subgroup	NOUN
bam-10833	6	7	and	and	CCONJ
bam-10833	6	8	funnel	funnel	NOUN
bam-10833	6	9	plots	plot	NOUN
bam-10833	6	10	were	be	AUX
bam-10833	6	11	graphed	graph	VERB
bam-10833	6	12	.	.	PUNCT
bam-10833	7	1	42	42	NUM
bam-10833	7	2	studies	study	NOUN
bam-10833	7	3	were	be	AUX
bam-10833	7	4	included	include	VERB
bam-10833	7	5	in	in	ADP
bam-10833	7	6	the	the	DET
bam-10833	7	7	study	study	NOUN
bam-10833	7	8	.	.	PUNCT
bam-10833	8	1	among	among	ADP
bam-10833	8	2	them	they	PRON
bam-10833	8	3	,	,	PUNCT
bam-10833	8	4	38	38	NUM
bam-10833	8	5	studies	study	NOUN
bam-10833	8	6	were	be	AUX
bam-10833	8	7	on	on	ADP
bam-10833	8	8	combination	combination	NOUN
bam-10833	8	9	therapy	therapy	NOUN
bam-10833	8	10	,	,	PUNCT
bam-10833	8	11	and	and	CCONJ
bam-10833	8	12	four	four	NUM
bam-10833	8	13	on	on	ADP
bam-10833	8	14	dose	dose	NOUN
bam-10833	8	15	interval	interval	NOUN
bam-10833	8	16	.	.	PUNCT
bam-10833	9	1	the	the	DET
bam-10833	9	2	overall	overall	ADJ
bam-10833	9	3	pooled	pool	VERB
bam-10833	9	4	odds	odd	NOUN
bam-10833	9	5	ratio	ratio	NOUN
bam-10833	9	6	is	be	AUX
bam-10833	9	7	0.77	0.77	NUM
bam-10833	9	8	(	(	PUNCT
bam-10833	9	9	ci	ci	NOUN
bam-10833	9	10	:	:	PUNCT
bam-10833	9	11	0.62	0.62	NUM
bam-10833	9	12	;	;	PUNCT
bam-10833	9	13	0.95	0.95	NUM
bam-10833	9	14	)	)	PUNCT
bam-10833	9	15	(	(	PUNCT
bam-10833	9	16	p	p	NOUN
bam-10833	9	17	value	value	NOUN
bam-10833	9	18	<	<	X
bam-10833	9	19	0.017	0.017	NUM
bam-10833	9	20	)	)	PUNCT
bam-10833	9	21	.	.	PUNCT
bam-10833	10	1	the	the	DET
bam-10833	10	2	i^2	i^2	PROPN
bam-10833	10	3	value	value	NOUN
bam-10833	10	4	was	be	AUX
bam-10833	10	5	43	43	NUM
bam-10833	10	6	%	%	NOUN
bam-10833	10	7	(	(	PUNCT
bam-10833	10	8	p	p	NOUN
bam-10833	10	9	value	value	NOUN
bam-10833	10	10	<	<	X
bam-10833	10	11	0.01	0.01	NUM
bam-10833	10	12	)	)	PUNCT
bam-10833	10	13	.	.	PUNCT
bam-10833	11	1	the	the	DET
bam-10833	11	2	begg	begg	PROPN
bam-10833	11	3	correlation	correlation	NOUN
bam-10833	11	4	test	test	NOUN
bam-10833	11	5	of	of	ADP
bam-10833	11	6	funnel	funnel	NOUN
bam-10833	11	7	plot	plot	NOUN
bam-10833	11	8	asymmetry	asymmetry	NOUN
bam-10833	11	9	showed	show	VERB
bam-10833	11	10	no	no	DET
bam-10833	11	11	significant	significant	ADJ
bam-10833	11	12	publication	publication	NOUN
bam-10833	11	13	bias	bias	NOUN
bam-10833	11	14	(	(	PUNCT
bam-10833	11	15	0.064	0.064	NUM
bam-10833	11	16	)	)	PUNCT
bam-10833	11	17	.	.	PUNCT
bam-10833	12	1	the	the	DET
bam-10833	12	2	overall	overall	ADJ
bam-10833	12	3	pooled	pool	VERB
bam-10833	12	4	odds	odd	NOUN
bam-10833	12	5	ratio	ratio	NOUN
bam-10833	12	6	for	for	ADP
bam-10833	12	7	carbapenem	carbapenem	PROPN
bam-10833	12	8	is	be	AUX
bam-10833	12	9	0.74	0.74	NUM
bam-10833	12	10	(	(	PUNCT
bam-10833	12	11	ci	ci	NOUN
bam-10833	12	12	:	:	PUNCT
bam-10833	12	13	0.48	0.48	NUM
bam-10833	12	14	;	;	PUNCT
bam-10833	12	15	1.13	1.13	NUM
bam-10833	12	16	)	)	PUNCT
bam-10833	12	17	.	.	PUNCT
bam-10833	13	1	a	a	DET
bam-10833	13	2	prospective	prospective	ADJ
bam-10833	13	3	randomized	randomized	ADJ
bam-10833	13	4	controlled	control	VERB
bam-10833	13	5	trials	trial	NOUN
bam-10833	13	6	(	(	PUNCT
bam-10833	13	7	rct	rct	PROPN
bam-10833	13	8	)	)	PUNCT
bam-10833	13	9	on	on	ADP
bam-10833	13	10	40	40	NUM
bam-10833	13	11	adults	adult	NOUN
bam-10833	13	12	intensive	intensive	ADJ
bam-10833	13	13	care	care	NOUN
bam-10833	13	14	unit	unit	NOUN
bam-10833	13	15	(	(	PUNCT
bam-10833	13	16	icu	icu	PROPN
bam-10833	13	17	)	)	PUNCT
bam-10833	13	18	patients	patient	NOUN
bam-10833	13	19	with	with	ADP
bam-10833	13	20	ventilatorassociated	ventilatorassociate	VERB
bam-10833	13	21	pneumonia	pneumonia	NOUN
bam-10833	13	22	(	(	PUNCT
bam-10833	13	23	vap	vap	NOUN
bam-10833	13	24	)	)	PUNCT
bam-10833	13	25	,	,	PUNCT
bam-10833	13	26	comparing	compare	VERB
bam-10833	13	27	the	the	DET
bam-10833	13	28	mortality	mortality	NOUN
bam-10833	13	29	and	and	CCONJ
bam-10833	13	30	icu	icu	PROPN
bam-10833	13	31	length	length	NOUN
bam-10833	13	32	of	of	ADP
bam-10833	13	33	stay	stay	NOUN
bam-10833	13	34	of	of	ADP
bam-10833	13	35	8or	8or	NOUN
bam-10833	13	36	24hour	24hour	NUM
bam-10833	13	37	intervals	interval	NOUN
bam-10833	13	38	regimens	regimen	NOUN
bam-10833	13	39	,	,	PUNCT
bam-10833	13	40	showed	show	VERB
bam-10833	13	41	that	that	SCONJ
bam-10833	13	42	the	the	DET
bam-10833	13	43	icu	icu	PROPN
bam-10833	13	44	length	length	NOUN
bam-10833	13	45	of	of	ADP
bam-10833	13	46	stay	stay	NOUN
bam-10833	13	47	and	and	CCONJ
bam-10833	13	48	icu	icu	PROPN
bam-10833	13	49	mortality	mortality	NOUN
bam-10833	13	50	were	be	AUX
bam-10833	13	51	;	;	PUNCT
bam-10833	13	52	31.31	31.31	NUM
bam-10833	13	53	,	,	PUNCT
bam-10833	13	54	35.3	35.3	NUM
bam-10833	13	55	days	day	NOUN
bam-10833	13	56	,	,	PUNCT
bam-10833	13	57	and	and	CCONJ
bam-10833	13	58	32.06	32.06	NUM
bam-10833	13	59	,	,	PUNCT
bam-10833	13	60	22.2	22.2	NUM
bam-10833	13	61	%	%	NOUN
bam-10833	13	62	in	in	ADP
bam-10833	13	63	groups	group	NOUN
bam-10833	13	64	24	24	NUM
bam-10833	13	65	-	-	PUNCT
bam-10833	13	66	h	h	NOUN
bam-10833	13	67	interval	interval	NOUN
bam-10833	13	68	and	and	CCONJ
bam-10833	13	69	8hour	8hour	NUM
bam-10833	13	70	interval	interval	NOUN
bam-10833	13	71	(	(	PUNCT
bam-10833	13	72	p	p	NOUN
bam-10833	13	73	value	value	NOUN
bam-10833	13	74	:	:	PUNCT
bam-10833	13	75	0.39	0.39	NUM
bam-10833	13	76	,	,	PUNCT
bam-10833	13	77	0.87	0.87	NUM
bam-10833	13	78	)	)	PUNCT
bam-10833	13	79	,	,	PUNCT
bam-10833	13	80	respectively	respectively	ADV
bam-10833	13	81	.	.	PUNCT
bam-10833	14	1	it	it	PRON
bam-10833	14	2	seems	seem	VERB
bam-10833	14	3	that	that	SCONJ
bam-10833	14	4	combination	combination	NOUN
bam-10833	14	5	therapy	therapy	NOUN
bam-10833	14	6	is	be	AUX
bam-10833	14	7	associated	associate	VERB
bam-10833	14	8	with	with	ADP
bam-10833	14	9	drug	drug	NOUN
bam-10833	14	10	synergism	synergism	NOUN
bam-10833	14	11	and	and	CCONJ
bam-10833	14	12	increased	increase	VERB
bam-10833	14	13	survival	survival	NOUN
bam-10833	14	14	.	.	PUNCT
bam-10833	15	1	the	the	DET
bam-10833	15	2	extended	extended	ADJ
bam-10833	15	3	interval	interval	NOUN
bam-10833	15	4	colistin	colistin	PROPN
bam-10833	15	5	administration	administration	PROPN
bam-10833	15	6	may	may	AUX
bam-10833	15	7	result	result	VERB
bam-10833	15	8	in	in	ADP
bam-10833	15	9	higher	high	ADJ
bam-10833	15	10	peak	peak	NOUN
bam-10833	15	11	concentration	concentration	NOUN
bam-10833	15	12	and	and	CCONJ
bam-10833	15	13	bacterial	bacterial	ADJ
bam-10833	15	14	eradication	eradication	NOUN
bam-10833	15	15	.	.	PUNCT
bam-10833	16	1	in	in	ADP
bam-10833	16	2	both	both	DET
bam-10833	16	3	cases	case	NOUN
bam-10833	16	4	,	,	PUNCT
bam-10833	16	5	we	we	PRON
bam-10833	16	6	face	face	VERB
bam-10833	16	7	a	a	DET
bam-10833	16	8	dearth	dearth	NOUN
bam-10833	16	9	of	of	ADP
bam-10833	16	10	literature	literature	NOUN
bam-10833	16	11	.	.	PUNCT
bam-10833	17	1	key	key	ADJ
bam-10833	17	2	words	word	NOUN
bam-10833	17	3	:	:	PUNCT
bam-10833	17	4	colistin	colistin	NOUN
bam-10833	17	5	;	;	PUNCT
bam-10833	17	6	carbapenem	carbapenem	PROPN
bam-10833	17	7	;	;	PUNCT
bam-10833	17	8	combination	combination	NOUN
bam-10833	17	9	therapy	therapy	NOUN
bam-10833	17	10	;	;	PUNCT
bam-10833	17	11	dosing	dose	VERB
bam-10833	17	12	interval	interval	NOUN
bam-10833	17	13	.	.	PUNCT
bam-10833	18	1	eur	eur	PROPN
bam-10833	18	2	j	j	PROPN
bam-10833	18	3	transl	transl	PROPN
bam-10833	18	4	myol	myol	ADV
bam-10833	18	5	32	32	NUM
bam-10833	18	6	(	(	PUNCT
bam-10833	18	7	4	4	NUM
bam-10833	18	8	):	):	PUNCT
bam-10833	18	9	10833	10833	NUM
bam-10833	18	10	,	,	PUNCT
bam-10833	18	11	2022	2022	NUM
bam-10833	18	12	doi	doi	NOUN
bam-10833	18	13	:	:	PUNCT
bam-10833	18	14	10.4081	10.4081	NUM
bam-10833	18	15	/	/	SYM
bam-10833	18	16	ejtm.2022.10833	ejtm.2022.10833	NOUN
bam-10833	18	17	colistin	colistin	NOUN
bam-10833	18	18	(	(	PUNCT
bam-10833	18	19	polymyxin	polymyxin	PROPN
bam-10833	18	20	e	e	NOUN
bam-10833	18	21	)	)	PUNCT
bam-10833	18	22	is	be	AUX
bam-10833	18	23	recognized	recognize	VERB
bam-10833	18	24	as	as	ADP
bam-10833	18	25	the	the	DET
bam-10833	18	26	last	last	ADJ
bam-10833	18	27	line	line	NOUN
bam-10833	18	28	treatment	treatment	NOUN
bam-10833	18	29	for	for	ADP
bam-10833	18	30	emerging	emerge	VERB
bam-10833	18	31	infections	infection	NOUN
bam-10833	18	32	due	due	ADJ
bam-10833	18	33	to	to	ADP
bam-10833	18	34	multi	multi	ADJ
bam-10833	18	35	-	-	ADJ
bam-10833	18	36	drug	drug	ADJ
bam-10833	18	37	(	(	PUNCT
bam-10833	18	38	mdr	mdr	NOUN
bam-10833	18	39	)	)	PUNCT
bam-10833	18	40	and	and	CCONJ
bam-10833	18	41	extensively	extensively	ADV
bam-10833	18	42	drug	drug	NOUN
bam-10833	18	43	-	-	PUNCT
bam-10833	18	44	resistant	resistant	ADJ
bam-10833	18	45	(	(	PUNCT
bam-10833	18	46	xdr	xdr	NOUN
bam-10833	18	47	)	)	PUNCT
bam-10833	18	48	gramnegative	gramnegative	NOUN
bam-10833	18	49	bacteria.1	bacteria.1	VERB
bam-10833	18	50	the	the	DET
bam-10833	18	51	use	use	NOUN
bam-10833	18	52	of	of	ADP
bam-10833	18	53	colistin	colistin	NOUN
bam-10833	18	54	was	be	AUX
bam-10833	18	55	limited	limit	VERB
bam-10833	18	56	in	in	ADP
bam-10833	18	57	the	the	DET
bam-10833	18	58	late	late	ADJ
bam-10833	18	59	1980s	1980	NOUN
bam-10833	18	60	due	due	ADP
bam-10833	18	61	to	to	ADP
bam-10833	18	62	its	its	PRON
bam-10833	18	63	nephrotoxicity	nephrotoxicity	NOUN
bam-10833	18	64	and	and	CCONJ
bam-10833	18	65	neurotoxicity	neurotoxicity	NOUN
bam-10833	18	66	.	.	PUNCT
bam-10833	19	1	however	however	ADV
bam-10833	19	2	,	,	PUNCT
bam-10833	19	3	colistin	colistin	PROPN
bam-10833	19	4	has	have	AUX
bam-10833	19	5	increasingly	increasingly	ADV
bam-10833	19	6	been	be	AUX
bam-10833	19	7	used	use	VERB
bam-10833	19	8	as	as	ADP
bam-10833	19	9	salvage	salvage	NOUN
bam-10833	19	10	therapy	therapy	NOUN
bam-10833	19	11	in	in	ADP
bam-10833	19	12	recent	recent	ADJ
bam-10833	19	13	years	year	NOUN
bam-10833	19	14	to	to	PART
bam-10833	19	15	treat	treat	VERB
bam-10833	19	16	severe	severe	ADJ
bam-10833	19	17	infections	infection	NOUN
bam-10833	19	18	in	in	ADP
bam-10833	19	19	critically	critically	ADV
bam-10833	19	20	ill	ill	ADJ
bam-10833	19	21	patients	patient	NOUN
bam-10833	19	22	.	.	PUNCT
bam-10833	20	1	the	the	DET
bam-10833	20	2	limited	limited	ADJ
bam-10833	20	3	use	use	NOUN
bam-10833	20	4	of	of	ADP
bam-10833	20	5	colistin	colistin	NOUN
bam-10833	20	6	as	as	ADP
bam-10833	20	7	the	the	DET
bam-10833	20	8	last	last	ADJ
bam-10833	20	9	line	line	NOUN
bam-10833	20	10	treatment	treatment	NOUN
bam-10833	20	11	is	be	AUX
bam-10833	20	12	the	the	DET
bam-10833	20	13	reason	reason	NOUN
bam-10833	20	14	for	for	ADP
bam-10833	20	15	its	its	PRON
bam-10833	20	16	retained	retain	VERB
bam-10833	20	17	antibacterial	antibacterial	ADJ
bam-10833	20	18	effect	effect	NOUN
bam-10833	20	19	against	against	ADP
bam-10833	20	20	mdr	mdr	PROPN
bam-10833	20	21	/	/	SYM
bam-10833	20	22	xdr	xdr	PROPN
bam-10833	20	23	gram	gram	PROPN
bam-10833	20	24	-	-	PUNCT
bam-10833	20	25	negative	negative	NOUN
bam-10833	20	26	bacilli.2	bacilli.2	PROPN
bam-10833	20	27	colistin	colistin	NOUN
bam-10833	20	28	is	be	AUX
bam-10833	20	29	a	a	DET
bam-10833	20	30	multicomponent	multicomponent	NOUN
bam-10833	20	31	polypeptide	polypeptide	ADJ
bam-10833	20	32	antibiotic	antibiotic	NOUN
bam-10833	20	33	,	,	PUNCT
bam-10833	20	34	which	which	PRON
bam-10833	20	35	is	be	AUX
bam-10833	20	36	composed	compose	VERB
bam-10833	20	37	mainly	mainly	ADV
bam-10833	20	38	of	of	ADP
bam-10833	20	39	colistin	colistin	NOUN
bam-10833	20	40	a	a	PRON
bam-10833	20	41	and	and	CCONJ
bam-10833	20	42	colistin	colistin	PROPN
bam-10833	20	43	b.2	b.2	PUNCT
bam-10833	20	44	colistin	colistin	PROPN
bam-10833	20	45	exerts	exert	VERB
bam-10833	20	46	its	its	PRON
bam-10833	20	47	effect	effect	NOUN
bam-10833	20	48	by	by	ADP
bam-10833	20	49	targeting	target	VERB
bam-10833	20	50	the	the	DET
bam-10833	20	51	outer	outer	ADJ
bam-10833	20	52	membrane	membrane	NOUN
bam-10833	20	53	of	of	ADP
bam-10833	20	54	gram	gram	NOUN
bam-10833	20	55	-	-	PUNCT
bam-10833	20	56	negative	negative	ADJ
bam-10833	20	57	bacteria.1	bacteria.1	NOUN
bam-10833	20	58	colistin	colistin	NOUN
bam-10833	20	59	is	be	AUX
bam-10833	20	60	administered	administer	VERB
bam-10833	20	61	in	in	ADP
bam-10833	20	62	the	the	DET
bam-10833	20	63	form	form	NOUN
bam-10833	20	64	of	of	ADP
bam-10833	20	65	an	an	DET
bam-10833	20	66	inactive	inactive	ADJ
bam-10833	20	67	pro	pro	ADJ
bam-10833	20	68	-	-	ADJ
bam-10833	20	69	drug	drug	ADJ
bam-10833	20	70	,	,	PUNCT
bam-10833	20	71	called	call	VERB
bam-10833	20	72	colistimethate	colistimethate	NOUN
bam-10833	20	73	sodium	sodium	NOUN
bam-10833	20	74	(	(	PUNCT
bam-10833	20	75	cms	cms	PROPN
bam-10833	20	76	)	)	PUNCT
bam-10833	20	77	which	which	PRON
bam-10833	20	78	presents	present	VERB
bam-10833	20	79	different	different	ADJ
bam-10833	20	80	pharmacokinetic	pharmacokinetic	ADJ
bam-10833	20	81	properties	property	NOUN
bam-10833	20	82	from	from	ADP
bam-10833	20	83	the	the	DET
bam-10833	20	84	active	active	ADJ
bam-10833	20	85	drug.3	drug.3	PROPN
bam-10833	20	86	to	to	PART
bam-10833	20	87	maximize	maximize	VERB
bam-10833	20	88	the	the	DET
bam-10833	20	89	clinical	clinical	ADJ
bam-10833	20	90	response	response	NOUN
bam-10833	20	91	and	and	CCONJ
bam-10833	20	92	effectiveness	effectiveness	NOUN
bam-10833	20	93	,	,	PUNCT
bam-10833	20	94	there	there	PRON
bam-10833	20	95	is	be	VERB
bam-10833	20	96	an	an	DET
bam-10833	20	97	increasing	increase	VERB
bam-10833	20	98	interest	interest	NOUN
bam-10833	20	99	in	in	ADP
bam-10833	20	100	colistin	colistin	NOUN
bam-10833	20	101	combination	combination	NOUN
bam-10833	20	102	therapy	therapy	NOUN
bam-10833	20	103	with	with	ADP
bam-10833	20	104	other	other	ADJ
bam-10833	20	105	antibiotics	antibiotic	NOUN
bam-10833	20	106	.	.	PUNCT
bam-10833	21	1	however	however	ADV
bam-10833	21	2	,	,	PUNCT
bam-10833	21	3	there	there	PRON
bam-10833	21	4	is	be	VERB
bam-10833	21	5	an	an	DET
bam-10833	21	6	existent	existent	ADJ
bam-10833	21	7	controversy	controversy	NOUN
bam-10833	21	8	in	in	ADP
bam-10833	21	9	this	this	DET
bam-10833	21	10	regard	regard	NOUN
bam-10833	21	11	,	,	PUNCT
bam-10833	21	12	and	and	CCONJ
bam-10833	21	13	there	there	PRON
bam-10833	21	14	are	be	VERB
bam-10833	21	15	concerns	concern	NOUN
bam-10833	21	16	about	about	ADP
bam-10833	21	17	the	the	DET
bam-10833	21	18	issue	issue	NOUN
bam-10833	21	19	of	of	ADP
bam-10833	21	20	increased	increase	VERB
bam-10833	21	21	nephrotoxicity	nephrotoxicity	NOUN
bam-10833	21	22	.	.	PUNCT
bam-10833	22	1	on	on	ADP
bam-10833	22	2	the	the	DET
bam-10833	22	3	other	other	ADJ
bam-10833	22	4	hand	hand	NOUN
bam-10833	22	5	,	,	PUNCT
bam-10833	22	6	in	in	ADP
bam-10833	22	7	case	case	NOUN
bam-10833	22	8	of	of	ADP
bam-10833	22	9	severe	severe	ADJ
bam-10833	22	10	infection	infection	NOUN
bam-10833	22	11	with	with	ADP
bam-10833	22	12	mdr	mdr	PROPN
bam-10833	22	13	and	and	CCONJ
bam-10833	22	14	xdr	xdr	PROPN
bam-10833	22	15	gram	gram	PROPN
bam-10833	22	16	-	-	PUNCT
bam-10833	22	17	negative	negative	ADJ
bam-10833	22	18	bacteria	bacteria	NOUN
bam-10833	22	19	in	in	ADP
bam-10833	22	20	clinically	clinically	ADV
bam-10833	22	21	very	very	ADV
bam-10833	22	22	ill	ill	ADJ
bam-10833	22	23	patients	patient	NOUN
bam-10833	22	24	,	,	PUNCT
bam-10833	22	25	some	some	DET
bam-10833	22	26	clinicians	clinician	NOUN
bam-10833	22	27	prefer	prefer	VERB
bam-10833	22	28	combination	combination	NOUN
bam-10833	22	29	therapy	therapy	NOUN
bam-10833	22	30	.	.	PUNCT
bam-10833	23	1	moreover	moreover	ADV
bam-10833	23	2	,	,	PUNCT
bam-10833	23	3	combination	combination	NOUN
bam-10833	23	4	therapy	therapy	NOUN
bam-10833	23	5	may	may	AUX
bam-10833	23	6	be	be	AUX
bam-10833	23	7	more	more	ADV
bam-10833	23	8	efficient	efficient	ADJ
bam-10833	23	9	in	in	ADP
bam-10833	23	10	case	case	NOUN
bam-10833	23	11	of	of	ADP
bam-10833	23	12	infection	infection	NOUN
bam-10833	23	13	with	with	ADP
bam-10833	23	14	hetero	hetero	NOUN
bam-10833	23	15	-	-	PUNCT
bam-10833	23	16	resistance	resistance	NOUN
bam-10833	23	17	gramintravenous	gramintravenous	ADJ
bam-10833	23	18	colistin	colistin	NOUN
bam-10833	23	19	monotherapy	monotherapy	NOUN
bam-10833	23	20	versus	versus	ADP
bam-10833	23	21	combination	combination	NOUN
bam-10833	23	22	therapy	therapy	NOUN
bam-10833	23	23	eur	eur	PROPN
bam-10833	23	24	j	j	PROPN
bam-10833	23	25	transl	transl	PROPN
bam-10833	23	26	myol	myol	ADV
bam-10833	23	27	32	32	NUM
bam-10833	23	28	(	(	PUNCT
bam-10833	23	29	4	4	NUM
bam-10833	23	30	):	):	PUNCT
bam-10833	23	31	10833	10833	NUM
bam-10833	23	32	,	,	PUNCT
bam-10833	23	33	2022	2022	NUM
bam-10833	23	34	doi	doi	NOUN
bam-10833	23	35	:	:	PUNCT
bam-10833	23	36	10.4081	10.4081	NUM
bam-10833	23	37	/	/	SYM
bam-10833	23	38	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	23	39	2	2	NUM
bam-10833	23	40	negative	negative	ADJ
bam-10833	23	41	bacteria.4	bacteria.4	NOUN
bam-10833	23	42	the	the	DET
bam-10833	23	43	type	type	NOUN
bam-10833	23	44	of	of	ADP
bam-10833	23	45	antibiotic	antibiotic	NOUN
bam-10833	23	46	that	that	PRON
bam-10833	23	47	can	can	AUX
bam-10833	23	48	be	be	AUX
bam-10833	23	49	used	use	VERB
bam-10833	23	50	in	in	ADP
bam-10833	23	51	combination	combination	NOUN
bam-10833	23	52	with	with	ADP
bam-10833	23	53	colistin	colistin	NOUN
bam-10833	23	54	is	be	AUX
bam-10833	23	55	also	also	ADV
bam-10833	23	56	of	of	ADP
bam-10833	23	57	interest	interest	NOUN
bam-10833	23	58	to	to	ADP
bam-10833	23	59	the	the	DET
bam-10833	23	60	medical	medical	ADJ
bam-10833	23	61	community	community	NOUN
bam-10833	23	62	.	.	PUNCT
bam-10833	24	1	another	another	DET
bam-10833	24	2	existent	existent	ADJ
bam-10833	24	3	controversy	controversy	NOUN
bam-10833	24	4	is	be	AUX
bam-10833	24	5	regarding	regard	VERB
bam-10833	24	6	the	the	DET
bam-10833	24	7	dosing	dosing	ADJ
bam-10833	24	8	interval	interval	NOUN
bam-10833	24	9	of	of	ADP
bam-10833	24	10	the	the	DET
bam-10833	24	11	colistin	colistin	PROPN
bam-10833	24	12	administration	administration	PROPN
bam-10833	24	13	and	and	CCONJ
bam-10833	24	14	the	the	DET
bam-10833	24	15	optimal	optimal	ADJ
bam-10833	24	16	dosing	dosing	ADJ
bam-10833	24	17	interval	interval	NOUN
bam-10833	24	18	that	that	PRON
bam-10833	24	19	maximizes	maximize	VERB
bam-10833	24	20	antibacterial	antibacterial	ADJ
bam-10833	24	21	activity	activity	NOUN
bam-10833	24	22	and	and	CCONJ
bam-10833	24	23	minimizes	minimize	VERB
bam-10833	24	24	the	the	DET
bam-10833	24	25	fig	fig	NOUN
bam-10833	24	26	1	1	NUM
bam-10833	24	27	.	.	PUNCT
bam-10833	24	28	flow	flow	NOUN
bam-10833	24	29	diagram	diagram	NOUN
bam-10833	24	30	of	of	ADP
bam-10833	24	31	selection	selection	NOUN
bam-10833	24	32	process	process	NOUN
bam-10833	24	33	.	.	PUNCT
bam-10833	25	1	intravenous	intravenous	ADJ
bam-10833	25	2	colistin	colistin	PROPN
bam-10833	25	3	monotherapy	monotherapy	NOUN
bam-10833	25	4	versus	versus	ADP
bam-10833	25	5	combination	combination	NOUN
bam-10833	25	6	therapy	therapy	NOUN
bam-10833	25	7	eur	eur	PROPN
bam-10833	25	8	j	j	PROPN
bam-10833	25	9	transl	transl	PROPN
bam-10833	25	10	myol	myol	ADV
bam-10833	25	11	32	32	NUM
bam-10833	25	12	(	(	PUNCT
bam-10833	25	13	4	4	NUM
bam-10833	25	14	):	):	PUNCT
bam-10833	25	15	10833	10833	NUM
bam-10833	25	16	,	,	PUNCT
bam-10833	25	17	2022	2022	NUM
bam-10833	25	18	doi	doi	NOUN
bam-10833	25	19	:	:	PUNCT
bam-10833	25	20	10.4081	10.4081	NUM
bam-10833	25	21	/	/	SYM
bam-10833	25	22	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	25	23	3	3	NUM
bam-10833	25	24	nephrotoxicity	nephrotoxicity	NOUN
bam-10833	25	25	and	and	CCONJ
bam-10833	25	26	emergence	emergence	NOUN
bam-10833	25	27	of	of	ADP
bam-10833	25	28	resistance	resistance	NOUN
bam-10833	25	29	.	.	PUNCT
bam-10833	26	1	at	at	ADP
bam-10833	26	2	present	present	ADJ
bam-10833	26	3	,	,	PUNCT
bam-10833	26	4	8-	8-	X
bam-10833	26	5	,	,	PUNCT
bam-10833	26	6	12-	12-	ADV
bam-10833	26	7	,	,	PUNCT
bam-10833	26	8	and	and	CCONJ
bam-10833	26	9	24	24	NUM
bam-10833	26	10	-	-	PUNCT
bam-10833	26	11	hourly	hourly	ADV
bam-10833	26	12	dosing	dose	VERB
bam-10833	26	13	intervals	interval	NOUN
bam-10833	26	14	of	of	ADP
bam-10833	26	15	colistin	colistin	PROPN
bam-10833	26	16	are	be	AUX
bam-10833	26	17	used	use	VERB
bam-10833	26	18	in	in	ADP
bam-10833	26	19	patients	patient	NOUN
bam-10833	26	20	without	without	ADP
bam-10833	26	21	renal	renal	ADJ
bam-10833	26	22	dysfunction.5	dysfunction.5	ADP
bam-10833	26	23	this	this	DET
bam-10833	26	24	systematic	systematic	ADJ
bam-10833	26	25	review	review	NOUN
bam-10833	26	26	and	and	CCONJ
bam-10833	26	27	meta	meta	ADJ
bam-10833	26	28	-	-	PUNCT
bam-10833	26	29	analysis	analysis	NOUN
bam-10833	26	30	aim	aim	NOUN
bam-10833	26	31	to	to	PART
bam-10833	26	32	evaluate	evaluate	VERB
bam-10833	26	33	if	if	SCONJ
bam-10833	26	34	the	the	DET
bam-10833	26	35	combination	combination	NOUN
bam-10833	26	36	therapy	therapy	NOUN
bam-10833	26	37	is	be	AUX
bam-10833	26	38	superior	superior	ADJ
bam-10833	26	39	to	to	ADP
bam-10833	26	40	monotherapy	monotherapy	NOUN
bam-10833	26	41	with	with	ADP
bam-10833	26	42	colistin	colistin	NOUN
bam-10833	26	43	regarding	regard	VERB
bam-10833	26	44	increased	increase	VERB
bam-10833	26	45	survival	survival	NOUN
bam-10833	26	46	and	and	CCONJ
bam-10833	26	47	also	also	ADV
bam-10833	26	48	which	which	DET
bam-10833	26	49	dose	dose	NOUN
bam-10833	26	50	interval	interval	NOUN
bam-10833	26	51	is	be	AUX
bam-10833	26	52	the	the	DET
bam-10833	26	53	safest	safe	ADJ
bam-10833	26	54	and	and	CCONJ
bam-10833	26	55	most	most	ADV
bam-10833	26	56	effective	effective	ADJ
bam-10833	26	57	.	.	PUNCT
bam-10833	27	1	materials	material	NOUN
bam-10833	27	2	and	and	CCONJ
bam-10833	27	3	methods	method	NOUN
bam-10833	27	4	we	we	PRON
bam-10833	27	5	conducted	conduct	VERB
bam-10833	27	6	a	a	DET
bam-10833	27	7	systematic	systematic	ADJ
bam-10833	27	8	review	review	NOUN
bam-10833	27	9	of	of	ADP
bam-10833	27	10	the	the	DET
bam-10833	27	11	evidence	evidence	NOUN
bam-10833	27	12	for	for	ADP
bam-10833	27	13	the	the	DET
bam-10833	27	14	effect	effect	NOUN
bam-10833	27	15	of	of	ADP
bam-10833	27	16	combination	combination	NOUN
bam-10833	27	17	therapy	therapy	NOUN
bam-10833	27	18	compared	compare	VERB
bam-10833	27	19	to	to	ADP
bam-10833	27	20	monotherapy	monotherapy	NOUN
bam-10833	27	21	of	of	ADP
bam-10833	27	22	colistin	colistin	NOUN
bam-10833	27	23	and	and	CCONJ
bam-10833	27	24	also	also	ADV
bam-10833	27	25	the	the	DET
bam-10833	27	26	most	most	ADV
bam-10833	27	27	efficient	efficient	ADJ
bam-10833	27	28	dosing	dosing	NOUN
bam-10833	27	29	interval	interval	NOUN
bam-10833	27	30	for	for	ADP
bam-10833	27	31	the	the	DET
bam-10833	27	32	colistin	colistin	PROPN
bam-10833	27	33	administration	administration	PROPN
bam-10833	27	34	.	.	PUNCT
bam-10833	28	1	english	english	PROPN
bam-10833	28	2	language	language	PROPN
bam-10833	28	3	,	,	PUNCT
bam-10833	28	4	peer	peer	NOUN
bam-10833	28	5	-	-	PUNCT
bam-10833	28	6	reviewed	review	VERB
bam-10833	28	7	journal	journal	NOUN
bam-10833	28	8	publications	publication	NOUN
bam-10833	28	9	from	from	ADP
bam-10833	28	10	the	the	DET
bam-10833	28	11	first	first	ADJ
bam-10833	28	12	date	date	NOUN
bam-10833	28	13	available	available	ADJ
bam-10833	28	14	to	to	ADP
bam-10833	28	15	25	25	NUM
bam-10833	28	16	january	january	PROPN
bam-10833	28	17	2022	2022	NUM
bam-10833	28	18	were	be	AUX
bam-10833	28	19	identified	identify	VERB
bam-10833	28	20	by	by	ADP
bam-10833	28	21	searching	search	VERB
bam-10833	28	22	the	the	DET
bam-10833	28	23	pubmed	pubmed	PROPN
bam-10833	28	24	and	and	CCONJ
bam-10833	28	25	web	web	NOUN
bam-10833	28	26	of	of	ADP
bam-10833	28	27	science	science	NOUN
bam-10833	28	28	databases.1	databases.1	PROPN
bam-10833	28	29	-	-	PUNCT
bam-10833	28	30	50	50	NUM
bam-10833	28	31	the	the	DET
bam-10833	28	32	various	various	ADJ
bam-10833	28	33	combinations	combination	NOUN
bam-10833	28	34	of	of	ADP
bam-10833	28	35	the	the	DET
bam-10833	28	36	following	follow	VERB
bam-10833	28	37	search	search	NOUN
bam-10833	28	38	terms	term	NOUN
bam-10833	28	39	were	be	AUX
bam-10833	28	40	used	use	VERB
bam-10833	28	41	:	:	PUNCT
bam-10833	28	42	polymyxin	polymyxin	ADJ
bam-10833	28	43	,	,	PUNCT
bam-10833	28	44	colistin	colistin	NOUN
bam-10833	28	45	,	,	PUNCT
bam-10833	28	46	colistimethate	colistimethate	NOUN
bam-10833	28	47	sodium	sodium	NOUN
bam-10833	28	48	,	,	PUNCT
bam-10833	28	49	combination	combination	NOUN
bam-10833	28	50	,	,	PUNCT
bam-10833	28	51	monotherapy	monotherapy	NOUN
bam-10833	28	52	,	,	PUNCT
bam-10833	28	53	synergism	synergism	NOUN
bam-10833	28	54	,	,	PUNCT
bam-10833	28	55	dosing	dosing	NOUN
bam-10833	28	56	interval	interval	NOUN
bam-10833	28	57	,	,	PUNCT
bam-10833	28	58	frequency	frequency	NOUN
bam-10833	28	59	.	.	PUNCT
bam-10833	29	1	after	after	ADP
bam-10833	29	2	removing	remove	VERB
bam-10833	29	3	duplicates	duplicate	NOUN
bam-10833	29	4	,	,	PUNCT
bam-10833	29	5	the	the	DET
bam-10833	29	6	retrieved	retrieve	VERB
bam-10833	29	7	records	record	NOUN
bam-10833	29	8	were	be	AUX
bam-10833	29	9	screened	screen	VERB
bam-10833	29	10	for	for	ADP
bam-10833	29	11	title	title	NOUN
bam-10833	29	12	and	and	CCONJ
bam-10833	29	13	abstract	abstract	ADJ
bam-10833	29	14	.	.	PUNCT
bam-10833	30	1	the	the	DET
bam-10833	30	2	eligible	eligible	ADJ
bam-10833	30	3	studies	study	NOUN
bam-10833	30	4	were	be	AUX
bam-10833	30	5	selected	select	VERB
bam-10833	30	6	for	for	ADP
bam-10833	30	7	fulltext	fulltext	NOUN
bam-10833	30	8	review	review	NOUN
bam-10833	30	9	and	and	CCONJ
bam-10833	30	10	screening	screen	VERB
bam-10833	30	11	.	.	PUNCT
bam-10833	31	1	the	the	DET
bam-10833	31	2	data	datum	NOUN
bam-10833	31	3	of	of	ADP
bam-10833	31	4	interest	interest	NOUN
bam-10833	31	5	were	be	AUX
bam-10833	31	6	extracted	extract	VERB
bam-10833	31	7	from	from	ADP
bam-10833	31	8	the	the	DET
bam-10833	31	9	studies	study	NOUN
bam-10833	31	10	which	which	PRON
bam-10833	31	11	did	do	AUX
bam-10833	31	12	not	not	PART
bam-10833	31	13	meet	meet	VERB
bam-10833	31	14	any	any	DET
bam-10833	31	15	exclusion	exclusion	NOUN
bam-10833	31	16	criteria	criterion	NOUN
bam-10833	31	17	.	.	PUNCT
bam-10833	32	1	the	the	DET
bam-10833	32	2	targeted	target	VERB
bam-10833	32	3	outcomes	outcome	NOUN
bam-10833	32	4	were	be	AUX
bam-10833	32	5	:	:	PUNCT
bam-10833	32	6	i	i	X
bam-10833	32	7	)	)	PUNCT
bam-10833	32	8	the	the	DET
bam-10833	32	9	pooled	pool	VERB
bam-10833	32	10	odds	odd	NOUN
bam-10833	32	11	ratio	ratio	NOUN
bam-10833	32	12	(	(	PUNCT
bam-10833	32	13	or	or	CCONJ
bam-10833	32	14	)	)	PUNCT
bam-10833	32	15	or	or	CCONJ
bam-10833	32	16	risk	risk	NOUN
bam-10833	32	17	ratio	ratio	NOUN
bam-10833	32	18	(	(	PUNCT
bam-10833	32	19	rr	rr	NOUN
bam-10833	32	20	)	)	PUNCT
bam-10833	32	21	to	to	PART
bam-10833	32	22	examine	examine	VERB
bam-10833	32	23	the	the	DET
bam-10833	32	24	effect	effect	NOUN
bam-10833	32	25	of	of	ADP
bam-10833	32	26	combination	combination	NOUN
bam-10833	32	27	therapy	therapy	NOUN
bam-10833	32	28	compared	compare	VERB
bam-10833	32	29	to	to	ADP
bam-10833	32	30	monotherapy	monotherapy	NOUN
bam-10833	32	31	on	on	ADP
bam-10833	32	32	survival	survival	NOUN
bam-10833	32	33	of	of	ADP
bam-10833	32	34	the	the	DET
bam-10833	32	35	patients	patient	NOUN
bam-10833	32	36	;	;	PUNCT
bam-10833	32	37	ii	ii	X
bam-10833	32	38	)	)	PUNCT
bam-10833	32	39	which	which	DET
bam-10833	32	40	antibiotic	antibiotic	ADJ
bam-10833	32	41	was	be	AUX
bam-10833	32	42	used	use	VERB
bam-10833	32	43	fig	fig	NOUN
bam-10833	32	44	2	2	NUM
bam-10833	32	45	.	.	PUNCT
bam-10833	32	46	forest	forest	NOUN
bam-10833	32	47	plot	plot	NOUN
bam-10833	32	48	of	of	ADP
bam-10833	32	49	all	all	PRON
bam-10833	32	50	included	include	VERB
bam-10833	32	51	studies	study	NOUN
bam-10833	32	52	in	in	ADP
bam-10833	32	53	combination	combination	NOUN
bam-10833	32	54	therapy	therapy	NOUN
bam-10833	32	55	.	.	PUNCT
bam-10833	33	1	intravenous	intravenous	ADJ
bam-10833	33	2	colistin	colistin	PROPN
bam-10833	33	3	monotherapy	monotherapy	NOUN
bam-10833	33	4	versus	versus	ADP
bam-10833	33	5	combination	combination	NOUN
bam-10833	33	6	therapy	therapy	NOUN
bam-10833	33	7	eur	eur	PROPN
bam-10833	33	8	j	j	PROPN
bam-10833	33	9	transl	transl	PROPN
bam-10833	33	10	myol	myol	ADV
bam-10833	33	11	32	32	NUM
bam-10833	33	12	(	(	PUNCT
bam-10833	33	13	4	4	NUM
bam-10833	33	14	):	):	PUNCT
bam-10833	33	15	10833	10833	NUM
bam-10833	33	16	,	,	PUNCT
bam-10833	33	17	2022	2022	NUM
bam-10833	33	18	doi	doi	NOUN
bam-10833	33	19	:	:	PUNCT
bam-10833	33	20	10.4081	10.4081	NUM
bam-10833	33	21	/	/	SYM
bam-10833	33	22	ejtm.2022.10833	ejtm.2022.10833	NOUN
bam-10833	33	23	4	4	NUM
bam-10833	33	24	for	for	ADP
bam-10833	33	25	combination	combination	NOUN
bam-10833	33	26	therapy	therapy	NOUN
bam-10833	33	27	;	;	PUNCT
bam-10833	33	28	iii	iii	X
bam-10833	33	29	)	)	PUNCT
bam-10833	33	30	the	the	DET
bam-10833	33	31	infection	infection	NOUN
bam-10833	33	32	type	type	NOUN
bam-10833	33	33	,	,	PUNCT
bam-10833	33	34	and	and	CCONJ
bam-10833	33	35	the	the	DET
bam-10833	33	36	organism	organism	NOUN
bam-10833	33	37	responsible	responsible	ADJ
bam-10833	33	38	for	for	ADP
bam-10833	33	39	the	the	DET
bam-10833	33	40	infection	infection	NOUN
bam-10833	33	41	.	.	PUNCT
bam-10833	34	1	the	the	DET
bam-10833	34	2	eligible	eligible	ADJ
bam-10833	34	3	studies	study	NOUN
bam-10833	34	4	were	be	AUX
bam-10833	34	5	observational	observational	ADJ
bam-10833	34	6	studies	study	NOUN
bam-10833	34	7	(	(	PUNCT
bam-10833	34	8	cross	cross	ADJ
bam-10833	34	9	-	-	ADJ
bam-10833	34	10	sectional	sectional	ADJ
bam-10833	34	11	and	and	CCONJ
bam-10833	34	12	cohort	cohort	NOUN
bam-10833	34	13	studies	study	NOUN
bam-10833	34	14	)	)	PUNCT
bam-10833	34	15	and	and	CCONJ
bam-10833	34	16	randomized	randomize	VERB
bam-10833	34	17	clinical	clinical	ADJ
bam-10833	34	18	trials	trial	NOUN
bam-10833	34	19	comparing	compare	VERB
bam-10833	34	20	intravenous	intravenous	ADJ
bam-10833	34	21	colistin	colistin	NOUN
bam-10833	34	22	monotherapy	monotherapy	NOUN
bam-10833	34	23	vs.	vs.	ADP
bam-10833	34	24	any	any	DET
bam-10833	34	25	colistin	colistin	NOUN
bam-10833	34	26	-	-	PUNCT
bam-10833	34	27	based	base	VERB
bam-10833	34	28	combination	combination	NOUN
bam-10833	34	29	therapy	therapy	NOUN
bam-10833	34	30	in	in	ADP
bam-10833	34	31	adult	adult	NOUN
bam-10833	34	32	patients	patient	NOUN
bam-10833	34	33	with	with	ADP
bam-10833	34	34	documented	document	VERB
bam-10833	34	35	infection	infection	NOUN
bam-10833	34	36	caused	cause	VERB
bam-10833	34	37	by	by	ADP
bam-10833	34	38	colistin	colistin	NOUN
bam-10833	34	39	-	-	PUNCT
bam-10833	34	40	susceptible	susceptible	ADJ
bam-10833	34	41	gram	gram	NOUN
bam-10833	34	42	-	-	PUNCT
bam-10833	34	43	negative	negative	ADJ
bam-10833	34	44	bacteria	bacteria	NOUN
bam-10833	34	45	.	.	PUNCT
bam-10833	35	1	we	we	PRON
bam-10833	35	2	excluded	exclude	VERB
bam-10833	35	3	the	the	DET
bam-10833	35	4	studies	study	NOUN
bam-10833	35	5	that	that	PRON
bam-10833	35	6	have	have	VERB
bam-10833	35	7	one	one	NUM
bam-10833	35	8	or	or	CCONJ
bam-10833	35	9	more	more	ADJ
bam-10833	35	10	of	of	ADP
bam-10833	35	11	the	the	DET
bam-10833	35	12	following	follow	VERB
bam-10833	35	13	criteria	criterion	NOUN
bam-10833	35	14	:	:	PUNCT
bam-10833	35	15	1	1	X
bam-10833	35	16	)	)	PUNCT
bam-10833	35	17	studies	study	NOUN
bam-10833	35	18	which	which	PRON
bam-10833	35	19	were	be	AUX
bam-10833	35	20	on	on	ADP
bam-10833	35	21	polymyxin	polymyxin	PROPN
bam-10833	35	22	b	b	NOUN
bam-10833	35	23	;	;	PUNCT
bam-10833	35	24	2	2	X
bam-10833	35	25	)	)	PUNCT
bam-10833	35	26	systematic	systematic	ADJ
bam-10833	35	27	review	review	NOUN
bam-10833	35	28	,	,	PUNCT
bam-10833	35	29	meta	meta	ADJ
bam-10833	35	30	-	-	PUNCT
bam-10833	35	31	analysis	analysis	NOUN
bam-10833	35	32	,	,	PUNCT
bam-10833	35	33	grey	grey	NOUN
bam-10833	35	34	literature	literature	NOUN
bam-10833	35	35	,	,	PUNCT
bam-10833	35	36	3	3	X
bam-10833	35	37	)	)	PUNCT
bam-10833	35	38	studies	study	NOUN
bam-10833	35	39	with	with	ADP
bam-10833	35	40	no	no	DET
bam-10833	35	41	control	control	NOUN
bam-10833	35	42	group	group	NOUN
bam-10833	35	43	,	,	PUNCT
bam-10833	35	44	4	4	X
bam-10833	35	45	)	)	PUNCT
bam-10833	35	46	studies	study	NOUN
bam-10833	35	47	that	that	DET
bam-10833	35	48	number	number	NOUN
bam-10833	35	49	of	of	ADP
bam-10833	35	50	patients	patient	NOUN
bam-10833	35	51	and	and	CCONJ
bam-10833	35	52	mortality	mortality	NOUN
bam-10833	35	53	are	be	AUX
bam-10833	35	54	not	not	PART
bam-10833	35	55	stratified	stratify	VERB
bam-10833	35	56	into	into	ADP
bam-10833	35	57	combination	combination	NOUN
bam-10833	35	58	and	and	CCONJ
bam-10833	35	59	monotherapy	monotherapy	NOUN
bam-10833	35	60	group	group	NOUN
bam-10833	35	61	;	;	PUNCT
bam-10833	35	62	5	5	X
bam-10833	35	63	)	)	PUNCT
bam-10833	35	64	full	full	ADJ
bam-10833	35	65	text	text	NOUN
bam-10833	35	66	in	in	ADP
bam-10833	35	67	any	any	DET
bam-10833	35	68	language	language	NOUN
bam-10833	35	69	other	other	ADJ
bam-10833	35	70	than	than	ADP
bam-10833	35	71	english	english	PROPN
bam-10833	35	72	.	.	PUNCT
bam-10833	36	1	we	we	PRON
bam-10833	36	2	used	use	VERB
bam-10833	36	3	a	a	DET
bam-10833	36	4	meta	meta	ADJ
bam-10833	36	5	package	package	NOUN
bam-10833	36	6	in	in	ADP
bam-10833	36	7	the	the	DET
bam-10833	36	8	r	r	NOUN
bam-10833	36	9	statistical	statistical	ADJ
bam-10833	36	10	software	software	NOUN
bam-10833	36	11	(	(	PUNCT
bam-10833	36	12	version	version	NOUN
bam-10833	36	13	4.1.1	4.1.1	NUM
bam-10833	36	14	)	)	PUNCT
bam-10833	36	15	.	.	PUNCT
bam-10833	37	1	the	the	DET
bam-10833	37	2	or	or	CCONJ
bam-10833	37	3	of	of	ADP
bam-10833	37	4	mortality	mortality	NOUN
bam-10833	37	5	following	follow	VERB
bam-10833	37	6	combination	combination	NOUN
bam-10833	37	7	therapy	therapy	NOUN
bam-10833	37	8	was	be	AUX
bam-10833	37	9	calculated	calculate	VERB
bam-10833	37	10	with	with	ADP
bam-10833	37	11	a	a	DET
bam-10833	37	12	95	95	NUM
bam-10833	37	13	%	%	NOUN
bam-10833	37	14	confidence	confidence	NOUN
bam-10833	37	15	interval	interval	NOUN
bam-10833	37	16	(	(	PUNCT
bam-10833	37	17	ci	ci	NOUN
bam-10833	37	18	)	)	PUNCT
bam-10833	37	19	for	for	ADP
bam-10833	37	20	all	all	DET
bam-10833	37	21	studies	study	NOUN
bam-10833	37	22	.	.	PUNCT
bam-10833	38	1	mantel	mantel	NOUN
bam-10833	38	2	-	-	PUNCT
bam-10833	38	3	haenszel	haenszel	NOUN
bam-10833	38	4	method	method	NOUN
bam-10833	38	5	was	be	AUX
bam-10833	38	6	used	use	VERB
bam-10833	38	7	to	to	PART
bam-10833	38	8	estimate	estimate	VERB
bam-10833	38	9	the	the	DET
bam-10833	38	10	pooled	pooled	ADJ
bam-10833	38	11	or	or	CCONJ
bam-10833	38	12	.	.	PUNCT
bam-10833	39	1	the	the	DET
bam-10833	39	2	random	random	ADJ
bam-10833	39	3	-	-	PUNCT
bam-10833	39	4	effects	effect	NOUN
bam-10833	39	5	model	model	NOUN
bam-10833	39	6	was	be	AUX
bam-10833	39	7	used	use	VERB
bam-10833	39	8	for	for	ADP
bam-10833	39	9	calculating	calculate	VERB
bam-10833	39	10	pooled	pool	VERB
bam-10833	39	11	or	or	CCONJ
bam-10833	39	12	.	.	PUNCT
bam-10833	40	1	in	in	ADP
bam-10833	40	2	this	this	DET
bam-10833	40	3	study	study	NOUN
bam-10833	40	4	,	,	PUNCT
bam-10833	40	5	subgroup	subgroup	NOUN
bam-10833	40	6	analysis	analysis	NOUN
bam-10833	40	7	was	be	AUX
bam-10833	40	8	used	use	VERB
bam-10833	40	9	to	to	PART
bam-10833	40	10	report	report	VERB
bam-10833	40	11	pooled	pool	VERB
bam-10833	40	12	or	or	CCONJ
bam-10833	40	13	for	for	ADP
bam-10833	40	14	different	different	ADJ
bam-10833	40	15	antibiotics	antibiotic	NOUN
bam-10833	40	16	used	use	VERB
bam-10833	40	17	for	for	ADP
bam-10833	40	18	combination	combination	NOUN
bam-10833	40	19	therapy	therapy	NOUN
bam-10833	40	20	.	.	PUNCT
bam-10833	41	1	the	the	DET
bam-10833	41	2	forest	forest	NOUN
bam-10833	41	3	plot	plot	NOUN
bam-10833	41	4	was	be	AUX
bam-10833	41	5	used	use	VERB
bam-10833	41	6	to	to	PART
bam-10833	41	7	graphically	graphically	ADV
bam-10833	41	8	represent	represent	VERB
bam-10833	41	9	the	the	DET
bam-10833	41	10	result	result	NOUN
bam-10833	41	11	of	of	ADP
bam-10833	41	12	calculated	calculate	VERB
bam-10833	41	13	or	or	CCONJ
bam-10833	41	14	for	for	ADP
bam-10833	41	15	individual	individual	ADJ
bam-10833	41	16	studies	study	NOUN
bam-10833	41	17	and	and	CCONJ
bam-10833	41	18	conducted	conduct	VERB
bam-10833	41	19	subgroup	subgroup	NOUN
bam-10833	41	20	and	and	CCONJ
bam-10833	41	21	overall	overall	ADJ
bam-10833	41	22	metaanalysis	metaanalysis	NOUN
bam-10833	41	23	.	.	PUNCT
bam-10833	42	1	the	the	DET
bam-10833	42	2	i2	i2	PROPN
bam-10833	42	3	statistic	statistic	NOUN
bam-10833	42	4	was	be	AUX
bam-10833	42	5	used	use	VERB
bam-10833	42	6	to	to	PART
bam-10833	42	7	evaluate	evaluate	VERB
bam-10833	42	8	the	the	DET
bam-10833	42	9	heterogeneity	heterogeneity	NOUN
bam-10833	42	10	in	in	ADP
bam-10833	42	11	the	the	DET
bam-10833	42	12	included	include	VERB
bam-10833	42	13	studies	study	NOUN
bam-10833	42	14	for	for	ADP
bam-10833	42	15	each	each	DET
bam-10833	42	16	subgroup	subgroup	NOUN
bam-10833	42	17	and	and	CCONJ
bam-10833	42	18	totally	totally	ADV
bam-10833	42	19	.	.	PUNCT
bam-10833	43	1	a	a	DET
bam-10833	43	2	funnel	funnel	NOUN
bam-10833	43	3	plot	plot	NOUN
bam-10833	43	4	was	be	AUX
bam-10833	43	5	used	use	VERB
bam-10833	43	6	to	to	PART
bam-10833	43	7	examine	examine	VERB
bam-10833	43	8	the	the	DET
bam-10833	43	9	publication	publication	NOUN
bam-10833	43	10	bias	bias	NOUN
bam-10833	43	11	in	in	ADP
bam-10833	43	12	studies	study	NOUN
bam-10833	43	13	.	.	PUNCT
bam-10833	44	1	the	the	DET
bam-10833	44	2	i2	i2	PROPN
bam-10833	44	3	value	value	NOUN
bam-10833	44	4	represents	represent	VERB
bam-10833	44	5	the	the	DET
bam-10833	44	6	percentage	percentage	NOUN
bam-10833	44	7	of	of	ADP
bam-10833	44	8	total	total	ADJ
bam-10833	44	9	variation	variation	NOUN
bam-10833	44	10	among	among	ADP
bam-10833	44	11	studies	study	NOUN
bam-10833	44	12	due	due	ADP
bam-10833	44	13	to	to	ADP
bam-10833	44	14	heterogeneity	heterogeneity	NOUN
bam-10833	44	15	.	.	PUNCT
bam-10833	45	1	the	the	DET
bam-10833	45	2	funnel	funnel	NOUN
bam-10833	45	3	plot	plot	NOUN
bam-10833	45	4	was	be	AUX
bam-10833	45	5	used	use	VERB
bam-10833	45	6	to	to	PART
bam-10833	45	7	assess	assess	VERB
bam-10833	45	8	the	the	DET
bam-10833	45	9	publication	publication	NOUN
bam-10833	45	10	bias	bias	NOUN
bam-10833	45	11	.	.	PUNCT
bam-10833	46	1	observing	observe	VERB
bam-10833	46	2	any	any	DET
bam-10833	46	3	asymmetry	asymmetry	NOUN
bam-10833	46	4	visually	visually	ADV
bam-10833	46	5	in	in	ADP
bam-10833	46	6	the	the	DET
bam-10833	46	7	funnel	funnel	NOUN
bam-10833	46	8	plot	plot	NOUN
bam-10833	46	9	was	be	AUX
bam-10833	46	10	considered	consider	VERB
bam-10833	46	11	as	as	ADP
bam-10833	46	12	a	a	DET
bam-10833	46	13	publication	publication	NOUN
bam-10833	46	14	bias	bias	NOUN
bam-10833	46	15	.	.	PUNCT
bam-10833	47	1	begg	begg	PROPN
bam-10833	47	2	rank	rank	PROPN
bam-10833	47	3	correlation	correlation	NOUN
bam-10833	47	4	method	method	NOUN
bam-10833	47	5	for	for	ADP
bam-10833	47	6	funnel	funnel	NOUN
bam-10833	47	7	plot	plot	NOUN
bam-10833	47	8	asymmetry	asymmetry	NOUN
bam-10833	47	9	was	be	AUX
bam-10833	47	10	conducted	conduct	VERB
bam-10833	47	11	to	to	PART
bam-10833	47	12	quantitatively	quantitatively	ADV
bam-10833	47	13	test	test	VERB
bam-10833	47	14	publication	publication	NOUN
bam-10833	47	15	bias	bias	NOUN
bam-10833	47	16	.	.	PUNCT
bam-10833	48	1	results	result	VERB
bam-10833	48	2	the	the	DET
bam-10833	48	3	flow	flow	NOUN
bam-10833	48	4	diagram	diagram	NOUN
bam-10833	48	5	of	of	ADP
bam-10833	48	6	selected	select	VERB
bam-10833	48	7	studies	study	NOUN
bam-10833	48	8	is	be	AUX
bam-10833	48	9	shown	show	VERB
bam-10833	48	10	in	in	ADP
bam-10833	48	11	figure	figure	NOUN
bam-10833	48	12	1	1	NUM
bam-10833	48	13	.	.	PUNCT
bam-10833	49	1	after	after	ADP
bam-10833	49	2	removing	remove	VERB
bam-10833	49	3	duplicate	duplicate	ADJ
bam-10833	49	4	records	record	NOUN
bam-10833	49	5	,	,	PUNCT
bam-10833	49	6	titles	title	NOUN
bam-10833	49	7	and	and	CCONJ
bam-10833	49	8	abstracts	abstract	NOUN
bam-10833	49	9	of	of	ADP
bam-10833	49	10	2,398	2,398	NUM
bam-10833	49	11	studies	study	NOUN
bam-10833	49	12	retrieved	retrieve	VERB
bam-10833	49	13	from	from	ADP
bam-10833	49	14	online	online	ADJ
bam-10833	49	15	databases	database	NOUN
bam-10833	49	16	were	be	AUX
bam-10833	49	17	screened	screen	VERB
bam-10833	49	18	based	base	VERB
bam-10833	49	19	on	on	ADP
bam-10833	49	20	title	title	NOUN
bam-10833	49	21	and	and	CCONJ
bam-10833	49	22	,	,	PUNCT
bam-10833	49	23	or	or	CCONJ
bam-10833	49	24	abstract	abstract	ADJ
bam-10833	49	25	.	.	PUNCT
bam-10833	50	1	fifty	fifty	NUM
bam-10833	50	2	-	-	PUNCT
bam-10833	50	3	four	four	NUM
bam-10833	50	4	studies	study	NOUN
bam-10833	50	5	accomplished	accomplish	VERB
bam-10833	50	6	the	the	DET
bam-10833	50	7	inclusion	inclusion	NOUN
bam-10833	50	8	criteria	criterion	NOUN
bam-10833	50	9	for	for	ADP
bam-10833	50	10	full	full	ADJ
bam-10833	50	11	-	-	PUNCT
bam-10833	50	12	text	text	NOUN
bam-10833	50	13	review	review	NOUN
bam-10833	50	14	.	.	PUNCT
bam-10833	51	1	twelve	twelve	NUM
bam-10833	51	2	studies	study	NOUN
bam-10833	51	3	were	be	AUX
bam-10833	51	4	excluded	exclude	VERB
bam-10833	51	5	leading	lead	VERB
bam-10833	51	6	to	to	ADP
bam-10833	51	7	a	a	DET
bam-10833	51	8	final	final	ADJ
bam-10833	51	9	inclusion	inclusion	NOUN
bam-10833	51	10	of	of	ADP
bam-10833	51	11	42	42	NUM
bam-10833	51	12	studies	study	NOUN
bam-10833	51	13	.	.	PUNCT
bam-10833	52	1	the	the	DET
bam-10833	52	2	characteristics	characteristic	NOUN
bam-10833	52	3	of	of	ADP
bam-10833	52	4	the	the	DET
bam-10833	52	5	selected	select	VERB
bam-10833	52	6	studies	study	NOUN
bam-10833	52	7	are	be	AUX
bam-10833	52	8	shown	show	VERB
bam-10833	52	9	in	in	ADP
bam-10833	52	10	table	table	NOUN
bam-10833	52	11	1	1	NUM
bam-10833	52	12	of	of	ADP
bam-10833	52	13	supplementary	supplementary	ADJ
bam-10833	52	14	materials	material	NOUN
bam-10833	52	15	.	.	PUNCT
bam-10833	53	1	among	among	ADP
bam-10833	53	2	them	they	PRON
bam-10833	53	3	,	,	PUNCT
bam-10833	53	4	38	38	NUM
bam-10833	53	5	studies	study	NOUN
bam-10833	53	6	were	be	AUX
bam-10833	53	7	on	on	ADP
bam-10833	53	8	combination	combination	NOUN
bam-10833	53	9	therapy	therapy	NOUN
bam-10833	53	10	,	,	PUNCT
bam-10833	53	11	and	and	CCONJ
bam-10833	53	12	four	four	NUM
bam-10833	53	13	studies	study	NOUN
bam-10833	53	14	were	be	AUX
bam-10833	53	15	on	on	ADP
bam-10833	53	16	dose	dose	NOUN
bam-10833	53	17	interval	interval	NOUN
bam-10833	53	18	,	,	PUNCT
bam-10833	53	19	and	and	CCONJ
bam-10833	53	20	38	38	NUM
bam-10833	53	21	studies	study	NOUN
bam-10833	53	22	were	be	AUX
bam-10833	53	23	used	use	VERB
bam-10833	53	24	for	for	ADP
bam-10833	53	25	meta	meta	ADJ
bam-10833	53	26	-	-	PUNCT
bam-10833	53	27	analysis	analysis	NOUN
bam-10833	53	28	.	.	PUNCT
bam-10833	54	1	thirty	thirty	NUM
bam-10833	54	2	-	-	PUNCT
bam-10833	54	3	five	five	NUM
bam-10833	54	4	studies	study	NOUN
bam-10833	54	5	were	be	AUX
bam-10833	54	6	included	include	VERB
bam-10833	54	7	in	in	ADP
bam-10833	54	8	our	our	PRON
bam-10833	54	9	study	study	NOUN
bam-10833	54	10	consisting	consist	VERB
bam-10833	54	11	of	of	ADP
bam-10833	54	12	2088	2088	NUM
bam-10833	54	13	total	total	ADJ
bam-10833	54	14	cases	case	NOUN
bam-10833	54	15	,	,	PUNCT
bam-10833	54	16	1774	1774	NUM
bam-10833	54	17	monotherapy	monotherapy	NOUN
bam-10833	54	18	patients	patient	NOUN
bam-10833	54	19	,	,	PUNCT
bam-10833	54	20	and	and	CCONJ
bam-10833	54	21	3862	3862	NUM
bam-10833	54	22	combination	combination	NOUN
bam-10833	54	23	therapy	therapy	NOUN
bam-10833	54	24	overall	overall	NOUN
bam-10833	54	25	.	.	PUNCT
bam-10833	55	1	combination	combination	NOUN
bam-10833	55	2	therapy	therapy	NOUN
bam-10833	55	3	as	as	ADP
bam-10833	55	4	figure	figure	NOUN
bam-10833	55	5	2	2	NUM
bam-10833	55	6	shows	show	NOUN
bam-10833	56	1	,	,	PUNCT
bam-10833	56	2	the	the	DET
bam-10833	56	3	overall	overall	ADJ
bam-10833	56	4	pooled	pool	VERB
bam-10833	56	5	odds	odd	NOUN
bam-10833	56	6	ratio	ratio	NOUN
bam-10833	56	7	is	be	AUX
bam-10833	56	8	0.77	0.77	NUM
bam-10833	56	9	(	(	PUNCT
bam-10833	56	10	ci	ci	NOUN
bam-10833	56	11	:	:	PUNCT
bam-10833	56	12	0.62	0.62	NUM
bam-10833	56	13	;	;	PUNCT
bam-10833	56	14	0.95	0.95	NUM
bam-10833	56	15	)	)	PUNCT
bam-10833	56	16	,	,	PUNCT
bam-10833	56	17	which	which	PRON
bam-10833	56	18	suggests	suggest	VERB
bam-10833	56	19	that	that	SCONJ
bam-10833	56	20	the	the	DET
bam-10833	56	21	odds	odd	NOUN
bam-10833	56	22	of	of	ADP
bam-10833	56	23	allcause	allcause	ADP
bam-10833	56	24	mortality	mortality	NOUN
bam-10833	56	25	in	in	ADP
bam-10833	56	26	combination	combination	NOUN
bam-10833	56	27	therapy	therapy	NOUN
bam-10833	56	28	was	be	AUX
bam-10833	56	29	23	23	NUM
bam-10833	56	30	%	%	NOUN
bam-10833	56	31	lower	low	ADJ
bam-10833	56	32	than	than	ADP
bam-10833	56	33	monotherapy	monotherapy	NOUN
bam-10833	56	34	patients	patient	NOUN
bam-10833	56	35	(	(	PUNCT
bam-10833	56	36	p	p	NOUN
bam-10833	56	37	value	value	NOUN
bam-10833	56	38	<	<	X
bam-10833	56	39	0.017	0.017	NUM
bam-10833	56	40	)	)	PUNCT
bam-10833	56	41	.	.	PUNCT
bam-10833	57	1	the	the	DET
bam-10833	57	2	i^2	i^2	PROPN
bam-10833	57	3	value	value	NOUN
bam-10833	57	4	was	be	AUX
bam-10833	57	5	43	43	NUM
bam-10833	57	6	%	%	NOUN
bam-10833	57	7	(	(	PUNCT
bam-10833	57	8	p	p	NOUN
bam-10833	57	9	value	value	NOUN
bam-10833	57	10	<	<	X
bam-10833	57	11	0.01	0.01	NUM
bam-10833	57	12	)	)	PUNCT
bam-10833	57	13	,	,	PUNCT
bam-10833	57	14	which	which	PRON
bam-10833	57	15	shows	show	VERB
bam-10833	57	16	that	that	SCONJ
bam-10833	57	17	included	include	VERB
bam-10833	57	18	studies	study	NOUN
bam-10833	57	19	are	be	AUX
bam-10833	57	20	heterogeneous	heterogeneous	ADJ
bam-10833	57	21	.	.	PUNCT
bam-10833	58	1	the	the	DET
bam-10833	58	2	evidence	evidence	NOUN
bam-10833	58	3	of	of	ADP
bam-10833	58	4	publication	publication	NOUN
bam-10833	58	5	bias	bias	NOUN
bam-10833	58	6	was	be	AUX
bam-10833	58	7	tested	test	VERB
bam-10833	58	8	by	by	ADP
bam-10833	58	9	visual	visual	ADJ
bam-10833	58	10	examination	examination	NOUN
bam-10833	58	11	of	of	ADP
bam-10833	58	12	funnel	funnel	NOUN
bam-10833	58	13	plot	plot	NOUN
bam-10833	58	14	symmetry	symmetry	NOUN
bam-10833	58	15	(	(	PUNCT
bam-10833	58	16	figure	figure	NOUN
bam-10833	58	17	3	3	NUM
bam-10833	58	18	)	)	PUNCT
bam-10833	58	19	.	.	PUNCT
bam-10833	59	1	there	there	ADV
bam-10833	59	2	begg	begg	PROPN
bam-10833	59	3	correlation	correlation	NOUN
bam-10833	59	4	test	test	NOUN
bam-10833	59	5	of	of	ADP
bam-10833	59	6	funnel	funnel	NOUN
bam-10833	59	7	plot	plot	NOUN
bam-10833	59	8	asymmetry	asymmetry	NOUN
bam-10833	59	9	showed	show	VERB
bam-10833	59	10	that	that	SCONJ
bam-10833	59	11	there	there	PRON
bam-10833	59	12	is	be	VERB
bam-10833	59	13	no	no	DET
bam-10833	59	14	significant	significant	ADJ
bam-10833	59	15	publication	publication	NOUN
bam-10833	59	16	bias	bias	NOUN
bam-10833	59	17	(	(	PUNCT
bam-10833	59	18	0.064	0.064	NUM
bam-10833	59	19	)	)	PUNCT
bam-10833	59	20	.	.	PUNCT
bam-10833	60	1	the	the	DET
bam-10833	60	2	subgroup	subgroup	NOUN
bam-10833	60	3	analysis	analysis	NOUN
bam-10833	60	4	showed	show	VERB
bam-10833	60	5	that	that	SCONJ
bam-10833	60	6	the	the	DET
bam-10833	60	7	overall	overall	ADJ
bam-10833	60	8	pooled	pool	VERB
bam-10833	60	9	odds	odd	NOUN
bam-10833	60	10	ratio	ratio	NOUN
bam-10833	60	11	for	for	ADP
bam-10833	60	12	aminoglycoside	aminoglycoside	ADJ
bam-10833	60	13	antibiotic	antibiotic	NOUN
bam-10833	60	14	is	be	AUX
bam-10833	60	15	0.25	0.25	NUM
bam-10833	60	16	(	(	PUNCT
bam-10833	60	17	ci	ci	NOUN
bam-10833	60	18	:	:	PUNCT
bam-10833	60	19	0.09	0.09	NUM
bam-10833	60	20	;	;	PUNCT
bam-10833	60	21	0.72	0.72	NUM
bam-10833	60	22	)	)	PUNCT
bam-10833	60	23	,	,	PUNCT
bam-10833	60	24	which	which	PRON
bam-10833	60	25	means	mean	VERB
bam-10833	60	26	that	that	SCONJ
bam-10833	60	27	the	the	DET
bam-10833	60	28	odds	odd	NOUN
bam-10833	60	29	of	of	ADP
bam-10833	60	30	all	all	DET
bam-10833	60	31	-	-	PUNCT
bam-10833	60	32	cause	cause	NOUN
bam-10833	60	33	mortality	mortality	NOUN
bam-10833	60	34	in	in	ADP
bam-10833	60	35	colistin	colistin	NOUN
bam-10833	60	36	with	with	ADP
bam-10833	60	37	aminoglycoside	aminoglycoside	ADJ
bam-10833	60	38	therapy	therapy	NOUN
bam-10833	60	39	was	be	AUX
bam-10833	60	40	75	75	NUM
bam-10833	60	41	%	%	NOUN
bam-10833	60	42	lower	low	ADJ
bam-10833	60	43	than	than	ADP
bam-10833	60	44	monotherapy	monotherapy	NOUN
bam-10833	60	45	patients	patient	NOUN
bam-10833	60	46	.	.	PUNCT
bam-10833	61	1	the	the	DET
bam-10833	61	2	overall	overall	ADJ
bam-10833	61	3	pooled	pool	VERB
bam-10833	61	4	odds	odd	NOUN
bam-10833	61	5	ratio	ratio	NOUN
bam-10833	61	6	for	for	ADP
bam-10833	61	7	carbapenem	carbapenem	PROPN
bam-10833	61	8	and	and	CCONJ
bam-10833	61	9	gentamicin	gentamicin	VERB
bam-10833	61	10	antibiotic	antibiotic	NOUN
bam-10833	61	11	is	be	AUX
bam-10833	61	12	0.74	0.74	NUM
bam-10833	61	13	(	(	PUNCT
bam-10833	61	14	ci	ci	NOUN
bam-10833	61	15	:	:	PUNCT
bam-10833	61	16	0.48	0.48	NUM
bam-10833	61	17	;	;	PUNCT
bam-10833	61	18	1.13	1.13	NUM
bam-10833	61	19	)	)	PUNCT
bam-10833	61	20	and	and	CCONJ
bam-10833	61	21	0.89	0.89	NUM
bam-10833	61	22	(	(	PUNCT
bam-10833	61	23	ci	ci	NOUN
bam-10833	61	24	:	:	PUNCT
bam-10833	61	25	0.32	0.32	NUM
bam-10833	61	26	;	;	PUNCT
bam-10833	61	27	2.48	2.48	NUM
bam-10833	61	28	)	)	PUNCT
bam-10833	61	29	,	,	PUNCT
bam-10833	61	30	respectively	respectively	ADV
bam-10833	61	31	,	,	PUNCT
bam-10833	61	32	which	which	PRON
bam-10833	61	33	statistically	statistically	ADV
bam-10833	61	34	is	be	AUX
bam-10833	61	35	nonsignificant	nonsignificant	ADJ
bam-10833	61	36	.	.	PUNCT
bam-10833	62	1	the	the	DET
bam-10833	62	2	overall	overall	ADJ
bam-10833	62	3	pooled	pool	VERB
bam-10833	62	4	odds	odd	NOUN
bam-10833	62	5	ratio	ratio	NOUN
bam-10833	62	6	for	for	ADP
bam-10833	62	7	rifampin	rifampin	ADJ
bam-10833	62	8	antibiotic	antibiotic	NOUN
bam-10833	62	9	is	be	AUX
bam-10833	62	10	0.95	0.95	NUM
bam-10833	62	11	(	(	PUNCT
bam-10833	62	12	ci	ci	NOUN
bam-10833	62	13	:	:	PUNCT
bam-10833	62	14	0.58	0.58	NUM
bam-10833	62	15	,	,	PUNCT
bam-10833	62	16	1.56	1.56	NUM
bam-10833	62	17	)	)	PUNCT
bam-10833	62	18	,	,	PUNCT
bam-10833	62	19	which	which	PRON
bam-10833	62	20	statistically	statistically	ADV
bam-10833	62	21	is	be	AUX
bam-10833	62	22	non	non	ADJ
bam-10833	62	23	-	-	ADJ
bam-10833	62	24	significant	significant	ADJ
bam-10833	62	25	.	.	PUNCT
bam-10833	63	1	the	the	DET
bam-10833	63	2	overall	overall	ADJ
bam-10833	63	3	pooled	pool	VERB
bam-10833	63	4	odds	odd	NOUN
bam-10833	63	5	ratio	ratio	NOUN
bam-10833	63	6	for	for	ADP
bam-10833	63	7	sulbactam	sulbactam	NOUN
bam-10833	63	8	,	,	PUNCT
bam-10833	63	9	tigecycline	tigecycline	NOUN
bam-10833	63	10	and	and	CCONJ
bam-10833	63	11	vancomycin	vancomycin	PROPN
bam-10833	63	12	antibiotic	antibiotic	PROPN
bam-10833	63	13	is	be	AUX
bam-10833	63	14	0.68	0.68	NUM
bam-10833	63	15	(	(	PUNCT
bam-10833	63	16	ci	ci	NOUN
bam-10833	63	17	:	:	PUNCT
bam-10833	63	18	0.14	0.14	NUM
bam-10833	63	19	;	;	PUNCT
bam-10833	63	20	3.41	3.41	NUM
bam-10833	63	21	)	)	PUNCT
bam-10833	63	22	,	,	PUNCT
bam-10833	63	23	0.78	0.78	NUM
bam-10833	63	24	(	(	PUNCT
bam-10833	63	25	ci	ci	NOUN
bam-10833	63	26	:	:	PUNCT
bam-10833	63	27	0.39	0.39	NUM
bam-10833	63	28	;	;	PUNCT
bam-10833	63	29	1.53	1.53	NUM
bam-10833	63	30	)	)	PUNCT
bam-10833	63	31	and	and	CCONJ
bam-10833	63	32	1.11	1.11	NUM
bam-10833	63	33	(	(	PUNCT
bam-10833	63	34	ci	ci	NOUN
bam-10833	63	35	:	:	PUNCT
bam-10833	63	36	0.75	0.75	NUM
bam-10833	63	37	;	;	PUNCT
bam-10833	63	38	1.65	1.65	NUM
bam-10833	63	39	)	)	PUNCT
bam-10833	63	40	respectively	respectively	ADV
bam-10833	63	41	,	,	PUNCT
bam-10833	63	42	which	which	PRON
bam-10833	63	43	statistically	statistically	ADV
bam-10833	63	44	is	be	AUX
bam-10833	63	45	nonsignificant	nonsignificant	ADJ
bam-10833	63	46	.	.	PUNCT
bam-10833	64	1	dosing	dose	VERB
bam-10833	64	2	interval	interval	NOUN
bam-10833	64	3	four	four	NUM
bam-10833	64	4	studies	study	NOUN
bam-10833	64	5	were	be	AUX
bam-10833	64	6	found	find	VERB
bam-10833	64	7	comparing	compare	VERB
bam-10833	64	8	the	the	DET
bam-10833	64	9	different	different	ADJ
bam-10833	64	10	dosing	dose	VERB
bam-10833	64	11	intervals	interval	NOUN
bam-10833	64	12	on	on	ADP
bam-10833	64	13	bacterial	bacterial	ADJ
bam-10833	64	14	eradication	eradication	NOUN
bam-10833	64	15	,	,	PUNCT
bam-10833	64	16	survival	survival	NOUN
bam-10833	64	17	,	,	PUNCT
bam-10833	64	18	the	the	DET
bam-10833	64	19	emergence	emergence	NOUN
bam-10833	64	20	of	of	ADP
bam-10833	64	21	resistant	resistant	ADJ
bam-10833	64	22	strains	strain	NOUN
bam-10833	64	23	and	and	CCONJ
bam-10833	64	24	,	,	PUNCT
bam-10833	64	25	serum	serum	NOUN
bam-10833	64	26	concentration	concentration	NOUN
bam-10833	64	27	of	of	ADP
bam-10833	64	28	colistin	colistin	NOUN
bam-10833	64	29	.	.	PUNCT
bam-10833	65	1	one	one	NUM
bam-10833	65	2	of	of	ADP
bam-10833	65	3	the	the	DET
bam-10833	65	4	studies	study	NOUN
bam-10833	65	5	was	be	AUX
bam-10833	65	6	in	in	ADP
bam-10833	65	7	vitro	vitro	X
bam-10833	65	8	setting	set	VERB
bam-10833	65	9	and	and	CCONJ
bam-10833	65	10	compared	compare	VERB
bam-10833	65	11	three	three	NUM
bam-10833	65	12	dosing	dose	VERB
bam-10833	65	13	intervals	interval	NOUN
bam-10833	65	14	regimens	regimen	NOUN
bam-10833	65	15	(	(	PUNCT
bam-10833	65	16	8-	8-	PROPN
bam-10833	65	17	,	,	PUNCT
bam-10833	65	18	12and	12and	NOUN
bam-10833	65	19	24hourly	24hourly	NUM
bam-10833	65	20	)	)	PUNCT
bam-10833	65	21	on	on	ADP
bam-10833	65	22	antimicrobial	antimicrobial	ADJ
bam-10833	65	23	activity	activity	NOUN
bam-10833	65	24	against	against	ADP
bam-10833	65	25	p.	p.	NOUN
bam-10833	65	26	aeruginosa	aeruginosa	PROPN
bam-10833	65	27	and	and	CCONJ
bam-10833	65	28	emergence	emergence	NOUN
bam-10833	65	29	of	of	ADP
bam-10833	65	30	resistance	resistance	NOUN
bam-10833	65	31	strain	strain	NOUN
bam-10833	65	32	were	be	AUX
bam-10833	65	33	evaluated	evaluate	VERB
bam-10833	65	34	.	.	PUNCT
bam-10833	66	1	the	the	DET
bam-10833	66	2	other	other	ADJ
bam-10833	66	3	was	be	AUX
bam-10833	66	4	in	in	ADP
bam-10833	66	5	vivo	vivo	ADJ
bam-10833	66	6	and	and	CCONJ
bam-10833	66	7	clinical	clinical	ADJ
bam-10833	66	8	settings	setting	NOUN
bam-10833	66	9	.	.	PUNCT
bam-10833	67	1	this	this	DET
bam-10833	67	2	study	study	NOUN
bam-10833	67	3	showed	show	VERB
bam-10833	67	4	no	no	DET
bam-10833	67	5	significant	significant	ADJ
bam-10833	67	6	difference	difference	NOUN
bam-10833	67	7	between	between	ADP
bam-10833	67	8	8-	8-	PROPN
bam-10833	67	9	,	,	PUNCT
bam-10833	67	10	12or	12or	ADJ
bam-10833	67	11	24	24	NUM
bam-10833	67	12	-	-	PUNCT
bam-10833	67	13	hour	hour	NOUN
bam-10833	67	14	intervals	interval	NOUN
bam-10833	67	15	in	in	ADP
bam-10833	67	16	overall	overall	ADJ
bam-10833	67	17	bacterial	bacterial	ADJ
bam-10833	67	18	kill	kill	NOUN
bam-10833	67	19	when	when	SCONJ
bam-10833	67	20	the	the	DET
bam-10833	67	21	recommended	recommend	VERB
bam-10833	67	22	maximum	maximum	ADJ
bam-10833	67	23	daily	daily	ADJ
bam-10833	67	24	dose	dose	NOUN
bam-10833	67	25	was	be	AUX
bam-10833	67	26	administered	administer	VERB
bam-10833	67	27	.	.	PUNCT
bam-10833	68	1	however	however	ADV
bam-10833	68	2	,	,	PUNCT
bam-10833	68	3	the	the	DET
bam-10833	68	4	eight	eight	NUM
bam-10833	68	5	hourly	hourly	ADJ
bam-10833	68	6	regimens	regimen	NOUN
bam-10833	68	7	showed	show	VERB
bam-10833	68	8	the	the	DET
bam-10833	68	9	best	good	ADJ
bam-10833	68	10	efficacy	efficacy	NOUN
bam-10833	68	11	at	at	ADP
bam-10833	68	12	minimizing	minimize	VERB
bam-10833	68	13	the	the	DET
bam-10833	68	14	emergence	emergence	NOUN
bam-10833	68	15	of	of	ADP
bam-10833	68	16	resistant	resistant	ADJ
bam-10833	68	17	strains.6	strains.6	NOUN
bam-10833	68	18	ghazaeian	ghazaeian	PROPN
bam-10833	68	19	et	et	PROPN
bam-10833	68	20	al	al	PROPN
bam-10833	68	21	.	.	PUNCT
bam-10833	69	1	(	(	PUNCT
bam-10833	69	2	2017)7	2017)7	PROPN
bam-10833	69	3	conducted	conduct	VERB
bam-10833	69	4	a	a	DET
bam-10833	69	5	prospective	prospective	ADJ
bam-10833	69	6	rct	rct	NOUN
bam-10833	69	7	on	on	ADP
bam-10833	69	8	40	40	NUM
bam-10833	69	9	adult	adult	NOUN
bam-10833	69	10	’s	’s	PART
bam-10833	69	11	icu	icu	PROPN
bam-10833	69	12	patients	patient	NOUN
bam-10833	69	13	with	with	ADP
bam-10833	69	14	ventilator	ventilator	NOUN
bam-10833	69	15	-	-	PUNCT
bam-10833	69	16	associated	associate	VERB
bam-10833	69	17	pneumonia	pneumonia	NOUN
bam-10833	69	18	(	(	PUNCT
bam-10833	69	19	vap	vap	NOUN
bam-10833	69	20	)	)	PUNCT
bam-10833	69	21	,	,	PUNCT
bam-10833	69	22	comparing	compare	VERB
bam-10833	69	23	the	the	DET
bam-10833	69	24	mortality	mortality	NOUN
bam-10833	69	25	and	and	CCONJ
bam-10833	69	26	icu	icu	PROPN
bam-10833	69	27	length	length	NOUN
bam-10833	69	28	of	of	ADP
bam-10833	69	29	stay	stay	NOUN
bam-10833	69	30	of	of	ADP
bam-10833	69	31	8or	8or	NOUN
bam-10833	69	32	24hour	24hour	NUM
bam-10833	69	33	intervals	interval	NOUN
bam-10833	69	34	regimens	regimen	VERB
bam-10833	69	35	.	.	PUNCT
bam-10833	70	1	the	the	DET
bam-10833	70	2	icu	icu	PROPN
bam-10833	70	3	length	length	NOUN
bam-10833	70	4	of	of	ADP
bam-10833	70	5	stay	stay	NOUN
bam-10833	70	6	and	and	CCONJ
bam-10833	70	7	icu	icu	PROPN
bam-10833	70	8	mortality	mortality	NOUN
bam-10833	70	9	were	be	AUX
bam-10833	70	10	;	;	PUNCT
bam-10833	70	11	31.31	31.31	NUM
bam-10833	70	12	,	,	PUNCT
bam-10833	70	13	35.3	35.3	NUM
bam-10833	70	14	days	day	NOUN
bam-10833	70	15	,	,	PUNCT
bam-10833	70	16	and	and	CCONJ
bam-10833	70	17	32.06	32.06	NUM
bam-10833	70	18	,	,	PUNCT
bam-10833	70	19	22.2	22.2	NUM
bam-10833	70	20	%	%	NOUN
bam-10833	70	21	in	in	ADP
bam-10833	70	22	groups	group	NOUN
bam-10833	70	23	24	24	NUM
bam-10833	70	24	-	-	PUNCT
bam-10833	70	25	h	h	NOUN
bam-10833	70	26	interval	interval	NOUN
bam-10833	70	27	and	and	CCONJ
bam-10833	70	28	8hour	8hour	NUM
bam-10833	70	29	interval	interval	NOUN
bam-10833	70	30	(	(	PUNCT
bam-10833	70	31	p	p	NOUN
bam-10833	70	32	value	value	NOUN
bam-10833	70	33	:	:	PUNCT
bam-10833	70	34	0.39	0.39	NUM
bam-10833	70	35	,	,	PUNCT
bam-10833	70	36	0.87	0.87	NUM
bam-10833	70	37	)	)	PUNCT
bam-10833	70	38	,	,	PUNCT
bam-10833	70	39	respectively	respectively	ADV
bam-10833	70	40	.	.	PUNCT
bam-10833	71	1	there	there	PRON
bam-10833	71	2	was	be	VERB
bam-10833	71	3	not	not	PART
bam-10833	71	4	any	any	DET
bam-10833	71	5	significant	significant	ADJ
bam-10833	71	6	difference	difference	NOUN
bam-10833	71	7	in	in	ADP
bam-10833	71	8	mortality	mortality	NOUN
bam-10833	71	9	and	and	CCONJ
bam-10833	71	10	length	length	NOUN
bam-10833	71	11	of	of	ADP
bam-10833	71	12	stay	stay	NOUN
bam-10833	71	13	between	between	ADP
bam-10833	71	14	the	the	DET
bam-10833	71	15	two	two	NUM
bam-10833	71	16	groups	group	NOUN
bam-10833	71	17	,	,	PUNCT
bam-10833	71	18	which	which	PRON
bam-10833	71	19	received	receive	VERB
bam-10833	71	20	the	the	DET
bam-10833	71	21	maximum	maximum	ADJ
bam-10833	71	22	recommended	recommend	VERB
bam-10833	71	23	dose	dose	NOUN
bam-10833	71	24	of	of	ADP
bam-10833	71	25	colistimethate	colistimethate	NOUN
bam-10833	71	26	sodium	sodium	NOUN
bam-10833	71	27	(	(	PUNCT
bam-10833	71	28	cms	cms	NOUN
bam-10833	71	29	)	)	PUNCT
bam-10833	71	30	with	with	ADP
bam-10833	71	31	two	two	NUM
bam-10833	71	32	different	different	ADJ
bam-10833	71	33	intervals	interval	NOUN
bam-10833	71	34	of	of	ADP
bam-10833	71	35	every	every	DET
bam-10833	71	36	8	8	NUM
bam-10833	71	37	or	or	CCONJ
bam-10833	71	38	24	24	NUM
bam-10833	71	39	h.7	h.7	NOUN
bam-10833	71	40	another	another	DET
bam-10833	71	41	study	study	NOUN
bam-10833	71	42	was	be	AUX
bam-10833	71	43	a	a	DET
bam-10833	71	44	case	case	NOUN
bam-10833	71	45	report	report	NOUN
bam-10833	71	46	by	by	ADP
bam-10833	71	47	luque	luque	PROPN
bam-10833	71	48	et	et	PROPN
bam-10833	71	49	al	al	PROPN
bam-10833	71	50	.	.	PUNCT
bam-10833	72	1	(	(	PUNCT
bam-10833	72	2	2013)8	2013)8	NUM
bam-10833	72	3	on	on	ADP
bam-10833	72	4	pharmacokinetic/	pharmacokinetic/	NUM
bam-10833	72	5	pharmacodynamic	pharmacodynamic	ADJ
bam-10833	72	6	of	of	ADP
bam-10833	72	7	incremental	incremental	ADJ
bam-10833	72	8	doses	dose	NOUN
bam-10833	72	9	of	of	ADP
bam-10833	72	10	cms	cms	PROPN
bam-10833	72	11	in	in	ADP
bam-10833	72	12	the	the	PRON
bam-10833	72	13	,	,	PUNCT
bam-10833	72	14	a	a	DET
bam-10833	72	15	critically	critically	ADV
bam-10833	72	16	ill	ill	ADJ
bam-10833	72	17	patient	patient	NOUN
bam-10833	72	18	infected	infect	VERB
bam-10833	72	19	by	by	ADP
bam-10833	72	20	an	an	DET
bam-10833	72	21	mdr	mdr	PROPN
bam-10833	72	22	a.	a.	NOUN
bam-10833	72	23	baumannii	baumannii	PROPN
bam-10833	72	24	.	.	PUNCT
bam-10833	73	1	it	it	PRON
bam-10833	73	2	was	be	AUX
bam-10833	73	3	shown	show	VERB
bam-10833	73	4	that	that	SCONJ
bam-10833	73	5	an	an	DET
bam-10833	73	6	extendedinterval	extendedinterval	NOUN
bam-10833	73	7	colistin	colistin	NOUN
bam-10833	73	8	regimen	regiman	NOUN
bam-10833	73	9	increased	increase	VERB
bam-10833	73	10	the	the	DET
bam-10833	73	11	exposure	exposure	NOUN
bam-10833	73	12	of	of	ADP
bam-10833	73	13	cms	cms	NOUN
bam-10833	73	14	and	and	CCONJ
bam-10833	73	15	colistin	colistin	VERB
bam-10833	73	16	and	and	CCONJ
bam-10833	73	17	allows	allow	VERB
bam-10833	73	18	a	a	DET
bam-10833	73	19	clinical	clinical	ADJ
bam-10833	73	20	and	and	CCONJ
bam-10833	73	21	microbiological	microbiological	ADJ
bam-10833	73	22	optimal	optimal	ADJ
bam-10833	73	23	response	response	NOUN
bam-10833	73	24	without	without	ADP
bam-10833	73	25	evidence	evidence	NOUN
bam-10833	73	26	of	of	ADP
bam-10833	73	27	toxicity.8	toxicity.8	PROPN
bam-10833	73	28	a	a	DET
bam-10833	73	29	study	study	NOUN
bam-10833	73	30	conducted	conduct	VERB
bam-10833	73	31	by	by	ADP
bam-10833	73	32	daikos	daikos	NOUN
bam-10833	73	33	et	et	PROPN
bam-10833	73	34	al	al	PROPN
bam-10833	73	35	.	.	PUNCT
bam-10833	74	1	(	(	PUNCT
bam-10833	74	2	2010)9	2010)9	NUM
bam-10833	74	3	on	on	ADP
bam-10833	74	4	13	13	NUM
bam-10833	74	5	patients	patient	NOUN
bam-10833	74	6	infected	infect	VERB
bam-10833	74	7	with	with	ADP
bam-10833	74	8	p.	p.	PROPN
bam-10833	74	9	aeruginosa	aeruginosa	PROPN
bam-10833	74	10	showed	show	VERB
bam-10833	74	11	that	that	SCONJ
bam-10833	74	12	8and	8and	NOUN
bam-10833	74	13	12	12	NUM
bam-10833	74	14	hourly	hourly	ADJ
bam-10833	74	15	regimens	regimen	NOUN
bam-10833	74	16	do	do	AUX
bam-10833	74	17	not	not	PART
bam-10833	74	18	provide	provide	VERB
bam-10833	74	19	the	the	DET
bam-10833	74	20	most	most	ADV
bam-10833	74	21	effective	effective	ADJ
bam-10833	74	22	intravenous	intravenous	ADJ
bam-10833	74	23	colistin	colistin	NOUN
bam-10833	74	24	monotherapy	monotherapy	NOUN
bam-10833	74	25	versus	versus	ADP
bam-10833	74	26	combination	combination	NOUN
bam-10833	74	27	therapy	therapy	NOUN
bam-10833	74	28	eur	eur	PROPN
bam-10833	74	29	j	j	PROPN
bam-10833	74	30	transl	transl	PROPN
bam-10833	74	31	myol	myol	ADV
bam-10833	74	32	32	32	NUM
bam-10833	74	33	(	(	PUNCT
bam-10833	74	34	4	4	NUM
bam-10833	74	35	):	):	PUNCT
bam-10833	74	36	10833	10833	NUM
bam-10833	74	37	,	,	PUNCT
bam-10833	74	38	2022	2022	NUM
bam-10833	74	39	doi	doi	NOUN
bam-10833	74	40	:	:	PUNCT
bam-10833	74	41	10.4081	10.4081	NUM
bam-10833	74	42	/	/	SYM
bam-10833	74	43	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	74	44	5	5	NUM
bam-10833	74	45	serum	serum	NOUN
bam-10833	74	46	concentration	concentration	NOUN
bam-10833	74	47	of	of	ADP
bam-10833	74	48	colistin	colistin	NOUN
bam-10833	74	49	and	and	CCONJ
bam-10833	74	50	bacterial	bacterial	ADJ
bam-10833	74	51	eradication	eradication	NOUN
bam-10833	74	52	and	and	CCONJ
bam-10833	74	53	justify	justify	VERB
bam-10833	74	54	administering	administer	VERB
bam-10833	74	55	larger	large	ADJ
bam-10833	74	56	dosages	dosage	NOUN
bam-10833	74	57	in	in	ADP
bam-10833	74	58	longer	long	ADJ
bam-10833	74	59	intervals	interval	NOUN
bam-10833	74	60	.	.	PUNCT
bam-10833	75	1	discussion	discussion	NOUN
bam-10833	75	2	our	our	PRON
bam-10833	75	3	systematic	systematic	ADJ
bam-10833	75	4	review	review	NOUN
bam-10833	75	5	and	and	CCONJ
bam-10833	75	6	meta	meta	ADJ
bam-10833	75	7	-	-	PUNCT
bam-10833	75	8	analysis	analysis	NOUN
bam-10833	75	9	showed	show	VERB
bam-10833	75	10	that	that	SCONJ
bam-10833	75	11	combination	combination	NOUN
bam-10833	75	12	therapy	therapy	NOUN
bam-10833	75	13	with	with	ADP
bam-10833	75	14	colistin	colistin	NOUN
bam-10833	75	15	as	as	SCONJ
bam-10833	75	16	the	the	DET
bam-10833	75	17	primary	primary	ADJ
bam-10833	75	18	drug	drug	NOUN
bam-10833	75	19	significantly	significantly	ADV
bam-10833	75	20	decreases	decrease	VERB
bam-10833	75	21	the	the	DET
bam-10833	75	22	odds	odd	NOUN
bam-10833	75	23	of	of	ADP
bam-10833	75	24	mortality	mortality	NOUN
bam-10833	75	25	by	by	ADP
bam-10833	75	26	23	23	NUM
bam-10833	75	27	%	%	NOUN
bam-10833	75	28	compared	compare	VERB
bam-10833	75	29	to	to	ADP
bam-10833	75	30	monotherapy	monotherapy	NOUN
bam-10833	75	31	.	.	PUNCT
bam-10833	76	1	various	various	ADJ
bam-10833	76	2	antibiotics	antibiotic	NOUN
bam-10833	76	3	have	have	AUX
bam-10833	76	4	been	be	AUX
bam-10833	76	5	used	use	VERB
bam-10833	76	6	in	in	ADP
bam-10833	76	7	combination	combination	NOUN
bam-10833	76	8	with	with	ADP
bam-10833	76	9	colistin	colistin	NOUN
bam-10833	76	10	to	to	PART
bam-10833	76	11	treat	treat	VERB
bam-10833	76	12	infection	infection	NOUN
bam-10833	76	13	with	with	ADP
bam-10833	76	14	multi	multi	ADJ
bam-10833	76	15	-	-	ADJ
bam-10833	76	16	drug	drug	ADJ
bam-10833	76	17	resistant	resistant	ADJ
bam-10833	76	18	gram	gram	NOUN
bam-10833	76	19	-	-	PUNCT
bam-10833	76	20	negative	negative	ADJ
bam-10833	76	21	bacteria	bacteria	NOUN
bam-10833	76	22	.	.	PUNCT
bam-10833	77	1	carbapenem	carbapenem	PROPN
bam-10833	77	2	(	(	PUNCT
bam-10833	77	3	specifically	specifically	ADV
bam-10833	77	4	meropenem	meropenem	ADJ
bam-10833	77	5	)	)	PUNCT
bam-10833	77	6	and	and	CCONJ
bam-10833	77	7	tigecycline	tigecycline	NOUN
bam-10833	77	8	are	be	AUX
bam-10833	77	9	the	the	DET
bam-10833	77	10	most	most	ADV
bam-10833	77	11	used	use	VERB
bam-10833	77	12	antibiotics	antibiotic	NOUN
bam-10833	77	13	in	in	ADP
bam-10833	77	14	previous	previous	ADJ
bam-10833	77	15	studies	study	NOUN
bam-10833	77	16	.	.	PUNCT
bam-10833	78	1	the	the	DET
bam-10833	78	2	odds	odd	NOUN
bam-10833	78	3	of	of	ADP
bam-10833	78	4	reducing	reduce	VERB
bam-10833	78	5	mortality	mortality	NOUN
bam-10833	78	6	by	by	ADP
bam-10833	78	7	combination	combination	NOUN
bam-10833	78	8	therapy	therapy	NOUN
bam-10833	78	9	with	with	ADP
bam-10833	78	10	carbapenem	carbapenem	PROPN
bam-10833	78	11	and	and	CCONJ
bam-10833	78	12	tigecycline	tigecycline	NOUN
bam-10833	78	13	are	be	AUX
bam-10833	78	14	26	26	NUM
bam-10833	78	15	%	%	NOUN
bam-10833	78	16	and	and	CCONJ
bam-10833	78	17	22	22	NUM
bam-10833	78	18	%	%	NOUN
bam-10833	78	19	,	,	PUNCT
bam-10833	78	20	respectively	respectively	ADV
bam-10833	78	21	.	.	PUNCT
bam-10833	79	1	however	however	ADV
bam-10833	79	2	,	,	PUNCT
bam-10833	79	3	the	the	DET
bam-10833	79	4	observed	observed	ADJ
bam-10833	79	5	decrease	decrease	NOUN
bam-10833	79	6	in	in	ADP
bam-10833	79	7	mortality	mortality	NOUN
bam-10833	79	8	by	by	ADP
bam-10833	79	9	these	these	DET
bam-10833	79	10	two	two	NUM
bam-10833	79	11	antibiotics	antibiotic	NOUN
bam-10833	79	12	is	be	AUX
bam-10833	79	13	non	non	ADJ
bam-10833	79	14	-	-	ADJ
bam-10833	79	15	significant	significant	ADJ
bam-10833	79	16	.	.	PUNCT
bam-10833	80	1	the	the	DET
bam-10833	80	2	in	in	ADP
bam-10833	80	3	vitro	vitro	X
bam-10833	80	4	studies	study	NOUN
bam-10833	80	5	such	such	ADJ
bam-10833	80	6	as	as	ADP
bam-10833	80	7	zusman	zusman	NOUN
bam-10833	80	8	et	et	PROPN
bam-10833	80	9	al	al	PROPN
bam-10833	80	10	.	.	PROPN
bam-10833	80	11	,	,	PUNCT
bam-10833	80	12	(	(	PUNCT
bam-10833	80	13	2017)48	2017)48	NUM
bam-10833	80	14	suggest	suggest	VERB
bam-10833	80	15	a	a	DET
bam-10833	80	16	synergism	synergism	NOUN
bam-10833	80	17	between	between	ADP
bam-10833	80	18	colistin	colistin	NOUN
bam-10833	80	19	and	and	CCONJ
bam-10833	80	20	carbapenem	carbapenem	PROPN
bam-10833	80	21	,	,	PUNCT
bam-10833	80	22	especially	especially	ADV
bam-10833	80	23	in	in	ADP
bam-10833	80	24	acinetobacter	acinetobacter	ADJ
bam-10833	80	25	strains	strain	NOUN
bam-10833	80	26	.	.	PUNCT
bam-10833	81	1	up	up	ADP
bam-10833	81	2	to	to	PART
bam-10833	81	3	50	50	NUM
bam-10833	81	4	%	%	NOUN
bam-10833	81	5	of	of	ADP
bam-10833	81	6	klebsiella	klebsiella	NOUN
bam-10833	81	7	and	and	CCONJ
bam-10833	81	8	pseudomonas	pseudomona	NOUN
bam-10833	81	9	strains	strain	NOUN
bam-10833	81	10	also	also	ADV
bam-10833	81	11	show	show	VERB
bam-10833	81	12	synergism	synergism	NOUN
bam-10833	81	13	.	.	PUNCT
bam-10833	82	1	the	the	DET
bam-10833	82	2	mechanism	mechanism	NOUN
bam-10833	82	3	suggested	suggest	VERB
bam-10833	82	4	for	for	ADP
bam-10833	82	5	this	this	DET
bam-10833	82	6	synergism	synergism	NOUN
bam-10833	82	7	is	be	AUX
bam-10833	82	8	that	that	SCONJ
bam-10833	82	9	the	the	DET
bam-10833	82	10	colistin	colistin	NOUN
bam-10833	82	11	molecule	molecule	NOUN
bam-10833	82	12	changes	change	VERB
bam-10833	82	13	the	the	DET
bam-10833	82	14	permeability	permeability	NOUN
bam-10833	82	15	of	of	ADP
bam-10833	82	16	bacterial	bacterial	ADJ
bam-10833	82	17	cells	cell	NOUN
bam-10833	82	18	,	,	PUNCT
bam-10833	82	19	which	which	PRON
bam-10833	82	20	allows	allow	VERB
bam-10833	82	21	meropenem	meropenem	PROPN
bam-10833	82	22	to	to	PART
bam-10833	82	23	enter	enter	VERB
bam-10833	82	24	the	the	DET
bam-10833	82	25	bacterial	bacterial	ADJ
bam-10833	82	26	cell	cell	NOUN
bam-10833	82	27	in	in	ADP
bam-10833	82	28	higher	high	ADJ
bam-10833	82	29	amounts	amount	NOUN
bam-10833	82	30	than	than	ADP
bam-10833	82	31	administering	administer	VERB
bam-10833	82	32	meropenem	meropenem	PROPN
bam-10833	82	33	alone	alone	ADV
bam-10833	82	34	.	.	PUNCT
bam-10833	83	1	this	this	DET
bam-10833	83	2	combination	combination	NOUN
bam-10833	83	3	could	could	AUX
bam-10833	83	4	even	even	ADV
bam-10833	83	5	reduce	reduce	VERB
bam-10833	83	6	fig	fig	NOUN
bam-10833	83	7	3	3	NUM
bam-10833	83	8	.	.	PUNCT
bam-10833	83	9	forest	forest	NOUN
bam-10833	83	10	plot	plot	NOUN
bam-10833	83	11	of	of	ADP
bam-10833	83	12	all	all	PRON
bam-10833	83	13	included	include	VERB
bam-10833	83	14	studies	study	NOUN
bam-10833	83	15	in	in	ADP
bam-10833	83	16	combination	combination	NOUN
bam-10833	83	17	therapy	therapy	NOUN
bam-10833	83	18	.	.	PUNCT
bam-10833	84	1	intravenous	intravenous	ADJ
bam-10833	84	2	colistin	colistin	PROPN
bam-10833	84	3	monotherapy	monotherapy	NOUN
bam-10833	84	4	versus	versus	ADP
bam-10833	84	5	combination	combination	NOUN
bam-10833	84	6	therapy	therapy	NOUN
bam-10833	84	7	eur	eur	PROPN
bam-10833	84	8	j	j	PROPN
bam-10833	84	9	transl	transl	PROPN
bam-10833	84	10	myol	myol	ADV
bam-10833	84	11	32	32	NUM
bam-10833	84	12	(	(	PUNCT
bam-10833	84	13	4	4	NUM
bam-10833	84	14	):	):	PUNCT
bam-10833	84	15	10833	10833	NUM
bam-10833	84	16	,	,	PUNCT
bam-10833	84	17	2022	2022	NUM
bam-10833	84	18	doi	doi	NOUN
bam-10833	84	19	:	:	PUNCT
bam-10833	84	20	10.4081	10.4081	NUM
bam-10833	84	21	/	/	SYM
bam-10833	84	22	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	84	23	6	6	NUM
bam-10833	84	24	the	the	DET
bam-10833	84	25	effect	effect	NOUN
bam-10833	84	26	of	of	ADP
bam-10833	84	27	resistance	resistance	NOUN
bam-10833	84	28	mechanisms.41	mechanisms.41	NOUN
bam-10833	84	29	however	however	ADV
bam-10833	84	30	,	,	PUNCT
bam-10833	84	31	in	in	ADP
bam-10833	84	32	clinical	clinical	ADJ
bam-10833	84	33	settings	setting	NOUN
bam-10833	84	34	,	,	PUNCT
bam-10833	84	35	the	the	DET
bam-10833	84	36	results	result	NOUN
bam-10833	84	37	are	be	AUX
bam-10833	84	38	various	various	ADJ
bam-10833	84	39	,	,	PUNCT
bam-10833	84	40	and	and	CCONJ
bam-10833	84	41	some	some	DET
bam-10833	84	42	studies	study	NOUN
bam-10833	84	43	have	have	AUX
bam-10833	84	44	failed	fail	VERB
bam-10833	84	45	to	to	PART
bam-10833	84	46	support	support	VERB
bam-10833	84	47	that	that	SCONJ
bam-10833	84	48	the	the	DET
bam-10833	84	49	superiority	superiority	NOUN
bam-10833	84	50	of	of	ADP
bam-10833	84	51	colistin	colistin	NOUN
bam-10833	84	52	plus	plus	CCONJ
bam-10833	84	53	meropenem	meropenem	PROPN
bam-10833	84	54	over	over	ADP
bam-10833	84	55	monotherapy	monotherapy	NOUN
bam-10833	84	56	.	.	PUNCT
bam-10833	85	1	our	our	PRON
bam-10833	85	2	metaanalysis	metaanalysis	NOUN
bam-10833	85	3	also	also	ADV
bam-10833	85	4	did	do	AUX
bam-10833	85	5	not	not	PART
bam-10833	85	6	show	show	VERB
bam-10833	85	7	any	any	DET
bam-10833	85	8	significant	significant	ADJ
bam-10833	85	9	superiority	superiority	NOUN
bam-10833	85	10	.	.	PUNCT
bam-10833	86	1	an	an	DET
bam-10833	86	2	explanation	explanation	NOUN
bam-10833	86	3	for	for	ADP
bam-10833	86	4	this	this	DET
bam-10833	86	5	result	result	NOUN
bam-10833	86	6	is	be	AUX
bam-10833	86	7	that	that	SCONJ
bam-10833	86	8	,	,	PUNCT
bam-10833	86	9	in	in	ADP
bam-10833	86	10	a	a	DET
bam-10833	86	11	severe	severe	ADJ
bam-10833	86	12	cases	case	NOUN
bam-10833	86	13	of	of	ADP
bam-10833	86	14	infections	infection	NOUN
bam-10833	86	15	,	,	PUNCT
bam-10833	86	16	it	it	PRON
bam-10833	86	17	is	be	AUX
bam-10833	86	18	more	more	ADV
bam-10833	86	19	likely	likely	ADJ
bam-10833	86	20	to	to	PART
bam-10833	86	21	administer	administer	VERB
bam-10833	86	22	the	the	DET
bam-10833	86	23	combination	combination	NOUN
bam-10833	86	24	therapy	therapy	NOUN
bam-10833	86	25	rather	rather	ADV
bam-10833	86	26	than	than	ADP
bam-10833	86	27	monotherapy	monotherapy	NOUN
bam-10833	86	28	,	,	PUNCT
bam-10833	86	29	particularly	particularly	ADV
bam-10833	86	30	in	in	ADP
bam-10833	86	31	observational	observational	ADJ
bam-10833	86	32	studies	study	NOUN
bam-10833	86	33	.	.	PUNCT
bam-10833	87	1	in	in	ADP
bam-10833	87	2	other	other	ADJ
bam-10833	87	3	words	word	NOUN
bam-10833	87	4	,	,	PUNCT
bam-10833	87	5	the	the	DET
bam-10833	87	6	combination	combination	NOUN
bam-10833	87	7	group	group	NOUN
bam-10833	87	8	had	have	VERB
bam-10833	87	9	a	a	DET
bam-10833	87	10	significantly	significantly	ADV
bam-10833	87	11	higher	high	ADJ
bam-10833	87	12	proportion	proportion	NOUN
bam-10833	87	13	of	of	ADP
bam-10833	87	14	severe	severe	ADJ
bam-10833	87	15	cases	case	NOUN
bam-10833	87	16	,	,	PUNCT
bam-10833	87	17	and	and	CCONJ
bam-10833	87	18	physicians	physician	NOUN
bam-10833	87	19	chose	choose	VERB
bam-10833	87	20	combination	combination	NOUN
bam-10833	87	21	therapy	therapy	NOUN
bam-10833	87	22	in	in	ADP
bam-10833	87	23	more	more	ADV
bam-10833	87	24	severe	severe	ADJ
bam-10833	87	25	cases	case	NOUN
bam-10833	87	26	.	.	PUNCT
bam-10833	88	1	thus	thus	ADV
bam-10833	88	2	,	,	PUNCT
bam-10833	88	3	if	if	SCONJ
bam-10833	88	4	more	more	ADV
bam-10833	88	5	severe	severe	ADJ
bam-10833	88	6	cases	case	NOUN
bam-10833	88	7	included	include	VERB
bam-10833	88	8	in	in	ADP
bam-10833	88	9	the	the	DET
bam-10833	88	10	combination	combination	NOUN
bam-10833	88	11	group	group	NOUN
bam-10833	88	12	had	have	VERB
bam-10833	88	13	the	the	DET
bam-10833	88	14	same	same	ADJ
bam-10833	88	15	mortality	mortality	NOUN
bam-10833	88	16	as	as	ADP
bam-10833	88	17	the	the	DET
bam-10833	88	18	monotherapy	monotherapy	NOUN
bam-10833	88	19	group	group	NOUN
bam-10833	88	20	,	,	PUNCT
bam-10833	88	21	there	there	PRON
bam-10833	88	22	is	be	VERB
bam-10833	88	23	a	a	DET
bam-10833	88	24	possibility	possibility	NOUN
bam-10833	88	25	that	that	SCONJ
bam-10833	88	26	combination	combination	NOUN
bam-10833	88	27	therapy	therapy	NOUN
bam-10833	88	28	has	have	AUX
bam-10833	88	29	better	well	ADJ
bam-10833	88	30	efficacy.41	efficacy.41	NOUN
bam-10833	88	31	tigecycline	tigecycline	NOUN
bam-10833	88	32	is	be	AUX
bam-10833	88	33	a	a	DET
bam-10833	88	34	member	member	NOUN
bam-10833	88	35	of	of	ADP
bam-10833	88	36	the	the	DET
bam-10833	88	37	glycylcycline	glycylcycline	ADJ
bam-10833	88	38	class	class	NOUN
bam-10833	88	39	of	of	ADP
bam-10833	88	40	antibiotics	antibiotic	NOUN
bam-10833	88	41	developed	develop	VERB
bam-10833	88	42	to	to	PART
bam-10833	88	43	treat	treat	VERB
bam-10833	88	44	multidrugresistant	multidrugresistant	ADJ
bam-10833	88	45	gram	gram	NOUN
bam-10833	88	46	-	-	PUNCT
bam-10833	88	47	positive	positive	ADJ
bam-10833	88	48	and	and	CCONJ
bam-10833	88	49	gram	gram	NOUN
bam-10833	88	50	-	-	PUNCT
bam-10833	88	51	negative	negative	ADJ
bam-10833	88	52	bacteria	bacteria	NOUN
bam-10833	88	53	and	and	CCONJ
bam-10833	88	54	acts	act	VERB
bam-10833	88	55	as	as	ADP
bam-10833	88	56	a	a	DET
bam-10833	88	57	bacteriostatic	bacteriostatic	ADJ
bam-10833	88	58	antibiotic.49	antibiotic.49	PROPN
bam-10833	88	59	previous	previous	ADJ
bam-10833	88	60	studies	study	NOUN
bam-10833	88	61	have	have	AUX
bam-10833	88	62	shown	show	VERB
bam-10833	88	63	a	a	DET
bam-10833	88	64	synergism	synergism	NOUN
bam-10833	88	65	between	between	ADP
bam-10833	88	66	tigecycline	tigecycline	NOUN
bam-10833	88	67	and	and	CCONJ
bam-10833	88	68	colistin	colistin	VERB
bam-10833	88	69	in	in	ADP
bam-10833	88	70	the	the	DET
bam-10833	88	71	high	high	ADJ
bam-10833	88	72	dosage	dosage	NOUN
bam-10833	88	73	of	of	ADP
bam-10833	88	74	tigecycline	tigecycline	NOUN
bam-10833	88	75	but	but	CCONJ
bam-10833	88	76	not	not	PART
bam-10833	88	77	in	in	ADP
bam-10833	88	78	the	the	DET
bam-10833	88	79	low	low	ADJ
bam-10833	88	80	dosage	dosage	NOUN
bam-10833	88	81	of	of	ADP
bam-10833	88	82	tigecycline.50	tigecycline.50	PROPN
bam-10833	88	83	however	however	ADV
bam-10833	88	84	,	,	PUNCT
bam-10833	88	85	again	again	ADV
bam-10833	88	86	in	in	ADP
bam-10833	88	87	clinical	clinical	ADJ
bam-10833	88	88	setting	setting	NOUN
bam-10833	88	89	,	,	PUNCT
bam-10833	88	90	tigecycline	tigecycline	NOUN
bam-10833	88	91	plus	plus	CCONJ
bam-10833	88	92	colistin	colistin	NOUN
bam-10833	88	93	combination	combination	NOUN
bam-10833	88	94	therapy	therapy	NOUN
bam-10833	88	95	was	be	AUX
bam-10833	88	96	not	not	PART
bam-10833	88	97	associated	associate	VERB
bam-10833	88	98	with	with	ADP
bam-10833	88	99	decreased	decrease	VERB
bam-10833	88	100	mortality	mortality	NOUN
bam-10833	88	101	.	.	PUNCT
bam-10833	89	1	like	like	ADP
bam-10833	89	2	the	the	DET
bam-10833	89	3	meropenem	meropenem	PROPN
bam-10833	89	4	case	case	NOUN
bam-10833	89	5	,	,	PUNCT
bam-10833	89	6	tigecycline	tigecycline	PROPN
bam-10833	89	7	plus	plus	CCONJ
bam-10833	89	8	colistin	colistin	NOUN
bam-10833	89	9	is	be	AUX
bam-10833	89	10	used	use	VERB
bam-10833	89	11	in	in	ADP
bam-10833	89	12	severe	severe	ADJ
bam-10833	89	13	cases	case	NOUN
bam-10833	89	14	.	.	PUNCT
bam-10833	90	1	these	these	DET
bam-10833	90	2	results	result	NOUN
bam-10833	90	3	highlight	highlight	VERB
bam-10833	90	4	a	a	DET
bam-10833	90	5	need	need	NOUN
bam-10833	90	6	for	for	ADP
bam-10833	90	7	matched	match	VERB
bam-10833	90	8	randomized	randomize	VERB
bam-10833	90	9	clinical	clinical	ADJ
bam-10833	90	10	trials	trial	NOUN
bam-10833	90	11	to	to	PART
bam-10833	90	12	assess	assess	VERB
bam-10833	90	13	the	the	DET
bam-10833	90	14	effect	effect	NOUN
bam-10833	90	15	of	of	ADP
bam-10833	90	16	combination	combination	NOUN
bam-10833	90	17	therapy	therapy	NOUN
bam-10833	90	18	on	on	ADP
bam-10833	90	19	survival	survival	NOUN
bam-10833	90	20	rate	rate	NOUN
bam-10833	90	21	.	.	PUNCT
bam-10833	91	1	at	at	ADP
bam-10833	91	2	present	present	ADJ
bam-10833	91	3	,	,	PUNCT
bam-10833	91	4	the	the	DET
bam-10833	91	5	recommended	recommend	VERB
bam-10833	91	6	dosing	dose	VERB
bam-10833	91	7	intervals	interval	NOUN
bam-10833	91	8	of	of	ADP
bam-10833	91	9	colistin	colistin	PROPN
bam-10833	91	10	are	be	AUX
bam-10833	91	11	8-	8-	PROPN
bam-10833	91	12	,	,	PUNCT
bam-10833	91	13	12-	12-	ADV
bam-10833	91	14	,	,	PUNCT
bam-10833	91	15	and	and	CCONJ
bam-10833	91	16	24	24	NUM
bam-10833	91	17	-	-	PUNCT
bam-10833	91	18	hourly	hourly	NOUN
bam-10833	91	19	in	in	ADP
bam-10833	91	20	patients	patient	NOUN
bam-10833	91	21	without	without	ADP
bam-10833	91	22	renal	renal	ADJ
bam-10833	91	23	dysfunction	dysfunction	NOUN
bam-10833	91	24	.	.	PUNCT
bam-10833	92	1	the	the	DET
bam-10833	92	2	dosing	dosing	NOUN
bam-10833	92	3	interval	interval	NOUN
bam-10833	92	4	can	can	AUX
bam-10833	92	5	affect	affect	VERB
bam-10833	92	6	the	the	DET
bam-10833	92	7	efficacy	efficacy	NOUN
bam-10833	92	8	of	of	ADP
bam-10833	92	9	the	the	DET
bam-10833	92	10	treatment	treatment	NOUN
bam-10833	92	11	,	,	PUNCT
bam-10833	92	12	side	side	NOUN
bam-10833	92	13	effects	effect	NOUN
bam-10833	92	14	of	of	ADP
bam-10833	92	15	the	the	DET
bam-10833	92	16	colistin	colistin	NOUN
bam-10833	92	17	,	,	PUNCT
bam-10833	92	18	and	and	CCONJ
bam-10833	92	19	emerging	emerge	VERB
bam-10833	92	20	resistant	resistant	ADJ
bam-10833	92	21	strains	strain	NOUN
bam-10833	92	22	.	.	PUNCT
bam-10833	93	1	theoretically	theoretically	ADV
bam-10833	93	2	,	,	PUNCT
bam-10833	93	3	the	the	DET
bam-10833	93	4	long	long	ADJ
bam-10833	93	5	half	half	ADJ
bam-10833	93	6	-	-	PUNCT
bam-10833	93	7	life	life	NOUN
bam-10833	93	8	of	of	ADP
bam-10833	93	9	colistin	colistin	PROPN
bam-10833	93	10	suggests	suggest	VERB
bam-10833	93	11	that	that	SCONJ
bam-10833	93	12	it	it	PRON
bam-10833	93	13	could	could	AUX
bam-10833	93	14	be	be	AUX
bam-10833	93	15	used	use	VERB
bam-10833	93	16	in	in	ADP
bam-10833	93	17	extended	extended	ADJ
bam-10833	93	18	intervals	interval	NOUN
bam-10833	93	19	,	,	PUNCT
bam-10833	93	20	which	which	PRON
bam-10833	93	21	could	could	AUX
bam-10833	93	22	result	result	VERB
bam-10833	93	23	in	in	ADP
bam-10833	93	24	higher	high	ADJ
bam-10833	93	25	peak	peak	NOUN
bam-10833	93	26	concentration	concentration	NOUN
bam-10833	93	27	and	and	CCONJ
bam-10833	93	28	better	well	ADJ
bam-10833	93	29	efficacy	efficacy	NOUN
bam-10833	93	30	,	,	PUNCT
bam-10833	93	31	more	more	ADV
bam-10833	93	32	effective	effective	ADJ
bam-10833	93	33	bacterial	bacterial	ADJ
bam-10833	93	34	eradication	eradication	NOUN
bam-10833	93	35	,	,	PUNCT
bam-10833	93	36	and	and	CCONJ
bam-10833	93	37	lower	low	ADJ
bam-10833	93	38	side	side	NOUN
bam-10833	93	39	effects	effect	NOUN
bam-10833	93	40	and	and	CCONJ
bam-10833	93	41	nephrotoxicity.9	nephrotoxicity.9	NOUN
bam-10833	93	42	however	however	ADV
bam-10833	93	43	,	,	PUNCT
bam-10833	93	44	an	an	DET
bam-10833	93	45	in	in	ADP
bam-10833	93	46	vitro	vitro	X
bam-10833	93	47	study	study	NOUN
bam-10833	93	48	showed	show	VERB
bam-10833	93	49	that	that	SCONJ
bam-10833	93	50	extended	extended	ADJ
bam-10833	93	51	intervals	interval	NOUN
bam-10833	93	52	are	be	AUX
bam-10833	93	53	associated	associate	VERB
bam-10833	93	54	with	with	ADP
bam-10833	93	55	the	the	DET
bam-10833	93	56	emergence	emergence	NOUN
bam-10833	93	57	of	of	ADP
bam-10833	93	58	resistant	resistant	ADJ
bam-10833	93	59	strains	strain	NOUN
bam-10833	93	60	because	because	SCONJ
bam-10833	93	61	of	of	ADP
bam-10833	93	62	periods	period	NOUN
bam-10833	93	63	of	of	ADP
bam-10833	93	64	low	low	ADJ
bam-10833	93	65	colistin	colistin	NOUN
bam-10833	93	66	concentration	concentration	NOUN
bam-10833	93	67	,	,	PUNCT
bam-10833	93	68	and	and	CCONJ
bam-10833	93	69	there	there	PRON
bam-10833	93	70	is	be	VERB
bam-10833	93	71	no	no	DET
bam-10833	93	72	significant	significant	ADJ
bam-10833	93	73	difference	difference	NOUN
bam-10833	93	74	regarding	regard	VERB
bam-10833	93	75	bacterial	bacterial	ADJ
bam-10833	93	76	eradication	eradication	NOUN
bam-10833	93	77	between	between	ADP
bam-10833	93	78	different	different	ADJ
bam-10833	93	79	dosing	dose	VERB
bam-10833	93	80	intervals.6	intervals.6	NOUN
bam-10833	93	81	another	another	DET
bam-10833	93	82	study	study	NOUN
bam-10833	93	83	in	in	ADP
bam-10833	93	84	a	a	DET
bam-10833	93	85	clinical	clinical	ADJ
bam-10833	93	86	setting	setting	NOUN
bam-10833	93	87	showed	show	VERB
bam-10833	93	88	that	that	SCONJ
bam-10833	93	89	there	there	PRON
bam-10833	93	90	is	be	VERB
bam-10833	93	91	no	no	DET
bam-10833	93	92	difference	difference	NOUN
bam-10833	93	93	in	in	ADP
bam-10833	93	94	survival	survival	NOUN
bam-10833	93	95	and	and	CCONJ
bam-10833	93	96	efficacy	efficacy	NOUN
bam-10833	93	97	between	between	ADP
bam-10833	93	98	8and	8and	PROPN
bam-10833	93	99	24	24	NUM
bam-10833	93	100	hour	hour	NOUN
bam-10833	93	101	intervals.7	intervals.7	NOUN
bam-10833	93	102	there	there	PRON
bam-10833	93	103	is	be	VERB
bam-10833	93	104	a	a	DET
bam-10833	93	105	dearth	dearth	NOUN
bam-10833	93	106	of	of	ADP
bam-10833	93	107	literature	literature	NOUN
bam-10833	93	108	in	in	ADP
bam-10833	93	109	randomized	randomized	ADJ
bam-10833	93	110	,	,	PUNCT
bam-10833	93	111	controlled	control	VERB
bam-10833	93	112	,	,	PUNCT
bam-10833	93	113	clinical	clinical	ADJ
bam-10833	93	114	trials	trial	NOUN
bam-10833	93	115	evaluating	evaluate	VERB
bam-10833	93	116	the	the	DET
bam-10833	93	117	efficacy	efficacy	NOUN
bam-10833	93	118	and	and	CCONJ
bam-10833	93	119	safety	safety	NOUN
bam-10833	93	120	of	of	ADP
bam-10833	93	121	once-	once-	X
bam-10833	93	122	,	,	PUNCT
bam-10833	93	123	twiceand	twiceand	NOUN
bam-10833	93	124	thrice	thrice	PROPN
bam-10833	93	125	-	-	PUNCT
bam-10833	93	126	daily	daily	PROPN
bam-10833	93	127	colistin	colistin	NOUN
bam-10833	93	128	dosing	dosing	NOUN
bam-10833	93	129	.	.	PUNCT
bam-10833	94	1	our	our	PRON
bam-10833	94	2	systematic	systematic	ADJ
bam-10833	94	3	review	review	NOUN
bam-10833	94	4	and	and	CCONJ
bam-10833	94	5	meta	meta	ADJ
bam-10833	94	6	-	-	PUNCT
bam-10833	94	7	analysis	analysis	NOUN
bam-10833	94	8	are	be	AUX
bam-10833	94	9	the	the	DET
bam-10833	94	10	first	first	ADJ
bam-10833	94	11	to	to	PART
bam-10833	94	12	investigate	investigate	VERB
bam-10833	94	13	the	the	DET
bam-10833	94	14	efficacy	efficacy	NOUN
bam-10833	94	15	of	of	ADP
bam-10833	94	16	different	different	ADJ
bam-10833	94	17	dosing	dose	VERB
bam-10833	94	18	intervals	interval	NOUN
bam-10833	94	19	of	of	ADP
bam-10833	94	20	colistin	colistin	PROPN
bam-10833	94	21	.	.	PUNCT
bam-10833	95	1	we	we	PRON
bam-10833	95	2	provide	provide	VERB
bam-10833	95	3	the	the	DET
bam-10833	95	4	subgroup	subgroup	NOUN
bam-10833	95	5	analysis	analysis	NOUN
bam-10833	95	6	for	for	ADP
bam-10833	95	7	the	the	DET
bam-10833	95	8	efficacy	efficacy	NOUN
bam-10833	95	9	of	of	ADP
bam-10833	95	10	different	different	ADJ
bam-10833	95	11	antibiotics	antibiotic	NOUN
bam-10833	95	12	plus	plus	CCONJ
bam-10833	95	13	colistin	colistin	NOUN
bam-10833	95	14	.	.	PUNCT
bam-10833	96	1	in	in	ADP
bam-10833	96	2	this	this	DET
bam-10833	96	3	study	study	NOUN
bam-10833	96	4	,	,	PUNCT
bam-10833	96	5	we	we	PRON
bam-10833	96	6	also	also	ADV
bam-10833	96	7	conducted	conduct	VERB
bam-10833	96	8	a	a	DET
bam-10833	96	9	publication	publication	NOUN
bam-10833	96	10	bias	bias	NOUN
bam-10833	96	11	analysis	analysis	NOUN
bam-10833	96	12	.	.	PUNCT
bam-10833	97	1	however	however	ADV
bam-10833	97	2	,	,	PUNCT
bam-10833	97	3	there	there	PRON
bam-10833	97	4	are	be	VERB
bam-10833	97	5	some	some	DET
bam-10833	97	6	limitations	limitation	NOUN
bam-10833	97	7	:	:	PUNCT
bam-10833	97	8	1	1	X
bam-10833	97	9	)	)	PUNCT
bam-10833	97	10	lack	lack	NOUN
bam-10833	97	11	of	of	ADP
bam-10833	97	12	sufficient	sufficient	ADJ
bam-10833	97	13	rcts	rct	NOUN
bam-10833	97	14	on	on	ADP
bam-10833	97	15	both	both	DET
bam-10833	97	16	combination	combination	NOUN
bam-10833	97	17	therapy	therapy	NOUN
bam-10833	97	18	and	and	CCONJ
bam-10833	97	19	dosing	dosing	NOUN
bam-10833	97	20	intervals	interval	NOUN
bam-10833	97	21	to	to	PART
bam-10833	97	22	include	include	VERB
bam-10833	97	23	in	in	ADP
bam-10833	97	24	our	our	PRON
bam-10833	97	25	study	study	NOUN
bam-10833	97	26	,	,	PUNCT
bam-10833	97	27	2	2	X
bam-10833	97	28	)	)	PUNCT
bam-10833	97	29	the	the	DET
bam-10833	97	30	results	result	NOUN
bam-10833	97	31	were	be	AUX
bam-10833	97	32	not	not	PART
bam-10833	97	33	stratified	stratify	VERB
bam-10833	97	34	by	by	ADP
bam-10833	97	35	infection	infection	NOUN
bam-10833	97	36	type	type	NOUN
bam-10833	97	37	and	and	CCONJ
bam-10833	97	38	type	type	NOUN
bam-10833	97	39	of	of	ADP
bam-10833	97	40	organism	organism	NOUN
bam-10833	97	41	.	.	PUNCT
bam-10833	98	1	3	3	X
bam-10833	98	2	)	)	PUNCT
bam-10833	98	3	because	because	SCONJ
bam-10833	98	4	of	of	ADP
bam-10833	98	5	the	the	DET
bam-10833	98	6	heterogenicity	heterogenicity	NOUN
bam-10833	98	7	of	of	ADP
bam-10833	98	8	the	the	DET
bam-10833	98	9	studies	study	NOUN
bam-10833	98	10	for	for	ADP
bam-10833	98	11	dosing	dosing	NOUN
bam-10833	98	12	intervals	interval	NOUN
bam-10833	98	13	,	,	PUNCT
bam-10833	98	14	we	we	PRON
bam-10833	98	15	could	could	AUX
bam-10833	98	16	not	not	PART
bam-10833	98	17	conduct	conduct	VERB
bam-10833	98	18	a	a	DET
bam-10833	98	19	metaanalysis	metaanalysis	NOUN
bam-10833	98	20	in	in	ADP
bam-10833	98	21	conclusion	conclusion	NOUN
bam-10833	98	22	,	,	PUNCT
bam-10833	98	23	it	it	PRON
bam-10833	98	24	seems	seem	VERB
bam-10833	98	25	that	that	SCONJ
bam-10833	98	26	combination	combination	NOUN
bam-10833	98	27	therapy	therapy	NOUN
bam-10833	98	28	,	,	PUNCT
bam-10833	98	29	particularly	particularly	ADV
bam-10833	98	30	colistin	colistin	NOUN
bam-10833	98	31	plus	plus	CCONJ
bam-10833	98	32	meropenem	meropenem	PROPN
bam-10833	98	33	,	,	PUNCT
bam-10833	98	34	is	be	AUX
bam-10833	98	35	associated	associate	VERB
bam-10833	98	36	with	with	ADP
bam-10833	98	37	drug	drug	NOUN
bam-10833	98	38	synergism	synergism	NOUN
bam-10833	98	39	and	and	CCONJ
bam-10833	98	40	result	result	VERB
bam-10833	98	41	in	in	ADP
bam-10833	98	42	increased	increase	VERB
bam-10833	98	43	survival	survival	NOUN
bam-10833	98	44	and	and	CCONJ
bam-10833	98	45	efficacy	efficacy	NOUN
bam-10833	98	46	.	.	PUNCT
bam-10833	99	1	however	however	ADV
bam-10833	99	2	,	,	PUNCT
bam-10833	99	3	it	it	PRON
bam-10833	99	4	is	be	AUX
bam-10833	99	5	not	not	PART
bam-10833	99	6	statistically	statistically	ADV
bam-10833	99	7	significant	significant	ADJ
bam-10833	99	8	.	.	PUNCT
bam-10833	100	1	the	the	DET
bam-10833	100	2	extended	extended	ADJ
bam-10833	100	3	interval	interval	NOUN
bam-10833	100	4	of	of	ADP
bam-10833	100	5	colistin	colistin	PROPN
bam-10833	100	6	administration	administration	PROPN
bam-10833	100	7	may	may	AUX
bam-10833	100	8	result	result	VERB
bam-10833	100	9	in	in	ADP
bam-10833	100	10	higher	high	ADJ
bam-10833	100	11	peak	peak	NOUN
bam-10833	100	12	concentration	concentration	NOUN
bam-10833	100	13	and	and	CCONJ
bam-10833	100	14	bacterial	bacterial	ADJ
bam-10833	100	15	eradication	eradication	NOUN
bam-10833	100	16	.	.	PUNCT
bam-10833	101	1	in	in	ADP
bam-10833	101	2	both	both	DET
bam-10833	101	3	cases	case	NOUN
bam-10833	101	4	,	,	PUNCT
bam-10833	101	5	we	we	PRON
bam-10833	101	6	face	face	VERB
bam-10833	101	7	a	a	DET
bam-10833	101	8	dearth	dearth	NOUN
bam-10833	101	9	of	of	ADP
bam-10833	101	10	literature	literature	NOUN
bam-10833	101	11	,	,	PUNCT
bam-10833	101	12	and	and	CCONJ
bam-10833	101	13	thus	thus	ADV
bam-10833	101	14	a	a	DET
bam-10833	101	15	need	need	NOUN
bam-10833	101	16	for	for	ADP
bam-10833	101	17	a	a	DET
bam-10833	101	18	randomized	randomized	ADJ
bam-10833	101	19	,	,	PUNCT
bam-10833	101	20	controlled	control	VERB
bam-10833	101	21	clinical	clinical	ADJ
bam-10833	101	22	trials	trial	NOUN
bam-10833	101	23	to	to	PART
bam-10833	101	24	investigate	investigate	VERB
bam-10833	101	25	dosing	dosing	NOUN
bam-10833	101	26	interval	interval	NOUN
bam-10833	101	27	of	of	ADP
bam-10833	101	28	colistin	colistin	PROPN
bam-10833	101	29	administration	administration	PROPN
bam-10833	101	30	and	and	CCONJ
bam-10833	101	31	the	the	DET
bam-10833	101	32	efficacy	efficacy	NOUN
bam-10833	101	33	and	and	CCONJ
bam-10833	101	34	safety	safety	NOUN
bam-10833	101	35	of	of	ADP
bam-10833	101	36	combination	combination	NOUN
bam-10833	101	37	therapy	therapy	NOUN
bam-10833	101	38	.	.	PUNCT
bam-10833	102	1	list	list	NOUN
bam-10833	102	2	of	of	ADP
bam-10833	102	3	acronyms	acronyms	PROPN
bam-10833	102	4	bsi	bsi	PROPN
bam-10833	102	5	–	–	PUNCT
bam-10833	102	6	bloodstream	bloodstream	NOUN
bam-10833	102	7	infection	infection	NOUN
bam-10833	102	8	ci	ci	NOUN
bam-10833	102	9	confidence	confidence	NOUN
bam-10833	102	10	interval	interval	NOUN
bam-10833	102	11	cms	cms	PROPN
bam-10833	102	12	colistimethate	colistimethate	NOUN
bam-10833	102	13	sodium	sodium	NOUN
bam-10833	102	14	icu	icu	PROPN
bam-10833	102	15	intensive	intensive	ADJ
bam-10833	102	16	care	care	PROPN
bam-10833	102	17	unit	unit	PROPN
bam-10833	102	18	mdr	mdr	PROPN
bam-10833	102	19	with	with	ADP
bam-10833	102	20	multi	multi	ADJ
bam-10833	102	21	-	-	ADJ
bam-10833	102	22	drug	drug	ADJ
bam-10833	102	23	resistence	resistence	NOUN
bam-10833	102	24	or	or	CCONJ
bam-10833	102	25	odds	odd	NOUN
bam-10833	102	26	ratio	ratio	NOUN
bam-10833	102	27	rct	rct	PROPN
bam-10833	102	28	randomized	randomize	VERB
bam-10833	102	29	controlled	control	VERB
bam-10833	102	30	trials	trial	NOUN
bam-10833	102	31	rr	rr	VERB
bam-10833	102	32	risk	risk	NOUN
bam-10833	102	33	ratio	ratio	NOUN
bam-10833	102	34	vap	vap	NOUN
bam-10833	102	35	ventilator	ventilator	NOUN
bam-10833	102	36	-	-	PUNCT
bam-10833	102	37	associated	associate	VERB
bam-10833	102	38	pneumonia	pneumonia	NOUN
bam-10833	102	39	xdr	xdr	PROPN
bam-10833	102	40	patients	patient	NOUN
bam-10833	102	41	extensively	extensively	ADV
bam-10833	102	42	drug	drug	NOUN
bam-10833	102	43	-	-	PUNCT
bam-10833	102	44	resistan	resistan	ADJ
bam-10833	102	45	contributions	contribution	NOUN
bam-10833	102	46	of	of	ADP
bam-10833	102	47	authors	author	NOUN
bam-10833	102	48	all	all	DET
bam-10833	102	49	authors	author	NOUN
bam-10833	102	50	have	have	AUX
bam-10833	102	51	read	read	VERB
bam-10833	102	52	and	and	CCONJ
bam-10833	102	53	approved	approve	VERB
bam-10833	102	54	the	the	DET
bam-10833	102	55	final	final	ADJ
bam-10833	102	56	edited	edited	ADJ
bam-10833	102	57	typescript	typescript	NOUN
bam-10833	102	58	.	.	PUNCT
bam-10833	103	1	acknowledgments	acknowledgment	NOUN
bam-10833	103	2	none	none	NOUN
bam-10833	103	3	.	.	PUNCT
bam-10833	104	1	funding	fund	VERB
bam-10833	104	2	the	the	DET
bam-10833	104	3	authors	author	NOUN
bam-10833	104	4	received	receive	VERB
bam-10833	104	5	no	no	DET
bam-10833	104	6	funding	funding	NOUN
bam-10833	104	7	for	for	ADP
bam-10833	104	8	this	this	DET
bam-10833	104	9	work	work	NOUN
bam-10833	104	10	.	.	PUNCT
bam-10833	105	1	conflict	conflict	NOUN
bam-10833	105	2	of	of	ADP
bam-10833	105	3	interest	interest	NOUN
bam-10833	105	4	the	the	DET
bam-10833	105	5	authors	author	NOUN
bam-10833	105	6	declare	declare	VERB
bam-10833	105	7	no	no	DET
bam-10833	105	8	conflicts	conflict	NOUN
bam-10833	105	9	of	of	ADP
bam-10833	105	10	interest	interest	NOUN
bam-10833	105	11	.	.	PUNCT
bam-10833	106	1	ethical	ethical	ADJ
bam-10833	106	2	publication	publication	NOUN
bam-10833	106	3	statement	statement	NOUN
bam-10833	106	4	we	we	PRON
bam-10833	106	5	confirm	confirm	VERB
bam-10833	106	6	that	that	SCONJ
bam-10833	106	7	we	we	PRON
bam-10833	106	8	have	have	AUX
bam-10833	106	9	read	read	VERB
bam-10833	106	10	the	the	DET
bam-10833	106	11	journal	journal	NOUN
bam-10833	106	12	’s	’s	PART
bam-10833	106	13	position	position	NOUN
bam-10833	106	14	on	on	ADP
bam-10833	106	15	issues	issue	NOUN
bam-10833	106	16	involved	involve	VERB
bam-10833	106	17	in	in	ADP
bam-10833	106	18	ethical	ethical	ADJ
bam-10833	106	19	publication	publication	NOUN
bam-10833	106	20	and	and	CCONJ
bam-10833	106	21	affirm	affirm	NOUN
bam-10833	106	22	that	that	SCONJ
bam-10833	106	23	this	this	DET
bam-10833	106	24	report	report	NOUN
bam-10833	106	25	is	be	AUX
bam-10833	106	26	consistent	consistent	ADJ
bam-10833	106	27	with	with	ADP
bam-10833	106	28	those	those	DET
bam-10833	106	29	guidelines	guideline	NOUN
bam-10833	106	30	.	.	PUNCT
bam-10833	107	1	fig	fig	NOUN
bam-10833	107	2	4	4	NUM
bam-10833	107	3	.	.	PUNCT
bam-10833	107	4	funnel	funnel	NOUN
bam-10833	107	5	plot	plot	NOUN
bam-10833	107	6	of	of	ADP
bam-10833	107	7	included	include	VERB
bam-10833	107	8	studies	study	NOUN
bam-10833	107	9	.	.	PUNCT
bam-10833	108	1	intravenous	intravenous	ADJ
bam-10833	108	2	colistin	colistin	PROPN
bam-10833	108	3	monotherapy	monotherapy	NOUN
bam-10833	108	4	versus	versus	ADP
bam-10833	108	5	combination	combination	NOUN
bam-10833	108	6	therapy	therapy	NOUN
bam-10833	108	7	eur	eur	PROPN
bam-10833	108	8	j	j	PROPN
bam-10833	108	9	transl	transl	PROPN
bam-10833	108	10	myol	myol	ADV
bam-10833	108	11	32	32	NUM
bam-10833	108	12	(	(	PUNCT
bam-10833	108	13	4	4	NUM
bam-10833	108	14	):	):	PUNCT
bam-10833	108	15	10833	10833	NUM
bam-10833	108	16	,	,	PUNCT
bam-10833	108	17	2022	2022	NUM
bam-10833	108	18	doi	doi	NOUN
bam-10833	108	19	:	:	PUNCT
bam-10833	108	20	10.4081	10.4081	NUM
bam-10833	108	21	/	/	SYM
bam-10833	108	22	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	108	23	7	7	NUM
bam-10833	108	24	corresponding	correspond	VERB
bam-10833	108	25	author	author	NOUN
bam-10833	108	26	farzaneh	farzaneh	PROPN
bam-10833	108	27	hematian	hematian	PROPN
bam-10833	108	28	,	,	PUNCT
bam-10833	108	29	assistant	assistant	NOUN
bam-10833	108	30	professor	professor	NOUN
bam-10833	108	31	of	of	ADP
bam-10833	108	32	clinical	clinical	ADJ
bam-10833	108	33	pharmacy	pharmacy	NOUN
bam-10833	108	34	,	,	PUNCT
bam-10833	108	35	department	department	NOUN
bam-10833	108	36	of	of	ADP
bam-10833	108	37	clinical	clinical	ADJ
bam-10833	108	38	pharmacy	pharmacy	NOUN
bam-10833	108	39	,	,	PUNCT
bam-10833	108	40	faculty	faculty	NOUN
bam-10833	108	41	of	of	ADP
bam-10833	108	42	pharmacy	pharmacy	NOUN
bam-10833	108	43	,	,	PUNCT
bam-10833	108	44	ahvaz	ahvaz	PROPN
bam-10833	108	45	jundishapur	jundishapur	PROPN
bam-10833	108	46	university	university	PROPN
bam-10833	108	47	of	of	ADP
bam-10833	108	48	medical	medical	ADJ
bam-10833	108	49	sciences	science	NOUN
bam-10833	108	50	,	,	PUNCT
bam-10833	108	51	ahvaz	ahvaz	PROPN
bam-10833	108	52	,	,	PUNCT
bam-10833	108	53	iran	iran	PROPN
bam-10833	108	54	.	.	PUNCT
bam-10833	109	1	orcid	orcid	NOUN
bam-10833	110	1	i	i	PRON
bam-10833	110	2	d	d	NOUN
bam-10833	110	3	:	:	PUNCT
bam-10833	110	4	0000	0000	NUM
bam-10833	110	5	-	-	PUNCT
bam-10833	110	6	0001	0001	NUM
bam-10833	110	7	-	-	PUNCT
bam-10833	110	8	7062	7062	NUM
bam-10833	110	9	-	-	SYM
bam-10833	110	10	4669	4669	NUM
bam-10833	110	11	e	e	NOUN
bam-10833	110	12	-	-	NOUN
bam-10833	110	13	mail	mail	NOUN
bam-10833	110	14	:	:	PUNCT
bam-10833	110	15	farzanehhematian@yahoo.com	farzanehhematian@yahoo.com	X
bam-10833	111	1	e	e	X
bam-10833	111	2	-	-	NOUN
bam-10833	111	3	mails	mail	NOUN
bam-10833	111	4	and	and	CCONJ
bam-10833	111	5	orcid	orcid	NOUN
bam-10833	111	6	i	i	INTJ
bam-10833	111	7	d	d	PROPN
bam-10833	111	8	of	of	ADP
bam-10833	111	9	co	co	NOUN
bam-10833	111	10	-	-	NOUN
bam-10833	111	11	authors	author	NOUN
bam-10833	111	12	forouzan	forouzan	NOUN
bam-10833	111	13	ahmadpour	ahmadpour	NOUN
bam-10833	111	14	:	:	PUNCT
bam-10833	111	15	ahmadpourforoz@yahoo.com	ahmadpourforoz@yahoo.com	X
bam-10833	112	1	orcid	orcid	PROPN
bam-10833	113	1	i	i	PRON
bam-10833	113	2	d	d	PROPN
bam-10833	113	3	:	:	PUNCT
bam-10833	113	4	:	:	PUNCT
bam-10833	113	5	0000	0000	NUM
bam-10833	113	6	-	-	PUNCT
bam-10833	113	7	0002	0002	NUM
bam-10833	113	8	-	-	PUNCT
bam-10833	113	9	1142	1142	NUM
bam-10833	113	10	-	-	PUNCT
bam-10833	113	11	6088	6088	NUM
bam-10833	113	12	elnaz	elnaz	ADJ
bam-10833	113	13	shaseb	shaseb	NOUN
bam-10833	113	14	:	:	PUNCT
bam-10833	113	15	shasebe@tbzmed.ac.ir	shasebe@tbzmed.ac.ir	ADJ
bam-10833	113	16	orcid	orcid	NOUN
bam-10833	113	17	i	i	NOUN
bam-10833	113	18	d	d	NOUN
bam-10833	113	19	:	:	PUNCT
bam-10833	113	20	0000	0000	NUM
bam-10833	113	21	-	-	PUNCT
bam-10833	113	22	0001	0001	NUM
bam-10833	113	23	-	-	PUNCT
bam-10833	113	24	7931	7931	NUM
bam-10833	113	25	-	-	PUNCT
bam-10833	113	26	4632	4632	NUM
bam-10833	113	27	mandana	mandana	PROPN
bam-10833	113	28	izadpanah	izadpanah	PROPN
bam-10833	113	29	:	:	PUNCT
bam-10833	114	1	mandana.i@gmail.com	mandana.i@gmail.com	X
bam-10833	114	2	orcid	orcid	NOUN
bam-10833	114	3	i	i	PRON
bam-10833	114	4	d	d	NOUN
bam-10833	114	5	:	:	PUNCT
bam-10833	114	6	0000	0000	NUM
bam-10833	114	7	-	-	PUNCT
bam-10833	114	8	0002	0002	NUM
bam-10833	114	9	-	-	PUNCT
bam-10833	114	10	1785	1785	NUM
bam-10833	114	11	-	-	PUNCT
bam-10833	114	12	4665	4665	NUM
bam-10833	114	13	amin	amin	NOUN
bam-10833	114	14	rakhshan	rakhshan	NOUN
bam-10833	114	15	:	:	PUNCT
bam-10833	114	16	aminrakhshan@gmail.com	aminrakhshan@gmail.com	X
bam-10833	115	1	orcid	orcid	NOUN
bam-10833	116	1	i	i	PRON
bam-10833	116	2	d	d	NOUN
bam-10833	116	3	:	:	PUNCT
bam-10833	116	4	0000	0000	NUM
bam-10833	116	5	-	-	PUNCT
bam-10833	116	6	0002	0002	NUM
bam-10833	116	7	-	-	PUNCT
bam-10833	116	8	1836	1836	NUM
bam-10833	116	9	-	-	SYM
bam-10833	116	10	7658	7658	NUM
bam-10833	116	11	references	reference	NOUN
bam-10833	116	12	1	1	NUM
bam-10833	116	13	.	.	PUNCT
bam-10833	117	1	li	li	PROPN
bam-10833	117	2	j	j	PROPN
bam-10833	117	3	,	,	PUNCT
bam-10833	117	4	nation	nation	NOUN
bam-10833	117	5	rl	rl	PROPN
bam-10833	117	6	,	,	PUNCT
bam-10833	117	7	turnidge	turnidge	PROPN
bam-10833	117	8	jd	jd	PROPN
bam-10833	117	9	,	,	PUNCT
bam-10833	117	10	milne	milne	PROPN
bam-10833	117	11	rw	rw	PROPN
bam-10833	117	12	,	,	PUNCT
bam-10833	117	13	coulthard	coulthard	PROPN
bam-10833	117	14	k	k	PROPN
bam-10833	117	15	,	,	PUNCT
bam-10833	117	16	rayner	rayner	PROPN
bam-10833	117	17	cr	cr	PROPN
bam-10833	117	18	,	,	PUNCT
bam-10833	117	19	paterson	paterson	PROPN
bam-10833	117	20	dl	dl	PROPN
bam-10833	117	21	.	.	PROPN
bam-10833	117	22	colistin	colistin	PROPN
bam-10833	117	23	:	:	PUNCT
bam-10833	117	24	the	the	DET
bam-10833	117	25	re	re	VERB
bam-10833	117	26	-	-	VERB
bam-10833	117	27	emerging	emerge	VERB
bam-10833	117	28	antibiotic	antibiotic	NOUN
bam-10833	117	29	for	for	ADP
bam-10833	117	30	multidrug	multidrug	NOUN
bam-10833	117	31	-	-	PUNCT
bam-10833	117	32	resistant	resistant	ADJ
bam-10833	117	33	gram	gram	NOUN
bam-10833	117	34	-	-	PUNCT
bam-10833	117	35	negative	negative	ADJ
bam-10833	117	36	bacterial	bacterial	ADJ
bam-10833	117	37	infections	infection	NOUN
bam-10833	117	38	.	.	PUNCT
bam-10833	118	1	lancet	lancet	PROPN
bam-10833	118	2	infect	infect	PROPN
bam-10833	118	3	dis	dis	PROPN
bam-10833	118	4	.	.	PUNCT
bam-10833	119	1	2006	2006	NUM
bam-10833	119	2	sep;6(9):589	sep;6(9):589	NOUN
bam-10833	119	3	-	-	PUNCT
bam-10833	119	4	601	601	PROPN
bam-10833	119	5	.	.	PUNCT
bam-10833	120	1	doi	doi	NOUN
bam-10833	120	2	:	:	PUNCT
bam-10833	120	3	10.1016	10.1016	NUM
bam-10833	120	4	/	/	SYM
bam-10833	120	5	s14733099(06)70580	s14733099(06)70580	PROPN
bam-10833	120	6	-	-	PUNCT
bam-10833	120	7	1	1	NUM
bam-10833	120	8	.	.	NOUN
bam-10833	120	9	2	2	NUM
bam-10833	120	10	.	.	X
bam-10833	120	11	brink	brink	PROPN
bam-10833	120	12	aj	aj	PROPN
bam-10833	120	13	,	,	PUNCT
bam-10833	120	14	richards	richards	PROPN
bam-10833	120	15	ga	ga	PROPN
bam-10833	120	16	,	,	PUNCT
bam-10833	120	17	colombo	colombo	NOUN
bam-10833	120	18	g	g	NOUN
bam-10833	120	19	,	,	PUNCT
bam-10833	120	20	bortolotti	bortolotti	PROPN
bam-10833	120	21	f	f	PROPN
bam-10833	120	22	,	,	PUNCT
bam-10833	120	23	colombo	colombo	NOUN
bam-10833	120	24	p	p	NOUN
bam-10833	120	25	,	,	PUNCT
bam-10833	120	26	jehl	jehl	PROPN
bam-10833	120	27	f.	f.	PROPN
bam-10833	120	28	multicomponent	multicomponent	PROPN
bam-10833	120	29	antibiotic	antibiotic	ADJ
bam-10833	120	30	substances	substance	NOUN
bam-10833	120	31	produced	produce	VERB
bam-10833	120	32	by	by	ADP
bam-10833	120	33	fermentation	fermentation	NOUN
bam-10833	120	34	:	:	PUNCT
bam-10833	120	35	implications	implication	NOUN
bam-10833	120	36	for	for	ADP
bam-10833	120	37	regulatory	regulatory	ADJ
bam-10833	120	38	authorities	authority	NOUN
bam-10833	120	39	,	,	PUNCT
bam-10833	120	40	critically	critically	ADV
bam-10833	120	41	ill	ill	ADJ
bam-10833	120	42	patients	patient	NOUN
bam-10833	120	43	and	and	CCONJ
bam-10833	120	44	generics	generic	NOUN
bam-10833	120	45	.	.	PUNCT
bam-10833	121	1	int	int	PROPN
bam-10833	121	2	j	j	PROPN
bam-10833	121	3	antimicrob	antimicrob	PROPN
bam-10833	121	4	agents	agent	NOUN
bam-10833	121	5	.	.	PUNCT
bam-10833	122	1	2014	2014	NUM
bam-10833	122	2	jan;43(1):1	jan;43(1):1	ADV
bam-10833	122	3	-	-	PUNCT
bam-10833	122	4	6	6	NUM
bam-10833	122	5	.	.	PUNCT
bam-10833	122	6	doi	doi	NOUN
bam-10833	122	7	:	:	PUNCT
bam-10833	122	8	10.1016	10.1016	NUM
bam-10833	122	9	/	/	SYM
bam-10833	122	10	j.ijantimicag.2013	j.ijantimicag.2013	PROPN
bam-10833	122	11	.	.	PUNCT
bam-10833	122	12	06.013	06.013	NUM
bam-10833	122	13	.	.	PUNCT
bam-10833	123	1	epub	epub	PROPN
bam-10833	123	2	2013	2013	NUM
bam-10833	123	3	aug	aug	PROPN
bam-10833	123	4	3	3	NUM
bam-10833	123	5	.	.	NOUN
bam-10833	123	6	3	3	NUM
bam-10833	123	7	.	.	X
bam-10833	123	8	nation	nation	NOUN
bam-10833	123	9	rl	rl	PROPN
bam-10833	123	10	,	,	PUNCT
bam-10833	123	11	li	li	PROPN
bam-10833	123	12	j	j	PROPN
bam-10833	123	13	,	,	PUNCT
bam-10833	123	14	cars	car	NOUN
bam-10833	123	15	o	o	NOUN
bam-10833	123	16	,	,	PUNCT
bam-10833	123	17	couet	couet	PROPN
bam-10833	123	18	w	w	PROPN
bam-10833	123	19	,	,	PUNCT
bam-10833	123	20	dudley	dudley	PROPN
bam-10833	123	21	mn	mn	PROPN
bam-10833	123	22	,	,	PUNCT
bam-10833	123	23	kaye	kaye	PROPN
bam-10833	123	24	ks	ks	PROPN
bam-10833	123	25	,	,	PUNCT
bam-10833	123	26	mouton	mouton	PROPN
bam-10833	123	27	jw	jw	PROPN
bam-10833	123	28	,	,	PUNCT
bam-10833	123	29	paterson	paterson	PROPN
bam-10833	123	30	dl	dl	PROPN
bam-10833	123	31	,	,	PUNCT
bam-10833	123	32	tam	tam	PROPN
bam-10833	123	33	vh	vh	PROPN
bam-10833	123	34	,	,	PUNCT
bam-10833	123	35	theuretzbacher	theuretzbacher	ADJ
bam-10833	123	36	u	u	NOUN
bam-10833	123	37	,	,	PUNCT
bam-10833	123	38	tsuji	tsuji	PROPN
bam-10833	123	39	bt	bt	PROPN
bam-10833	123	40	,	,	PUNCT
bam-10833	123	41	turnidge	turnidge	PROPN
bam-10833	123	42	jd	jd	PROPN
bam-10833	123	43	.	.	PUNCT
bam-10833	123	44	framework	framework	NOUN
bam-10833	123	45	for	for	ADP
bam-10833	123	46	optimisation	optimisation	NOUN
bam-10833	123	47	of	of	ADP
bam-10833	123	48	the	the	DET
bam-10833	123	49	clinical	clinical	ADJ
bam-10833	123	50	use	use	NOUN
bam-10833	123	51	of	of	ADP
bam-10833	123	52	colistin	colistin	NOUN
bam-10833	123	53	and	and	CCONJ
bam-10833	123	54	polymyxin	polymyxin	ADJ
bam-10833	123	55	b	b	PROPN
bam-10833	123	56	:	:	PUNCT
bam-10833	123	57	the	the	DET
bam-10833	123	58	prato	prato	PROPN
bam-10833	123	59	polymyxin	polymyxin	PROPN
bam-10833	123	60	consensus	consensus	NOUN
bam-10833	123	61	.	.	PUNCT
bam-10833	124	1	lancet	lancet	PROPN
bam-10833	124	2	infect	infect	PROPN
bam-10833	124	3	dis	dis	PROPN
bam-10833	124	4	.	.	PUNCT
bam-10833	125	1	2015	2015	NUM
bam-10833	125	2	feb;15(2):22534	feb;15(2):22534	PROPN
bam-10833	125	3	.	.	PUNCT
bam-10833	125	4	doi	doi	NOUN
bam-10833	125	5	:	:	PUNCT
bam-10833	125	6	10.1016	10.1016	NUM
bam-10833	125	7	/	/	SYM
bam-10833	125	8	s1473	s1473	PROPN
bam-10833	125	9	-	-	PUNCT
bam-10833	125	10	3099(14)70850	3099(14)70850	NUM
bam-10833	125	11	-	-	SYM
bam-10833	125	12	3	3	NUM
bam-10833	125	13	.	.	PUNCT
bam-10833	126	1	epub	epub	PROPN
bam-10833	126	2	2014	2014	NUM
bam-10833	126	3	oct	oct	NOUN
bam-10833	126	4	21	21	NUM
bam-10833	126	5	.	.	PUNCT
bam-10833	127	1	4	4	NUM
bam-10833	127	2	.	.	X
bam-10833	127	3	petrosillo	petrosillo	PROPN
bam-10833	127	4	n	n	CCONJ
bam-10833	127	5	,	,	PUNCT
bam-10833	127	6	ioannidou	ioannidou	NOUN
bam-10833	127	7	e	e	NOUN
bam-10833	127	8	,	,	PUNCT
bam-10833	127	9	falagas	falagas	VERB
bam-10833	127	10	me	i	PRON
bam-10833	127	11	.	.	PUNCT
bam-10833	128	1	colistin	colistin	PROPN
bam-10833	128	2	monotherapy	monotherapy	NOUN
bam-10833	128	3	vs.	vs.	ADP
bam-10833	128	4	combination	combination	NOUN
bam-10833	128	5	therapy	therapy	NOUN
bam-10833	128	6	:	:	PUNCT
bam-10833	128	7	evidence	evidence	NOUN
bam-10833	128	8	from	from	ADP
bam-10833	128	9	microbiological	microbiological	ADJ
bam-10833	128	10	,	,	PUNCT
bam-10833	128	11	animal	animal	NOUN
bam-10833	128	12	and	and	CCONJ
bam-10833	128	13	clinical	clinical	ADJ
bam-10833	128	14	studies	study	NOUN
bam-10833	128	15	.	.	PUNCT
bam-10833	129	1	clin	clin	PROPN
bam-10833	129	2	microbiol	microbiol	PROPN
bam-10833	129	3	infect	infect	PROPN
bam-10833	129	4	.	.	PUNCT
bam-10833	130	1	2008	2008	NUM
bam-10833	130	2	sep;14(9):816	sep;14(9):816	NOUN
bam-10833	130	3	-	-	PUNCT
bam-10833	130	4	27	27	NUM
bam-10833	130	5	.	.	PUNCT
bam-10833	131	1	doi	doi	NOUN
bam-10833	131	2	:	:	PUNCT
bam-10833	131	3	10.1111	10.1111	NUM
bam-10833	131	4	/	/	SYM
bam-10833	131	5	j.1469	j.1469	PROPN
bam-10833	131	6	-	-	PUNCT
bam-10833	131	7	0691.2008.02061.x	0691.2008.02061.x	NOUN
bam-10833	131	8	.	.	PUNCT
bam-10833	132	1	5	5	NUM
bam-10833	132	2	.	.	X
bam-10833	132	3	bergen	bergen	PROPN
bam-10833	132	4	pj	pj	PROPN
bam-10833	132	5	,	,	PUNCT
bam-10833	132	6	li	li	PROPN
bam-10833	132	7	j	j	PROPN
bam-10833	132	8	,	,	PUNCT
bam-10833	132	9	nation	nation	NOUN
bam-10833	132	10	rl	rl	PROPN
bam-10833	132	11	,	,	PUNCT
bam-10833	132	12	turnidge	turnidge	PROPN
bam-10833	132	13	jd	jd	PROPN
bam-10833	132	14	,	,	PUNCT
bam-10833	132	15	coulthard	coulthard	PROPN
bam-10833	132	16	k	k	PROPN
bam-10833	132	17	,	,	PUNCT
bam-10833	132	18	milne	milne	PROPN
bam-10833	132	19	rw	rw	PROPN
bam-10833	132	20	.	.	PROPN
bam-10833	132	21	comparison	comparison	NOUN
bam-10833	132	22	of	of	ADP
bam-10833	132	23	once-	once-	X
bam-10833	132	24	,	,	PUNCT
bam-10833	132	25	twiceand	twiceand	NOUN
bam-10833	132	26	thrice	thrice	PROPN
bam-10833	132	27	-	-	PUNCT
bam-10833	132	28	daily	daily	PROPN
bam-10833	132	29	dosing	dosing	NOUN
bam-10833	132	30	of	of	ADP
bam-10833	132	31	colistin	colistin	NOUN
bam-10833	132	32	on	on	ADP
bam-10833	132	33	antibacterial	antibacterial	ADJ
bam-10833	132	34	effect	effect	NOUN
bam-10833	132	35	and	and	CCONJ
bam-10833	132	36	emergence	emergence	NOUN
bam-10833	132	37	of	of	ADP
bam-10833	132	38	resistance	resistance	NOUN
bam-10833	132	39	:	:	PUNCT
bam-10833	132	40	studies	study	NOUN
bam-10833	132	41	with	with	ADP
bam-10833	132	42	pseudomonas	pseudomona	NOUN
bam-10833	132	43	aeruginosa	aeruginosa	NOUN
bam-10833	132	44	in	in	ADP
bam-10833	132	45	an	an	DET
bam-10833	132	46	in	in	ADP
bam-10833	132	47	vitro	vitro	X
bam-10833	132	48	pharmacodynamic	pharmacodynamic	ADJ
bam-10833	132	49	model	model	NOUN
bam-10833	132	50	.	.	PUNCT
bam-10833	133	1	j	j	PROPN
bam-10833	133	2	antimicrob	antimicrob	PROPN
bam-10833	133	3	chemother	chemother	PROPN
bam-10833	133	4	.	.	PUNCT
bam-10833	134	1	2008	2008	NUM
bam-10833	134	2	mar;61(3):636	mar;61(3):636	NOUN
bam-10833	134	3	-	-	PUNCT
bam-10833	134	4	42	42	NUM
bam-10833	134	5	.	.	PUNCT
bam-10833	135	1	doi	doi	NOUN
bam-10833	135	2	:	:	PUNCT
bam-10833	135	3	10.1093	10.1093	NUM
bam-10833	135	4	/	/	SYM
bam-10833	135	5	jac	jac	PROPN
bam-10833	135	6	/	/	SYM
bam-10833	135	7	dkm511	dkm511	PROPN
bam-10833	135	8	.	.	PUNCT
bam-10833	136	1	epub	epub	PROPN
bam-10833	136	2	2008	2008	NUM
bam-10833	136	3	jan	jan	PROPN
bam-10833	136	4	28	28	NUM
bam-10833	136	5	.	.	PROPN
bam-10833	137	1	6	6	NUM
bam-10833	137	2	.	.	PUNCT
bam-10833	137	3	mohamed	mohamed	PROPN
bam-10833	137	4	af	af	PROPN
bam-10833	137	5	,	,	PUNCT
bam-10833	137	6	cars	car	NOUN
bam-10833	137	7	o	o	PROPN
bam-10833	137	8	,	,	PUNCT
bam-10833	137	9	friberg	friberg	PROPN
bam-10833	137	10	le	le	PROPN
bam-10833	137	11	.	.	PUNCT
bam-10833	138	1	a	a	DET
bam-10833	138	2	pharmacokinetic	pharmacokinetic	ADJ
bam-10833	138	3	/	/	SYM
bam-10833	138	4	pharmacodynamic	pharmacodynamic	ADJ
bam-10833	138	5	model	model	NOUN
bam-10833	138	6	developed	develop	VERB
bam-10833	138	7	for	for	ADP
bam-10833	138	8	the	the	DET
bam-10833	138	9	effect	effect	NOUN
bam-10833	138	10	of	of	ADP
bam-10833	138	11	colistin	colistin	NOUN
bam-10833	138	12	on	on	ADP
bam-10833	138	13	pseudomonas	pseudomona	NOUN
bam-10833	138	14	aeruginosa	aeruginosa	NOUN
bam-10833	138	15	in	in	ADP
bam-10833	138	16	vitro	vitro	X
bam-10833	138	17	with	with	ADP
bam-10833	138	18	evaluation	evaluation	NOUN
bam-10833	138	19	of	of	ADP
bam-10833	138	20	population	population	NOUN
bam-10833	138	21	pharmacokinetic	pharmacokinetic	ADJ
bam-10833	138	22	variability	variability	NOUN
bam-10833	138	23	on	on	ADP
bam-10833	138	24	simulated	simulate	VERB
bam-10833	138	25	bacterial	bacterial	ADJ
bam-10833	138	26	killing	killing	NOUN
bam-10833	138	27	.	.	PUNCT
bam-10833	139	1	j	j	PROPN
bam-10833	139	2	antimicrob	antimicrob	PROPN
bam-10833	139	3	chemother	chemother	PROPN
bam-10833	139	4	.	.	PUNCT
bam-10833	140	1	2014	2014	NUM
bam-10833	140	2	may;69(5):1350	may;69(5):1350	PROPN
bam-10833	140	3	-	-	PUNCT
bam-10833	140	4	61	61	NUM
bam-10833	140	5	.	.	PUNCT
bam-10833	141	1	doi	doi	NOUN
bam-10833	141	2	:	:	PUNCT
bam-10833	141	3	10.1093	10.1093	NUM
bam-10833	141	4	/	/	SYM
bam-10833	141	5	jac	jac	PROPN
bam-10833	141	6	/	/	SYM
bam-10833	141	7	dkt520	dkt520	PROPN
bam-10833	141	8	.	.	PUNCT
bam-10833	142	1	epub	epub	PROPN
bam-10833	142	2	2014	2014	NUM
bam-10833	142	3	jan	jan	PROPN
bam-10833	142	4	27	27	NUM
bam-10833	142	5	.	.	PUNCT
bam-10833	143	1	7	7	X
bam-10833	143	2	.	.	PUNCT
bam-10833	143	3	ghazaeian	ghazaeian	PROPN
bam-10833	143	4	m	m	PROPN
bam-10833	143	5	,	,	PUNCT
bam-10833	143	6	mokhtari	mokhtari	PROPN
bam-10833	143	7	m	m	PROPN
bam-10833	143	8	,	,	PUNCT
bam-10833	143	9	kouchek	kouchek	PROPN
bam-10833	143	10	m	m	PROPN
bam-10833	143	11	,	,	PUNCT
bam-10833	143	12	miri	miri	PROPN
bam-10833	143	13	m	m	PROPN
bam-10833	143	14	,	,	PUNCT
bam-10833	143	15	goharani	goharani	ADJ
bam-10833	143	16	r	r	NOUN
bam-10833	143	17	,	,	PUNCT
bam-10833	143	18	ghodssi	ghodssi	ADJ
bam-10833	143	19	-	-	PUNCT
bam-10833	143	20	ghassemabadi	ghassemabadi	NOUN
bam-10833	143	21	r	r	NOUN
bam-10833	143	22	,	,	PUNCT
bam-10833	143	23	sistanizad	sistanizad	ADJ
bam-10833	143	24	m.	m.	NOUN
bam-10833	143	25	once	once	ADV
bam-10833	143	26	versus	versus	ADP
bam-10833	143	27	thrice	thrice	PROPN
bam-10833	143	28	daily	daily	PROPN
bam-10833	143	29	colistin	colistin	NOUN
bam-10833	143	30	in	in	ADP
bam-10833	143	31	critically	critically	ADV
bam-10833	143	32	ill	ill	ADJ
bam-10833	143	33	ptients	ptient	NOUN
bam-10833	143	34	with	with	ADP
bam-10833	143	35	multi	multi	ADJ
bam-10833	143	36	-	-	ADJ
bam-10833	143	37	drug	drug	ADJ
bam-10833	143	38	resistant	resistant	ADJ
bam-10833	143	39	infections	infection	NOUN
bam-10833	143	40	.	.	PUNCT
bam-10833	144	1	iran	iran	PROPN
bam-10833	144	2	j	j	PROPN
bam-10833	144	3	pharm	pharm	PROPN
bam-10833	144	4	res	re	NOUN
bam-10833	144	5	.	.	PROPN
bam-10833	144	6	2017	2017	NUM
bam-10833	144	7	summer;16(3):1247	summer;16(3):1247	NOUN
bam-10833	144	8	-	-	PUNCT
bam-10833	144	9	1253	1253	NUM
bam-10833	144	10	.	.	PUNCT
bam-10833	144	11	8	8	NUM
bam-10833	144	12	.	.	PUNCT
bam-10833	145	1	luque	luque	PROPN
bam-10833	145	2	s	s	PROPN
bam-10833	145	3	,	,	PUNCT
bam-10833	145	4	grau	grau	PROPN
bam-10833	145	5	s	s	PROPN
bam-10833	145	6	,	,	PUNCT
bam-10833	145	7	valle	valle	PROPN
bam-10833	145	8	m	m	NOUN
bam-10833	145	9	,	,	PUNCT
bam-10833	145	10	sorlí	sorlí	PROPN
bam-10833	145	11	l	l	NOUN
bam-10833	145	12	,	,	PUNCT
bam-10833	145	13	horcajada	horcajada	PROPN
bam-10833	145	14	jp	jp	PROPN
bam-10833	145	15	,	,	PUNCT
bam-10833	145	16	segura	segura	PROPN
bam-10833	145	17	c	c	PROPN
bam-10833	145	18	,	,	PUNCT
bam-10833	145	19	alvarez	alvarez	PROPN
bam-10833	145	20	-	-	PUNCT
bam-10833	145	21	lerma	lerma	PROPN
bam-10833	145	22	f.	f.	PROPN
bam-10833	145	23	differences	difference	NOUN
bam-10833	145	24	in	in	ADP
bam-10833	145	25	pharmacokinetics	pharmacokinetic	NOUN
bam-10833	145	26	and	and	CCONJ
bam-10833	145	27	pharmacodynamics	pharmacodynamic	NOUN
bam-10833	145	28	of	of	ADP
bam-10833	145	29	colistimethate	colistimethate	NOUN
bam-10833	145	30	sodium	sodium	NOUN
bam-10833	145	31	(	(	PUNCT
bam-10833	145	32	cms	cms	NOUN
bam-10833	145	33	)	)	PUNCT
bam-10833	145	34	and	and	CCONJ
bam-10833	145	35	colistin	colistin	VERB
bam-10833	145	36	between	between	ADP
bam-10833	145	37	three	three	NUM
bam-10833	145	38	different	different	ADJ
bam-10833	145	39	cms	cms	NOUN
bam-10833	145	40	dosage	dosage	NOUN
bam-10833	145	41	regimens	regimen	NOUN
bam-10833	145	42	in	in	ADP
bam-10833	145	43	a	a	DET
bam-10833	145	44	critically	critically	ADV
bam-10833	145	45	ill	ill	ADJ
bam-10833	145	46	patient	patient	NOUN
bam-10833	145	47	infected	infect	VERB
bam-10833	145	48	by	by	ADP
bam-10833	145	49	a	a	DET
bam-10833	145	50	multidrug	multidrug	NOUN
bam-10833	145	51	-	-	PUNCT
bam-10833	145	52	resistant	resistant	ADJ
bam-10833	145	53	acinetobacter	acinetobacter	ADJ
bam-10833	145	54	baumannii	baumannii	PROPN
bam-10833	145	55	.	.	PUNCT
bam-10833	146	1	int	int	PROPN
bam-10833	146	2	j	j	PROPN
bam-10833	146	3	antimicrob	antimicrob	PROPN
bam-10833	146	4	agents	agent	NOUN
bam-10833	146	5	.	.	PUNCT
bam-10833	147	1	2013	2013	NUM
bam-10833	147	2	aug;42(2):178	aug;42(2):178	PROPN
bam-10833	147	3	-	-	PUNCT
bam-10833	147	4	81	81	NUM
bam-10833	147	5	.	.	PUNCT
bam-10833	148	1	doi	doi	NOUN
bam-10833	148	2	:	:	PUNCT
bam-10833	148	3	10.1016	10.1016	NUM
bam-10833	148	4	/	/	SYM
bam-10833	148	5	j.ijan	j.ijan	NOUN
bam-10833	148	6	timicag.2013.04.018	timicag.2013.04.018	NOUN
bam-10833	148	7	.	.	PUNCT
bam-10833	149	1	epub	epub	PROPN
bam-10833	149	2	2013	2013	NUM
bam-10833	149	3	jun	jun	PROPN
bam-10833	149	4	14	14	NUM
bam-10833	149	5	.	.	PUNCT
bam-10833	150	1	9	9	X
bam-10833	150	2	.	.	X
bam-10833	150	3	daikos	daikos	PROPN
bam-10833	150	4	gl	gl	PROPN
bam-10833	150	5	,	,	PUNCT
bam-10833	150	6	skiada	skiada	PROPN
bam-10833	150	7	a	a	X
bam-10833	150	8	,	,	PUNCT
bam-10833	150	9	pavleas	pavleas	PROPN
bam-10833	150	10	j	j	PROPN
bam-10833	150	11	,	,	PUNCT
bam-10833	150	12	vafiadi	vafiadi	PROPN
bam-10833	150	13	c	c	PROPN
bam-10833	150	14	,	,	PUNCT
bam-10833	150	15	salatas	salatas	PROPN
bam-10833	150	16	k	k	PROPN
bam-10833	150	17	,	,	PUNCT
bam-10833	150	18	tofas	tofas	NOUN
bam-10833	150	19	p	p	NOUN
bam-10833	150	20	,	,	PUNCT
bam-10833	150	21	tzanetou	tzanetou	PROPN
bam-10833	150	22	k	k	PROPN
bam-10833	150	23	,	,	PUNCT
bam-10833	150	24	markogiannakis	markogiannaki	VERB
bam-10833	150	25	a	a	PRON
bam-10833	150	26	,	,	PUNCT
bam-10833	150	27	thomopoulos	thomopoulos	ADP
bam-10833	150	28	g	g	PROPN
bam-10833	150	29	,	,	PUNCT
bam-10833	150	30	vafiadi	vafiadi	NOUN
bam-10833	150	31	i	i	PROPN
bam-10833	150	32	,	,	PUNCT
bam-10833	150	33	petrikkos	petrikkos	PROPN
bam-10833	150	34	g.	g.	NOUN
bam-10833	150	35	serum	serum	NOUN
bam-10833	150	36	bactericidal	bactericidal	ADJ
bam-10833	150	37	activity	activity	NOUN
bam-10833	150	38	of	of	ADP
bam-10833	150	39	three	three	NUM
bam-10833	150	40	different	different	ADJ
bam-10833	150	41	dosing	dosing	ADJ
bam-10833	150	42	regimens	regimen	NOUN
bam-10833	150	43	of	of	ADP
bam-10833	150	44	colistin	colistin	NOUN
bam-10833	150	45	with	with	ADP
bam-10833	150	46	implications	implication	NOUN
bam-10833	150	47	for	for	ADP
bam-10833	150	48	optimum	optimum	ADJ
bam-10833	150	49	clinical	clinical	ADJ
bam-10833	150	50	use	use	NOUN
bam-10833	150	51	.	.	PUNCT
bam-10833	151	1	j	j	PROPN
bam-10833	151	2	chemother	chemother	PROPN
bam-10833	151	3	.	.	PUNCT
bam-10833	152	1	2010	2010	NUM
bam-10833	152	2	jun;22(3):175	jun;22(3):175	NOUN
bam-10833	152	3	-	-	PUNCT
bam-10833	152	4	8	8	NUM
bam-10833	152	5	.	.	PUNCT
bam-10833	153	1	doi	doi	NOUN
bam-10833	153	2	:	:	PUNCT
bam-10833	153	3	10.1179	10.1179	NUM
bam-10833	153	4	/	/	SYM
bam-10833	153	5	joc.2010.22.3.175	joc.2010.22.3.175	PROPN
bam-10833	153	6	.	.	PUNCT
bam-10833	154	1	10	10	NUM
bam-10833	154	2	.	.	PUNCT
bam-10833	155	1	abdelsalam	abdelsalam	PROPN
bam-10833	155	2	mfa	mfa	PROPN
bam-10833	155	3	,	,	PUNCT
bam-10833	155	4	abdalla	abdalla	PROPN
bam-10833	155	5	ms	ms	PROPN
bam-10833	155	6	,	,	PUNCT
bam-10833	155	7	el	el	PROPN
bam-10833	155	8	-	-	PUNCT
bam-10833	155	9	abhar	abhar	PROPN
bam-10833	155	10	hse	hse	PROPN
bam-10833	155	11	.	.	PROPN
bam-10833	155	12	prospective	prospective	ADJ
bam-10833	155	13	,	,	PUNCT
bam-10833	155	14	comparative	comparative	ADJ
bam-10833	155	15	clinical	clinical	ADJ
bam-10833	155	16	study	study	NOUN
bam-10833	155	17	between	between	ADP
bam-10833	155	18	high	high	ADJ
bam-10833	155	19	-	-	PUNCT
bam-10833	155	20	dose	dose	NOUN
bam-10833	155	21	colistin	colistin	NOUN
bam-10833	155	22	monotherapy	monotherapy	NOUN
bam-10833	155	23	and	and	CCONJ
bam-10833	155	24	colistinmeropenem	colistinmeropenem	NOUN
bam-10833	155	25	combination	combination	NOUN
bam-10833	155	26	therapy	therapy	NOUN
bam-10833	155	27	for	for	ADP
bam-10833	155	28	treatment	treatment	NOUN
bam-10833	155	29	of	of	ADP
bam-10833	155	30	hospital	hospital	NOUN
bam-10833	155	31	-	-	PUNCT
bam-10833	155	32	acquired	acquire	VERB
bam-10833	155	33	pneumonia	pneumonia	NOUN
bam-10833	155	34	and	and	CCONJ
bam-10833	155	35	ventilatorassociated	ventilatorassociate	VERB
bam-10833	155	36	pneumonia	pneumonia	NOUN
bam-10833	155	37	caused	cause	VERB
bam-10833	155	38	by	by	ADP
bam-10833	155	39	multidrugresistant	multidrugresistant	ADJ
bam-10833	155	40	klebsiella	klebsiella	PROPN
bam-10833	155	41	pneumoniae	pneumoniae	ADJ
bam-10833	155	42	.	.	PUNCT
bam-10833	156	1	j	j	PROPN
bam-10833	156	2	glob	glob	PROPN
bam-10833	156	3	antimicrob	antimicrob	PROPN
bam-10833	156	4	resist	resist	VERB
bam-10833	156	5	.	.	PUNCT
bam-10833	157	1	2018	2018	NUM
bam-10833	157	2	dec;15:127	dec;15:127	NOUN
bam-10833	157	3	-	-	SYM
bam-10833	157	4	135	135	NUM
bam-10833	157	5	.	.	PUNCT
bam-10833	158	1	doi	doi	NOUN
bam-10833	158	2	:	:	PUNCT
bam-10833	158	3	10.1016	10.1016	NUM
bam-10833	158	4	/	/	SYM
bam-10833	158	5	j.jgar.2018.07.003	j.jgar.2018.07.003	PROPN
bam-10833	158	6	.	.	PROPN
bam-10833	158	7	epub	epub	PROPN
bam-10833	158	8	2018	2018	NUM
bam-10833	158	9	oct	oct	PROPN
bam-10833	158	10	11	11	NUM
bam-10833	158	11	.	.	PUNCT
bam-10833	159	1	11	11	NUM
bam-10833	159	2	.	.	PUNCT
bam-10833	160	1	aydemir	aydemir	PROPN
bam-10833	160	2	h	h	PROPN
bam-10833	160	3	,	,	PUNCT
bam-10833	160	4	akduman	akduman	NOUN
bam-10833	160	5	d	d	PROPN
bam-10833	160	6	,	,	PUNCT
bam-10833	160	7	piskin	piskin	NOUN
bam-10833	160	8	n	n	CCONJ
bam-10833	160	9	,	,	PUNCT
bam-10833	160	10	comert	comert	PROPN
bam-10833	160	11	f	f	PROPN
bam-10833	160	12	,	,	PUNCT
bam-10833	160	13	horuz	horuz	PROPN
bam-10833	160	14	e	e	NOUN
bam-10833	160	15	,	,	PUNCT
bam-10833	160	16	terzi	terzi	NOUN
bam-10833	160	17	a	a	PRON
bam-10833	160	18	,	,	PUNCT
bam-10833	160	19	kokturk	kokturk	PROPN
bam-10833	160	20	f	f	PROPN
bam-10833	160	21	,	,	PUNCT
bam-10833	160	22	ornek	ornek	PROPN
bam-10833	160	23	t	t	PROPN
bam-10833	160	24	,	,	PUNCT
bam-10833	160	25	celebi	celebi	NOUN
bam-10833	160	26	g.	g.	PROPN
bam-10833	160	27	colistin	colistin	NOUN
bam-10833	160	28	vs.	vs.	ADP
bam-10833	160	29	the	the	DET
bam-10833	160	30	combination	combination	NOUN
bam-10833	160	31	of	of	ADP
bam-10833	160	32	colistin	colistin	NOUN
bam-10833	160	33	and	and	CCONJ
bam-10833	160	34	rifampicin	rifampicin	VERB
bam-10833	160	35	for	for	ADP
bam-10833	160	36	the	the	DET
bam-10833	160	37	treatment	treatment	NOUN
bam-10833	160	38	of	of	ADP
bam-10833	160	39	carbapenemresistant	carbapenemresistant	NOUN
bam-10833	160	40	acinetobacter	acinetobacter	ADV
bam-10833	160	41	baumannii	baumannii	ADJ
bam-10833	160	42	ventilatorassociated	ventilatorassociate	VERB
bam-10833	160	43	pneumonia	pneumonia	NOUN
bam-10833	160	44	.	.	PUNCT
bam-10833	161	1	epidemiol	epidemiol	PROPN
bam-10833	161	2	infect	infect	PROPN
bam-10833	161	3	.	.	PUNCT
bam-10833	162	1	2013	2013	NUM
bam-10833	162	2	jun;141(6):1214	jun;141(6):1214	ADV
bam-10833	162	3	-	-	SYM
bam-10833	162	4	22	22	NUM
bam-10833	162	5	.	.	PUNCT
bam-10833	163	1	doi	doi	NOUN
bam-10833	163	2	:	:	PUNCT
bam-10833	163	3	10.1017	10.1017	NUM
bam-10833	163	4	/	/	SYM
bam-10833	163	5	s095026881200194x	s095026881200194x	NOUN
bam-10833	163	6	.	.	PUNCT
bam-10833	163	7	epub	epub	PROPN
bam-10833	163	8	2012	2012	NUM
bam-10833	163	9	sep	sep	PROPN
bam-10833	163	10	7	7	NUM
bam-10833	163	11	.	.	NOUN
bam-10833	163	12	12	12	NUM
bam-10833	163	13	.	.	PUNCT
bam-10833	164	1	batirel	batirel	PROPN
bam-10833	164	2	a	a	PROPN
bam-10833	164	3	,	,	PUNCT
bam-10833	164	4	balkan	balkan	PROPN
bam-10833	164	5	ii	ii	PROPN
bam-10833	164	6	,	,	PUNCT
bam-10833	164	7	karabay	karabay	ADJ
bam-10833	164	8	o	o	NOUN
bam-10833	164	9	,	,	PUNCT
bam-10833	164	10	agalar	agalar	ADJ
bam-10833	164	11	c	c	NOUN
bam-10833	164	12	,	,	PUNCT
bam-10833	164	13	akalin	akalin	PROPN
bam-10833	164	14	s	s	PROPN
bam-10833	164	15	,	,	PUNCT
bam-10833	164	16	alici	alici	ADJ
bam-10833	164	17	o	o	NOUN
bam-10833	164	18	,	,	PUNCT
bam-10833	164	19	alp	alp	PROPN
bam-10833	164	20	e	e	PROPN
bam-10833	164	21	,	,	PUNCT
bam-10833	164	22	altay	altay	NOUN
bam-10833	164	23	fa	fa	PROPN
bam-10833	164	24	,	,	PUNCT
bam-10833	164	25	altin	altin	PROPN
bam-10833	164	26	n	n	CCONJ
bam-10833	164	27	,	,	PUNCT
bam-10833	164	28	arslan	arslan	PROPN
bam-10833	164	29	f	f	PROPN
bam-10833	164	30	,	,	PUNCT
bam-10833	164	31	aslan	aslan	PROPN
bam-10833	164	32	t	t	PROPN
bam-10833	164	33	,	,	PUNCT
bam-10833	164	34	bekiroglu	bekiroglu	PROPN
bam-10833	164	35	n	n	CCONJ
bam-10833	164	36	,	,	PUNCT
bam-10833	164	37	cesur	cesur	PROPN
bam-10833	164	38	s	s	PROPN
bam-10833	164	39	,	,	PUNCT
bam-10833	164	40	celik	celik	VERB
bam-10833	164	41	ad	ad	NOUN
bam-10833	164	42	,	,	PUNCT
bam-10833	164	43	dogan	dogan	PROPN
bam-10833	164	44	m	m	PROPN
bam-10833	164	45	,	,	PUNCT
bam-10833	164	46	durdu	durdu	PROPN
bam-10833	164	47	b	b	PROPN
bam-10833	164	48	,	,	PUNCT
bam-10833	164	49	duygu	duygu	PROPN
bam-10833	164	50	f	f	PROPN
bam-10833	164	51	,	,	PUNCT
bam-10833	164	52	engin	engin	PROPN
bam-10833	164	53	a	a	PRON
bam-10833	164	54	,	,	PUNCT
bam-10833	164	55	engin	engin	PROPN
bam-10833	164	56	do	do	VERB
bam-10833	164	57	,	,	PUNCT
bam-10833	164	58	gonen	gonen	PROPN
bam-10833	164	59	i	i	PROPN
bam-10833	164	60	,	,	PUNCT
bam-10833	164	61	guclu	guclu	PROPN
bam-10833	164	62	e	e	NOUN
bam-10833	164	63	,	,	PUNCT
bam-10833	164	64	guven	guven	PROPN
bam-10833	164	65	t	t	PROPN
bam-10833	164	66	,	,	PUNCT
bam-10833	164	67	hatipoglu	hatipoglu	PROPN
bam-10833	164	68	ca	ca	PROPN
bam-10833	164	69	,	,	PUNCT
bam-10833	164	70	hosoglu	hosoglu	PROPN
bam-10833	164	71	s	s	PROPN
bam-10833	164	72	,	,	PUNCT
bam-10833	164	73	karahocagil	karahocagil	PROPN
bam-10833	164	74	mk	mk	PROPN
bam-10833	164	75	,	,	PUNCT
bam-10833	164	76	kilic	kilic	NOUN
bam-10833	164	77	au	au	PROPN
bam-10833	164	78	,	,	PUNCT
bam-10833	164	79	ormen	ormen	PROPN
bam-10833	164	80	b	b	NUM
bam-10833	164	81	,	,	PUNCT
bam-10833	164	82	ozdemir	ozdemir	PROPN
bam-10833	164	83	d	d	PROPN
bam-10833	164	84	,	,	PUNCT
bam-10833	164	85	ozer	ozer	PROPN
bam-10833	164	86	s	s	PROPN
bam-10833	164	87	,	,	PUNCT
bam-10833	164	88	oztoprak	oztoprak	NOUN
bam-10833	164	89	n	n	NOUN
bam-10833	164	90	,	,	PUNCT
bam-10833	164	91	sezak	sezak	NOUN
bam-10833	164	92	n	n	CCONJ
bam-10833	164	93	,	,	PUNCT
bam-10833	164	94	turhan	turhan	ADV
bam-10833	164	95	v	v	NOUN
bam-10833	164	96	,	,	PUNCT
bam-10833	164	97	turker	turker	NOUN
bam-10833	164	98	n	n	CCONJ
bam-10833	164	99	,	,	PUNCT
bam-10833	164	100	yilmaz	yilmaz	PROPN
bam-10833	164	101	h.	h.	PROPN
bam-10833	164	102	comparison	comparison	NOUN
bam-10833	164	103	of	of	ADP
bam-10833	164	104	colistin	colistin	PROPN
bam-10833	164	105	-	-	PUNCT
bam-10833	164	106	carbapenem	carbapenem	PROPN
bam-10833	164	107	,	,	PUNCT
bam-10833	164	108	colistin	colistin	NOUN
bam-10833	164	109	-	-	PUNCT
bam-10833	164	110	sulbactam	sulbactam	NOUN
bam-10833	164	111	,	,	PUNCT
bam-10833	164	112	and	and	CCONJ
bam-10833	164	113	colistin	colistin	NOUN
bam-10833	164	114	plus	plus	CCONJ
bam-10833	164	115	other	other	ADJ
bam-10833	164	116	antibacterial	antibacterial	ADJ
bam-10833	164	117	agents	agent	NOUN
bam-10833	164	118	for	for	ADP
bam-10833	164	119	the	the	DET
bam-10833	164	120	treatment	treatment	NOUN
bam-10833	164	121	of	of	ADP
bam-10833	164	122	extremely	extremely	ADV
bam-10833	164	123	drug	drug	NOUN
bam-10833	164	124	-	-	PUNCT
bam-10833	164	125	resistant	resistant	ADJ
bam-10833	164	126	acinetobacter	acinetobacter	ADJ
bam-10833	164	127	baumannii	baumannii	ADJ
bam-10833	164	128	bloodstream	bloodstream	NOUN
bam-10833	164	129	infections	infection	NOUN
bam-10833	164	130	.	.	PUNCT
bam-10833	165	1	eur	eur	PROPN
bam-10833	165	2	j	j	PROPN
bam-10833	165	3	clin	clin	PROPN
bam-10833	165	4	microbiol	microbiol	PROPN
bam-10833	165	5	infect	infect	VERB
bam-10833	165	6	dis	dis	PROPN
bam-10833	165	7	.	.	PUNCT
bam-10833	165	8	2014	2014	NUM
bam-10833	166	1	aug;33(8):1311	aug;33(8):1311	PROPN
bam-10833	166	2	-	-	PUNCT
bam-10833	166	3	22	22	NUM
bam-10833	166	4	.	.	PUNCT
bam-10833	167	1	doi	doi	NOUN
bam-10833	167	2	:	:	PUNCT
bam-10833	167	3	10.1007	10.1007	NUM
bam-10833	167	4	/	/	SYM
bam-10833	167	5	s10096	s10096	NOUN
bam-10833	167	6	-	-	PUNCT
bam-10833	167	7	014	014	NUM
bam-10833	167	8	-	-	PUNCT
bam-10833	167	9	2070	2070	NUM
bam-10833	167	10	-	-	SYM
bam-10833	167	11	6	6	NUM
bam-10833	167	12	.	.	PUNCT
bam-10833	168	1	epub	epub	PROPN
bam-10833	168	2	2014	2014	NUM
bam-10833	168	3	feb	feb	NOUN
bam-10833	168	4	15	15	NUM
bam-10833	168	5	.	.	PUNCT
bam-10833	169	1	pmid	pmid	NOUN
bam-10833	169	2	:	:	PUNCT
bam-10833	169	3	24532009	24532009	NUM
bam-10833	169	4	.	.	PUNCT
bam-10833	170	1	13	13	NUM
bam-10833	170	2	.	.	PUNCT
bam-10833	171	1	capone	capone	PROPN
bam-10833	171	2	a	a	PROPN
bam-10833	171	3	,	,	PUNCT
bam-10833	171	4	giannella	giannella	NOUN
bam-10833	171	5	m	m	PROPN
bam-10833	171	6	,	,	PUNCT
bam-10833	171	7	fortini	fortini	PROPN
bam-10833	171	8	d	d	PROPN
bam-10833	171	9	,	,	PUNCT
bam-10833	171	10	giordano	giordano	PROPN
bam-10833	171	11	a	a	PRON
bam-10833	171	12	,	,	PUNCT
bam-10833	171	13	meledandri	meledandri	PROPN
bam-10833	171	14	m	m	PROPN
bam-10833	171	15	,	,	PUNCT
bam-10833	171	16	ballardini	ballardini	PROPN
bam-10833	171	17	m	m	PROPN
bam-10833	171	18	,	,	PUNCT
bam-10833	171	19	venditti	venditti	PROPN
bam-10833	171	20	m	m	PROPN
bam-10833	171	21	,	,	PUNCT
bam-10833	171	22	bordi	bordi	NOUN
bam-10833	171	23	e	e	NOUN
bam-10833	171	24	,	,	PUNCT
bam-10833	171	25	https://orcid.org/0000-0001-7062-4669	https://orcid.org/0000-0001-7062-4669	PROPN
bam-10833	171	26	mailto:farzanehhematian@yahoo.com	mailto:farzanehhematian@yahoo.com	PROPN
bam-10833	171	27	mailto:ahmadpourforoz@yahoo.com	mailto:ahmadpourforoz@yahoo.com	PROPN
bam-10833	171	28	https://orcid.org/0000-0002-1142-6088	https://orcid.org/0000-0002-1142-6088	PROPN
bam-10833	171	29	mailto:shasebe@tbzmed.ac.ir	mailto:shasebe@tbzmed.ac.ir	PROPN
bam-10833	172	1	https://orcid.org/0000-0001-7931-4632	https://orcid.org/0000-0001-7931-4632	NOUN
bam-10833	172	2	mailto:mandana.i@gmail.com	mailto:mandana.i@gmail.com	PROPN
bam-10833	173	1	https://orcid.org/0000-0002-1785-4665	https://orcid.org/0000-0002-1785-4665	PROPN
bam-10833	173	2	mailto:aminrakhshan@gmail.com	mailto:aminrakhshan@gmail.com	PROPN
bam-10833	173	3	https://orcid.org/0000-0002-1836-7658	https://orcid.org/0000-0002-1836-7658	PROPN
bam-10833	173	4	intravenous	intravenous	PROPN
bam-10833	173	5	colistin	colistin	NOUN
bam-10833	173	6	monotherapy	monotherapy	NOUN
bam-10833	173	7	versus	versus	ADP
bam-10833	173	8	combination	combination	NOUN
bam-10833	173	9	therapy	therapy	NOUN
bam-10833	173	10	eur	eur	PROPN
bam-10833	173	11	j	j	PROPN
bam-10833	173	12	transl	transl	PROPN
bam-10833	173	13	myol	myol	ADV
bam-10833	173	14	32	32	NUM
bam-10833	173	15	(	(	PUNCT
bam-10833	173	16	4	4	NUM
bam-10833	173	17	):	):	PUNCT
bam-10833	173	18	10833	10833	NUM
bam-10833	173	19	,	,	PUNCT
bam-10833	173	20	2022	2022	NUM
bam-10833	173	21	doi	doi	NOUN
bam-10833	173	22	:	:	PUNCT
bam-10833	173	23	10.4081	10.4081	NUM
bam-10833	173	24	/	/	SYM
bam-10833	173	25	ejtm.2022.10833	ejtm.2022.10833	NOUN
bam-10833	173	26	8	8	NUM
bam-10833	173	27	capozzi	capozzi	NOUN
bam-10833	173	28	d	d	NOUN
bam-10833	173	29	,	,	PUNCT
bam-10833	173	30	balice	balice	PROPN
bam-10833	173	31	mp	mp	PROPN
bam-10833	173	32	,	,	PUNCT
bam-10833	173	33	tarasi	tarasi	PROPN
bam-10833	173	34	a	a	NOUN
bam-10833	173	35	,	,	PUNCT
bam-10833	173	36	parisi	parisi	PROPN
bam-10833	173	37	g	g	PROPN
bam-10833	173	38	,	,	PUNCT
bam-10833	173	39	lappa	lappa	VERB
bam-10833	173	40	a	a	DET
bam-10833	173	41	,	,	PUNCT
bam-10833	173	42	carattoli	carattoli	NOUN
bam-10833	173	43	a	a	DET
bam-10833	173	44	,	,	PUNCT
bam-10833	173	45	petrosillo	petrosillo	PROPN
bam-10833	173	46	n.	n.	NOUN
bam-10833	173	47	high	high	ADJ
bam-10833	173	48	rate	rate	NOUN
bam-10833	173	49	of	of	ADP
bam-10833	173	50	colistin	colistin	PROPN
bam-10833	173	51	resistance	resistance	NOUN
bam-10833	173	52	among	among	ADP
bam-10833	173	53	patients	patient	NOUN
bam-10833	173	54	with	with	ADP
bam-10833	173	55	carbapenemresistant	carbapenemresistant	PROPN
bam-10833	173	56	klebsiella	klebsiella	PROPN
bam-10833	173	57	pneumoniae	pneumoniae	ADJ
bam-10833	173	58	infection	infection	NOUN
bam-10833	173	59	accounts	account	VERB
bam-10833	173	60	for	for	ADP
bam-10833	173	61	an	an	DET
bam-10833	173	62	excess	excess	NOUN
bam-10833	173	63	of	of	ADP
bam-10833	173	64	mortality	mortality	NOUN
bam-10833	173	65	.	.	PUNCT
bam-10833	174	1	clin	clin	PROPN
bam-10833	174	2	microbiol	microbiol	PROPN
bam-10833	174	3	infect	infect	PROPN
bam-10833	174	4	.	.	PUNCT
bam-10833	175	1	2013	2013	NUM
bam-10833	175	2	jan;19(1):e23	jan;19(1):e23	NOUN
bam-10833	175	3	-	-	PUNCT
bam-10833	175	4	e30	e30	NOUN
bam-10833	175	5	.	.	PUNCT
bam-10833	176	1	doi	doi	NOUN
bam-10833	176	2	:	:	PUNCT
bam-10833	176	3	10.1111/14690691.12070	10.1111/14690691.12070	NUM
bam-10833	176	4	.	.	PUNCT
bam-10833	177	1	epub	epub	NOUN
bam-10833	177	2	2012	2012	NUM
bam-10833	177	3	nov	nov	NOUN
bam-10833	177	4	9	9	NUM
bam-10833	177	5	.	.	NOUN
bam-10833	177	6	14	14	NUM
bam-10833	177	7	.	.	PUNCT
bam-10833	178	1	daikos	daikos	PROPN
bam-10833	178	2	gl	gl	PROPN
bam-10833	178	3	,	,	PUNCT
bam-10833	178	4	petrikkos	petrikkos	NOUN
bam-10833	178	5	p	p	NOUN
bam-10833	178	6	,	,	PUNCT
bam-10833	178	7	psichogiou	psichogiou	NOUN
bam-10833	178	8	m	m	PRON
bam-10833	178	9	,	,	PUNCT
bam-10833	178	10	kosmidis	kosmidi	NOUN
bam-10833	178	11	c	c	PROPN
bam-10833	178	12	,	,	PUNCT
bam-10833	178	13	vryonis	vryonis	X
bam-10833	178	14	e	e	NOUN
bam-10833	178	15	,	,	PUNCT
bam-10833	178	16	skoutelis	skouteli	VERB
bam-10833	178	17	a	a	PRON
bam-10833	178	18	,	,	PUNCT
bam-10833	178	19	georgousi	georgousi	PROPN
bam-10833	178	20	k	k	PROPN
bam-10833	178	21	,	,	PUNCT
bam-10833	178	22	tzouvelekis	tzouvelekis	PROPN
bam-10833	178	23	ls	ls	PROPN
bam-10833	178	24	,	,	PUNCT
bam-10833	178	25	tassios	tassio	NOUN
bam-10833	178	26	pt	pt	PROPN
bam-10833	178	27	,	,	PUNCT
bam-10833	178	28	bamia	bamia	NOUN
bam-10833	178	29	c	c	PROPN
bam-10833	178	30	,	,	PUNCT
bam-10833	178	31	petrikkos	petrikkos	ADJ
bam-10833	178	32	g.	g.	NOUN
bam-10833	178	33	prospective	prospective	ADJ
bam-10833	178	34	observational	observational	ADJ
bam-10833	178	35	study	study	NOUN
bam-10833	178	36	of	of	ADP
bam-10833	178	37	the	the	DET
bam-10833	178	38	impact	impact	NOUN
bam-10833	178	39	of	of	ADP
bam-10833	178	40	vim-1	vim-1	ADJ
bam-10833	178	41	metallo	metallo	PROPN
bam-10833	178	42	-	-	PUNCT
bam-10833	178	43	beta	beta	NOUN
bam-10833	178	44	-	-	PUNCT
bam-10833	178	45	lactamase	lactamase	NOUN
bam-10833	178	46	on	on	ADP
bam-10833	178	47	the	the	DET
bam-10833	178	48	outcome	outcome	NOUN
bam-10833	178	49	of	of	ADP
bam-10833	178	50	patients	patient	NOUN
bam-10833	178	51	with	with	ADP
bam-10833	178	52	klebsiella	klebsiella	PROPN
bam-10833	178	53	pneumoniae	pneumoniae	ADJ
bam-10833	178	54	bloodstream	bloodstream	NOUN
bam-10833	178	55	infections	infection	NOUN
bam-10833	178	56	.	.	PUNCT
bam-10833	179	1	antimicrob	antimicrob	PROPN
bam-10833	179	2	agents	agents	PROPN
bam-10833	179	3	chemother	chemother	PROPN
bam-10833	179	4	.	.	PUNCT
bam-10833	180	1	2009	2009	NUM
bam-10833	180	2	may;53(5):1868	may;53(5):1868	NOUN
bam-10833	180	3	-	-	PUNCT
bam-10833	180	4	73	73	NUM
bam-10833	180	5	.	.	PUNCT
bam-10833	181	1	doi	doi	NOUN
bam-10833	181	2	:	:	PUNCT
bam-10833	181	3	10.1128	10.1128	NUM
bam-10833	181	4	/	/	SYM
bam-10833	181	5	aac.00782	aac.00782	NUM
bam-10833	181	6	-	-	PUNCT
bam-10833	181	7	08	08	NUM
bam-10833	181	8	.	.	PUNCT
bam-10833	182	1	epub	epub	PROPN
bam-10833	182	2	2009	2009	NUM
bam-10833	182	3	feb	feb	NOUN
bam-10833	182	4	17	17	NUM
bam-10833	182	5	.	.	NOUN
bam-10833	182	6	15	15	NUM
bam-10833	182	7	.	.	PUNCT
bam-10833	183	1	daikos	daikos	PROPN
bam-10833	183	2	gl	gl	PROPN
bam-10833	183	3	,	,	PUNCT
bam-10833	183	4	tsaousi	tsaousi	PROPN
bam-10833	183	5	s	s	PROPN
bam-10833	183	6	,	,	PUNCT
bam-10833	183	7	tzouvelekis	tzouvelekis	PROPN
bam-10833	183	8	ls	ls	PROPN
bam-10833	183	9	,	,	PUNCT
bam-10833	183	10	anyfantis	anyfantis	PROPN
bam-10833	183	11	i	i	PRON
bam-10833	183	12	,	,	PUNCT
bam-10833	183	13	psichogiou	psichogiou	VERB
bam-10833	183	14	m	m	PROPN
bam-10833	183	15	,	,	PUNCT
bam-10833	183	16	argyropoulou	argyropoulou	NOUN
bam-10833	183	17	a	a	PRON
bam-10833	183	18	,	,	PUNCT
bam-10833	183	19	stefanou	stefanou	NOUN
bam-10833	184	1	i	i	PRON
bam-10833	184	2	,	,	PUNCT
bam-10833	184	3	sypsa	sypsa	PROPN
bam-10833	184	4	v	v	PROPN
bam-10833	184	5	,	,	PUNCT
bam-10833	184	6	miriagou	miriagou	PROPN
bam-10833	184	7	v	v	NOUN
bam-10833	184	8	,	,	PUNCT
bam-10833	184	9	nepka	nepka	PROPN
bam-10833	184	10	m	m	NOUN
bam-10833	184	11	,	,	PUNCT
bam-10833	184	12	georgiadou	georgiadou	PROPN
bam-10833	184	13	s	s	PROPN
bam-10833	184	14	,	,	PUNCT
bam-10833	184	15	markogiannakis	markogiannakis	PROPN
bam-10833	184	16	a	a	PRON
bam-10833	184	17	,	,	PUNCT
bam-10833	184	18	goukos	goukos	NOUN
bam-10833	184	19	d	d	PROPN
bam-10833	184	20	,	,	PUNCT
bam-10833	184	21	skoutelis	skoutelis	ADJ
bam-10833	184	22	a.	a.	NOUN
bam-10833	184	23	carbapenemase	carbapenemase	NOUN
bam-10833	184	24	-	-	PUNCT
bam-10833	184	25	producing	produce	VERB
bam-10833	184	26	klebsiella	klebsiella	NOUN
bam-10833	184	27	pneumoniae	pneumoniae	ADJ
bam-10833	184	28	bloodstream	bloodstream	NOUN
bam-10833	184	29	infections	infection	NOUN
bam-10833	184	30	:	:	PUNCT
bam-10833	184	31	lowering	lower	VERB
bam-10833	184	32	mortality	mortality	NOUN
bam-10833	184	33	by	by	ADP
bam-10833	184	34	antibiotic	antibiotic	ADJ
bam-10833	184	35	combination	combination	NOUN
bam-10833	184	36	schemes	scheme	NOUN
bam-10833	184	37	and	and	CCONJ
bam-10833	184	38	the	the	DET
bam-10833	184	39	role	role	NOUN
bam-10833	184	40	of	of	ADP
bam-10833	184	41	carbapenems	carbapenem	NOUN
bam-10833	184	42	.	.	PUNCT
bam-10833	185	1	antimicrob	antimicrob	PROPN
bam-10833	185	2	agents	agents	PROPN
bam-10833	185	3	chemother	chemother	PROPN
bam-10833	185	4	.	.	PUNCT
bam-10833	186	1	2014;58(4):2322	2014;58(4):2322	PROPN
bam-10833	186	2	-	-	SYM
bam-10833	186	3	8	8	NUM
bam-10833	186	4	.	.	PUNCT
bam-10833	186	5	doi	doi	NOUN
bam-10833	186	6	:	:	PUNCT
bam-10833	186	7	10.1128	10.1128	NUM
bam-10833	186	8	/	/	SYM
bam-10833	186	9	aac.02166	aac.02166	PROPN
bam-10833	186	10	-	-	PUNCT
bam-10833	186	11	13	13	NUM
bam-10833	186	12	.	.	PUNCT
bam-10833	187	1	epub	epub	PROPN
bam-10833	187	2	2014	2014	NUM
bam-10833	187	3	feb	feb	NOUN
bam-10833	187	4	10	10	NUM
bam-10833	187	5	.	.	PUNCT
bam-10833	188	1	16	16	NUM
bam-10833	188	2	.	.	PUNCT
bam-10833	189	1	durante	durante	PROPN
bam-10833	189	2	-	-	PUNCT
bam-10833	189	3	mangoni	mangoni	PROPN
bam-10833	189	4	e	e	PROPN
bam-10833	189	5	,	,	PUNCT
bam-10833	189	6	signoriello	signoriello	VERB
bam-10833	189	7	g	g	NOUN
bam-10833	189	8	,	,	PUNCT
bam-10833	189	9	andini	andini	VERB
bam-10833	189	10	r	r	NOUN
bam-10833	189	11	,	,	PUNCT
bam-10833	189	12	mattei	mattei	NOUN
bam-10833	189	13	a	a	PRON
bam-10833	189	14	,	,	PUNCT
bam-10833	189	15	de	de	X
bam-10833	189	16	cristoforo	cristoforo	NOUN
bam-10833	189	17	m	m	PROPN
bam-10833	189	18	,	,	PUNCT
bam-10833	189	19	murino	murino	NOUN
bam-10833	189	20	p	p	NOUN
bam-10833	189	21	,	,	PUNCT
bam-10833	189	22	bassetti	bassetti	NOUN
bam-10833	189	23	m	m	PROPN
bam-10833	189	24	,	,	PUNCT
bam-10833	189	25	malacarne	malacarne	PROPN
bam-10833	189	26	p	p	X
bam-10833	189	27	,	,	PUNCT
bam-10833	189	28	petrosillo	petrosillo	NOUN
bam-10833	189	29	n	n	CCONJ
bam-10833	189	30	,	,	PUNCT
bam-10833	189	31	galdieri	galdieri	NOUN
bam-10833	189	32	n	n	CCONJ
bam-10833	189	33	,	,	PUNCT
bam-10833	189	34	mocavero	mocavero	PROPN
bam-10833	189	35	p	p	NOUN
bam-10833	189	36	,	,	PUNCT
bam-10833	189	37	corcione	corcione	PROPN
bam-10833	189	38	a	a	PROPN
bam-10833	189	39	,	,	PUNCT
bam-10833	189	40	viscoli	viscoli	NOUN
bam-10833	189	41	c	c	NOUN
bam-10833	189	42	,	,	PUNCT
bam-10833	189	43	zarrilli	zarrilli	PROPN
bam-10833	190	1	r	r	PROPN
bam-10833	190	2	,	,	PUNCT
bam-10833	190	3	gallo	gallo	PROPN
bam-10833	190	4	c	c	PROPN
bam-10833	190	5	,	,	PUNCT
bam-10833	190	6	utili	utili	PROPN
bam-10833	190	7	r.	r.	PROPN
bam-10833	190	8	colistin	colistin	PROPN
bam-10833	190	9	and	and	CCONJ
bam-10833	190	10	rifampicin	rifampicin	VERB
bam-10833	190	11	compared	compare	VERB
bam-10833	190	12	with	with	ADP
bam-10833	190	13	colistin	colistin	NOUN
bam-10833	190	14	alone	alone	ADV
bam-10833	190	15	for	for	ADP
bam-10833	190	16	the	the	DET
bam-10833	190	17	treatment	treatment	NOUN
bam-10833	190	18	of	of	ADP
bam-10833	190	19	serious	serious	ADJ
bam-10833	190	20	infections	infection	NOUN
bam-10833	190	21	due	due	ADJ
bam-10833	190	22	to	to	ADP
bam-10833	190	23	extensively	extensively	ADV
bam-10833	190	24	drug	drug	NOUN
bam-10833	190	25	-	-	PUNCT
bam-10833	190	26	resistant	resistant	ADJ
bam-10833	190	27	acinetobacter	acinetobacter	ADJ
bam-10833	190	28	baumannii	baumannii	NOUN
bam-10833	190	29	:	:	PUNCT
bam-10833	190	30	a	a	DET
bam-10833	190	31	multicenter	multicenter	NOUN
bam-10833	190	32	,	,	PUNCT
bam-10833	190	33	randomized	randomize	VERB
bam-10833	190	34	clinical	clinical	ADJ
bam-10833	190	35	trial	trial	NOUN
bam-10833	190	36	.	.	PUNCT
bam-10833	191	1	clin	clin	PROPN
bam-10833	191	2	infect	infect	PROPN
bam-10833	191	3	dis	dis	PROPN
bam-10833	191	4	.	.	PUNCT
bam-10833	192	1	2013	2013	NUM
bam-10833	192	2	aug;57(3):349	aug;57(3):349	SYM
bam-10833	192	3	-	-	PUNCT
bam-10833	192	4	58	58	PROPN
bam-10833	192	5	.	.	PUNCT
bam-10833	193	1	doi	doi	NOUN
bam-10833	193	2	:	:	PUNCT
bam-10833	193	3	10.1093	10.1093	NUM
bam-10833	193	4	/	/	SYM
bam-10833	193	5	cid	cid	PROPN
bam-10833	193	6	/	/	SYM
bam-10833	193	7	cit253	cit253	PROPN
bam-10833	193	8	.	.	PUNCT
bam-10833	194	1	epub	epub	PROPN
bam-10833	194	2	2013	2013	NUM
bam-10833	194	3	apr	apr	NOUN
bam-10833	194	4	24	24	NUM
bam-10833	194	5	.	.	PUNCT
bam-10833	194	6	17	17	NUM
bam-10833	194	7	.	.	PUNCT
bam-10833	195	1	falagas	falagas	PROPN
bam-10833	195	2	me	i	PRON
bam-10833	195	3	,	,	PUNCT
bam-10833	195	4	rafailidis	rafailidis	NOUN
bam-10833	195	5	pi	pi	NOUN
bam-10833	195	6	,	,	PUNCT
bam-10833	195	7	matthaiou	matthaiou	NOUN
bam-10833	195	8	dk	dk	PROPN
bam-10833	195	9	,	,	PUNCT
bam-10833	195	10	virtzili	virtzili	NOUN
bam-10833	195	11	s	s	PROPN
bam-10833	195	12	,	,	PUNCT
bam-10833	195	13	nikita	nikita	PROPN
bam-10833	195	14	d	d	PROPN
bam-10833	195	15	,	,	PUNCT
bam-10833	195	16	michalopoulos	michalopoulos	PROPN
bam-10833	195	17	a.	a.	PROPN
bam-10833	195	18	pandrug	pandrug	VERB
bam-10833	195	19	-	-	PUNCT
bam-10833	195	20	resistant	resistant	ADJ
bam-10833	195	21	klebsiella	klebsiella	NOUN
bam-10833	195	22	pneumoniae	pneumoniae	NOUN
bam-10833	195	23	,	,	PUNCT
bam-10833	195	24	pseudomonas	pseudomona	VERB
bam-10833	195	25	aeruginosa	aeruginosa	NOUN
bam-10833	195	26	and	and	CCONJ
bam-10833	195	27	acinetobacter	acinetobacter	ADJ
bam-10833	195	28	baumannii	baumannii	ADJ
bam-10833	195	29	infections	infection	NOUN
bam-10833	195	30	:	:	PUNCT
bam-10833	195	31	characteristics	characteristic	NOUN
bam-10833	195	32	and	and	CCONJ
bam-10833	195	33	outcome	outcome	VERB
bam-10833	195	34	in	in	ADP
bam-10833	195	35	a	a	DET
bam-10833	195	36	series	series	NOUN
bam-10833	195	37	of	of	ADP
bam-10833	195	38	28	28	NUM
bam-10833	195	39	patients	patient	NOUN
bam-10833	195	40	.	.	PUNCT
bam-10833	196	1	int	int	NOUN
bam-10833	196	2	j	j	PROPN
bam-10833	196	3	antimicrob	antimicrob	PROPN
bam-10833	196	4	agents	agent	NOUN
bam-10833	196	5	.	.	PUNCT
bam-10833	197	1	2008	2008	NUM
bam-10833	197	2	nov;32(5):450	nov;32(5):450	NUM
bam-10833	197	3	-	-	PUNCT
bam-10833	197	4	4	4	NUM
bam-10833	197	5	.	.	PUNCT
bam-10833	198	1	doi	doi	NOUN
bam-10833	198	2	:	:	PUNCT
bam-10833	198	3	10.1016	10.1016	NUM
bam-10833	198	4	/	/	SYM
bam-10833	198	5	j.ijantimicag.2008	j.ijantimicag.2008	NOUN
bam-10833	198	6	.	.	PUNCT
bam-10833	199	1	05.016	05.016	NUM
bam-10833	199	2	.	.	PUNCT
bam-10833	200	1	epub	epub	PROPN
bam-10833	200	2	2008	2008	NUM
bam-10833	200	3	sep	sep	NOUN
bam-10833	200	4	2	2	NUM
bam-10833	200	5	.	.	NOUN
bam-10833	200	6	18	18	NUM
bam-10833	200	7	.	.	PUNCT
bam-10833	201	1	garnacho	garnacho	NOUN
bam-10833	201	2	-	-	PUNCT
bam-10833	201	3	montero	montero	PROPN
bam-10833	201	4	j	j	PROPN
bam-10833	201	5	,	,	PUNCT
bam-10833	201	6	amaya	amaya	PROPN
bam-10833	201	7	-	-	PUNCT
bam-10833	201	8	villar	villar	PROPN
bam-10833	201	9	r	r	PROPN
bam-10833	201	10	,	,	PUNCT
bam-10833	201	11	gutiérrezpizarraya	gutiérrezpizarraya	NOUN
bam-10833	201	12	a	a	NOUN
bam-10833	201	13	,	,	PUNCT
bam-10833	201	14	espejo	espejo	ADJ
bam-10833	201	15	-	-	PUNCT
bam-10833	201	16	gutiérrez	gutiérrez	PROPN
bam-10833	201	17	de	de	PROPN
bam-10833	201	18	tena	tena	PROPN
bam-10833	201	19	e	e	PROPN
bam-10833	201	20	,	,	PUNCT
bam-10833	201	21	arterogonzález	arterogonzález	PROPN
bam-10833	201	22	ml	ml	NOUN
bam-10833	201	23	,	,	PUNCT
bam-10833	201	24	corcia	corcia	NOUN
bam-10833	201	25	-	-	PUNCT
bam-10833	201	26	palomo	palomo	NOUN
bam-10833	201	27	y	y	PROPN
bam-10833	201	28	,	,	PUNCT
bam-10833	201	29	bautista	bautista	PROPN
bam-10833	201	30	-	-	PUNCT
bam-10833	201	31	paloma	paloma	PROPN
bam-10833	201	32	j.	j.	PROPN
bam-10833	201	33	clinical	clinical	PROPN
bam-10833	201	34	efficacy	efficacy	NOUN
bam-10833	201	35	and	and	CCONJ
bam-10833	201	36	safety	safety	NOUN
bam-10833	201	37	of	of	ADP
bam-10833	201	38	the	the	DET
bam-10833	201	39	combination	combination	NOUN
bam-10833	201	40	of	of	ADP
bam-10833	201	41	colistin	colistin	NOUN
bam-10833	201	42	plus	plus	CCONJ
bam-10833	201	43	vancomycin	vancomycin	PROPN
bam-10833	201	44	for	for	ADP
bam-10833	201	45	the	the	DET
bam-10833	201	46	treatment	treatment	NOUN
bam-10833	201	47	of	of	ADP
bam-10833	201	48	severe	severe	ADJ
bam-10833	201	49	infections	infection	NOUN
bam-10833	201	50	caused	cause	VERB
bam-10833	201	51	by	by	ADP
bam-10833	201	52	carbapenem	carbapenem	NOUN
bam-10833	201	53	-	-	PUNCT
bam-10833	201	54	resistant	resistant	ADJ
bam-10833	201	55	acinetobacter	acinetobacter	ADJ
bam-10833	201	56	baumannii	baumannii	PROPN
bam-10833	201	57	.	.	PUNCT
bam-10833	202	1	chemotherapy	chemotherapy	NOUN
bam-10833	202	2	.	.	PUNCT
bam-10833	203	1	2013;59(3):225	2013;59(3):225	NUM
bam-10833	203	2	-	-	SYM
bam-10833	203	3	31	31	NUM
bam-10833	203	4	.	.	PUNCT
bam-10833	204	1	doi	doi	NOUN
bam-10833	204	2	:	:	PUNCT
bam-10833	204	3	10.1159/000356004	10.1159/000356004	NUM
bam-10833	204	4	.	.	PUNCT
bam-10833	205	1	epub	epub	PROPN
bam-10833	205	2	2013	2013	NUM
bam-10833	205	3	dec	dec	PROPN
bam-10833	205	4	13	13	NUM
bam-10833	205	5	.	.	PROPN
bam-10833	206	1	19	19	NUM
bam-10833	206	2	.	.	PUNCT
bam-10833	206	3	hernández	hernández	PROPN
bam-10833	206	4	-	-	PUNCT
bam-10833	206	5	torres	torre	VERB
bam-10833	206	6	a	a	DET
bam-10833	206	7	,	,	PUNCT
bam-10833	206	8	garcía	garcía	ADJ
bam-10833	206	9	-	-	PUNCT
bam-10833	206	10	vázquez	vázquez	NOUN
bam-10833	206	11	e	e	NOUN
bam-10833	206	12	,	,	PUNCT
bam-10833	206	13	gómez	gómez	PROPN
bam-10833	206	14	j	j	PROPN
bam-10833	206	15	,	,	PUNCT
bam-10833	206	16	canteras	canteras	PROPN
bam-10833	206	17	m	m	PROPN
bam-10833	206	18	,	,	PUNCT
bam-10833	206	19	ruiz	ruiz	PROPN
bam-10833	206	20	j	j	PROPN
bam-10833	206	21	,	,	PUNCT
bam-10833	206	22	yagüe	yagüe	PROPN
bam-10833	206	23	g.	g.	PROPN
bam-10833	206	24	multidrug	multidrug	PROPN
bam-10833	206	25	and	and	CCONJ
bam-10833	206	26	carbapenem	carbapenem	NOUN
bam-10833	206	27	-	-	PUNCT
bam-10833	206	28	resistant	resistant	ADJ
bam-10833	206	29	acinetobacter	acinetobacter	ADJ
bam-10833	206	30	baumannii	baumannii	ADJ
bam-10833	206	31	infections	infection	NOUN
bam-10833	206	32	:	:	PUNCT
bam-10833	207	1	factors	factor	NOUN
bam-10833	207	2	associated	associate	VERB
bam-10833	207	3	with	with	ADP
bam-10833	207	4	mortality	mortality	NOUN
bam-10833	207	5	.	.	PUNCT
bam-10833	208	1	med	med	PROPN
bam-10833	208	2	clin	clin	PROPN
bam-10833	208	3	(	(	PUNCT
bam-10833	208	4	barc	barc	PROPN
bam-10833	208	5	)	)	PUNCT
bam-10833	208	6	.	.	PUNCT
bam-10833	209	1	2012	2012	NUM
bam-10833	209	2	may	may	AUX
bam-10833	209	3	26;138(15):650	26;138(15):650	NUM
bam-10833	209	4	-	-	SYM
bam-10833	209	5	5	5	NUM
bam-10833	209	6	.	.	PUNCT
bam-10833	209	7	doi	doi	NOUN
bam-10833	209	8	:	:	PUNCT
bam-10833	209	9	10.1016	10.1016	NUM
bam-10833	209	10	/	/	SYM
bam-10833	209	11	j.medcli.2011.06.024	j.medcli.2011.06.024	PROPN
bam-10833	209	12	.	.	PUNCT
bam-10833	210	1	epub	epub	PROPN
bam-10833	210	2	2011	2011	NUM
bam-10833	210	3	nov	nov	PROPN
bam-10833	210	4	16	16	NUM
bam-10833	210	5	.	.	PUNCT
bam-10833	211	1	20	20	NUM
bam-10833	211	2	.	.	PUNCT
bam-10833	212	1	kalin	kalin	PROPN
bam-10833	212	2	g	g	PROPN
bam-10833	212	3	,	,	PUNCT
bam-10833	212	4	alp	alp	PROPN
bam-10833	212	5	e	e	PROPN
bam-10833	212	6	,	,	PUNCT
bam-10833	212	7	akin	akin	ADJ
bam-10833	212	8	a	a	DET
bam-10833	212	9	,	,	PUNCT
bam-10833	212	10	coskun	coskun	NOUN
bam-10833	212	11	r	r	NOUN
bam-10833	212	12	,	,	PUNCT
bam-10833	212	13	doganay	doganay	PROPN
bam-10833	212	14	m.	m.	NOUN
bam-10833	212	15	comparison	comparison	NOUN
bam-10833	212	16	of	of	ADP
bam-10833	212	17	colistin	colistin	NOUN
bam-10833	212	18	and	and	CCONJ
bam-10833	212	19	colistin	colistin	PROPN
bam-10833	212	20	/	/	SYM
bam-10833	212	21	sulbactam	sulbactam	NOUN
bam-10833	212	22	for	for	ADP
bam-10833	212	23	the	the	DET
bam-10833	212	24	treatment	treatment	NOUN
bam-10833	212	25	of	of	ADP
bam-10833	212	26	multidrug	multidrug	NOUN
bam-10833	212	27	resistant	resistant	ADJ
bam-10833	212	28	acinetobacter	acinetobacter	ADV
bam-10833	212	29	baumannii	baumannii	ADJ
bam-10833	212	30	ventilator	ventilator	NOUN
bam-10833	212	31	-	-	PUNCT
bam-10833	212	32	associated	associate	VERB
bam-10833	212	33	pneumonia	pneumonia	NOUN
bam-10833	212	34	.	.	PUNCT
bam-10833	213	1	infection	infection	NOUN
bam-10833	213	2	.	.	PUNCT
bam-10833	214	1	2014	2014	NUM
bam-10833	215	1	feb;42(1):37	feb;42(1):37	VERB
bam-10833	215	2	-	-	PUNCT
bam-10833	215	3	42	42	NUM
bam-10833	215	4	.	.	PUNCT
bam-10833	216	1	doi	doi	NOUN
bam-10833	216	2	:	:	PUNCT
bam-10833	216	3	10.1007	10.1007	NUM
bam-10833	216	4	/	/	SYM
bam-10833	216	5	s15010	s15010	NOUN
bam-10833	216	6	-	-	PUNCT
bam-10833	216	7	013	013	NUM
bam-10833	216	8	-	-	PUNCT
bam-10833	216	9	0495	0495	NUM
bam-10833	216	10	-	-	PUNCT
bam-10833	216	11	y.	y.	NOUN
bam-10833	216	12	epub	epub	PROPN
bam-10833	216	13	2013	2013	NUM
bam-10833	216	14	jul	jul	PROPN
bam-10833	216	15	5	5	NUM
bam-10833	216	16	.	.	PROPN
bam-10833	216	17	21	21	NUM
bam-10833	216	18	.	.	PUNCT
bam-10833	217	1	katip	katip	PROPN
bam-10833	217	2	w	w	PROPN
bam-10833	217	3	,	,	PUNCT
bam-10833	217	4	oberdorfer	oberdorfer	NOUN
bam-10833	217	5	p.	p.	NOUN
bam-10833	217	6	clinical	clinical	ADJ
bam-10833	217	7	efficacy	efficacy	NOUN
bam-10833	217	8	and	and	CCONJ
bam-10833	217	9	nephrotoxicity	nephrotoxicity	NOUN
bam-10833	217	10	of	of	ADP
bam-10833	217	11	colistin	colistin	NOUN
bam-10833	217	12	alone	alone	ADV
bam-10833	217	13	versus	versus	ADP
bam-10833	217	14	colistin	colistin	PROPN
bam-10833	217	15	plus	plus	CCONJ
bam-10833	217	16	vancomycin	vancomycin	PROPN
bam-10833	217	17	in	in	ADP
bam-10833	217	18	critically	critically	ADV
bam-10833	217	19	ill	ill	ADJ
bam-10833	217	20	patients	patient	NOUN
bam-10833	217	21	infected	infect	VERB
bam-10833	217	22	with	with	ADP
bam-10833	217	23	carbapenem	carbapenem	NOUN
bam-10833	217	24	-	-	PUNCT
bam-10833	217	25	resistant	resistant	ADJ
bam-10833	217	26	acinetobacter	acinetobacter	ADJ
bam-10833	217	27	baumannii	baumannii	PROPN
bam-10833	217	28	:	:	PUNCT
bam-10833	217	29	a	a	DET
bam-10833	217	30	propensity	propensity	NOUN
bam-10833	217	31	score	score	NOUN
bam-10833	217	32	-	-	PUNCT
bam-10833	217	33	matched	match	VERB
bam-10833	217	34	analysis	analysis	NOUN
bam-10833	217	35	.	.	PUNCT
bam-10833	218	1	pharmaceutics	pharmaceutic	NOUN
bam-10833	218	2	.	.	PUNCT
bam-10833	219	1	2021	2021	NUM
bam-10833	219	2	jan	jan	PROPN
bam-10833	219	3	26;13(2):162	26;13(2):162	PROPN
bam-10833	219	4	.	.	PUNCT
bam-10833	220	1	doi	doi	NOUN
bam-10833	220	2	:	:	PUNCT
bam-10833	220	3	10.3390	10.3390	NUM
bam-10833	220	4	/	/	SYM
bam-10833	220	5	pharmaceutics13020162	pharmaceutics13020162	PROPN
bam-10833	220	6	.	.	PUNCT
bam-10833	221	1	22	22	NUM
bam-10833	221	2	.	.	PUNCT
bam-10833	222	1	katip	katip	PROPN
bam-10833	222	2	w	w	PROPN
bam-10833	222	3	,	,	PUNCT
bam-10833	222	4	uitrakul	uitrakul	PROPN
bam-10833	222	5	s	s	PROPN
bam-10833	222	6	,	,	PUNCT
bam-10833	222	7	oberdorfer	oberdorfer	NOUN
bam-10833	222	8	p.	p.	NOUN
bam-10833	222	9	the	the	DET
bam-10833	222	10	effectiveness	effectiveness	NOUN
bam-10833	222	11	and	and	CCONJ
bam-10833	222	12	nephrotoxicity	nephrotoxicity	NOUN
bam-10833	222	13	of	of	ADP
bam-10833	222	14	loading	loading	NOUN
bam-10833	222	15	dose	dose	NOUN
bam-10833	222	16	colistin	colistin	NOUN
bam-10833	222	17	combined	combine	VERB
bam-10833	222	18	with	with	ADP
bam-10833	222	19	or	or	CCONJ
bam-10833	222	20	without	without	ADP
bam-10833	222	21	meropenem	meropenem	NOUN
bam-10833	222	22	for	for	ADP
bam-10833	222	23	the	the	DET
bam-10833	222	24	treatment	treatment	NOUN
bam-10833	222	25	of	of	ADP
bam-10833	222	26	carbapenem	carbapenem	NOUN
bam-10833	222	27	-	-	PUNCT
bam-10833	222	28	resistant	resistant	ADJ
bam-10833	222	29	a.	a.	NOUN
bam-10833	222	30	baumannii	baumannii	PROPN
bam-10833	222	31	.	.	PUNCT
bam-10833	223	1	int	int	PROPN
bam-10833	223	2	j	j	PROPN
bam-10833	223	3	infect	infect	VERB
bam-10833	223	4	dis	dis	PROPN
bam-10833	223	5	.	.	PROPN
bam-10833	223	6	2020	2020	NUM
bam-10833	223	7	aug;97:391	aug;97:391	PROPN
bam-10833	223	8	-	-	SYM
bam-10833	223	9	395	395	NUM
bam-10833	223	10	.	.	PUNCT
bam-10833	224	1	doi	doi	NOUN
bam-10833	224	2	:	:	PUNCT
bam-10833	224	3	10.1016	10.1016	NUM
bam-10833	224	4	/	/	SYM
bam-10833	224	5	j.ijid.2020.05.100	j.ijid.2020.05.100	PROPN
bam-10833	224	6	.	.	PUNCT
bam-10833	225	1	epub	epub	PROPN
bam-10833	225	2	2020	2020	NUM
bam-10833	225	3	jun	jun	PROPN
bam-10833	225	4	2	2	NUM
bam-10833	225	5	.	.	NUM
bam-10833	225	6	23	23	NUM
bam-10833	225	7	.	.	PUNCT
bam-10833	226	1	katip	katip	PROPN
bam-10833	226	2	w	w	PROPN
bam-10833	226	3	,	,	PUNCT
bam-10833	226	4	uitrakul	uitrakul	PROPN
bam-10833	226	5	s	s	PROPN
bam-10833	226	6	,	,	PUNCT
bam-10833	226	7	oberdorfer	oberdorfer	NOUN
bam-10833	227	1	p.	p.	NOUN
bam-10833	227	2	a	a	DET
bam-10833	227	3	comparison	comparison	NOUN
bam-10833	227	4	of	of	ADP
bam-10833	227	5	colistin	colistin	NOUN
bam-10833	227	6	versus	versus	ADP
bam-10833	227	7	colistin	colistin	PROPN
bam-10833	227	8	plus	plus	CCONJ
bam-10833	227	9	meropenem	meropenem	PROPN
bam-10833	227	10	for	for	ADP
bam-10833	227	11	the	the	DET
bam-10833	227	12	treatment	treatment	NOUN
bam-10833	227	13	of	of	ADP
bam-10833	227	14	carbapenem	carbapenem	NOUN
bam-10833	227	15	-	-	PUNCT
bam-10833	227	16	resistant	resistant	ADJ
bam-10833	227	17	acinetobacter	acinetobacter	ADJ
bam-10833	227	18	baumannii	baumannii	ADJ
bam-10833	227	19	in	in	ADP
bam-10833	227	20	critically	critically	ADV
bam-10833	227	21	ill	ill	ADJ
bam-10833	227	22	patients	patient	NOUN
bam-10833	227	23	:	:	PUNCT
bam-10833	227	24	a	a	DET
bam-10833	227	25	propensity	propensity	NOUN
bam-10833	227	26	score	score	NOUN
bam-10833	227	27	-	-	PUNCT
bam-10833	227	28	matched	match	VERB
bam-10833	227	29	analysis	analysis	NOUN
bam-10833	227	30	.	.	PUNCT
bam-10833	228	1	antibiotics	antibiotic	NOUN
bam-10833	228	2	(	(	PUNCT
bam-10833	228	3	basel	basel	PROPN
bam-10833	228	4	)	)	PUNCT
bam-10833	228	5	.	.	PUNCT
bam-10833	229	1	2020	2020	NUM
bam-10833	229	2	sep	sep	PROPN
bam-10833	229	3	28;9(10):647	28;9(10):647	NUM
bam-10833	229	4	.	.	PUNCT
bam-10833	230	1	doi	doi	NOUN
bam-10833	230	2	:	:	PUNCT
bam-10833	230	3	10.3390	10.3390	NUM
bam-10833	230	4	/	/	SYM
bam-10833	230	5	antibiotics	antibiotic	NOUN
bam-10833	230	6	9100647	9100647	NUM
bam-10833	230	7	.	.	PUNCT
bam-10833	231	1	24	24	NUM
bam-10833	231	2	.	.	PUNCT
bam-10833	232	1	kontopidou	kontopidou	PROPN
bam-10833	233	1	f	f	X
bam-10833	233	2	,	,	PUNCT
bam-10833	233	3	giamarellou	giamarellou	ADJ
bam-10833	233	4	h	h	NOUN
bam-10833	233	5	,	,	PUNCT
bam-10833	233	6	katerelos	katerelos	PROPN
bam-10833	233	7	p	p	NOUN
bam-10833	233	8	,	,	PUNCT
bam-10833	233	9	maragos	marago	NOUN
bam-10833	233	10	a	a	PRON
bam-10833	233	11	,	,	PUNCT
bam-10833	233	12	kioumis	kioumis	PROPN
bam-10833	233	13	i	i	PRON
bam-10833	233	14	,	,	PUNCT
bam-10833	233	15	trikka	trikka	NOUN
bam-10833	233	16	-	-	PUNCT
bam-10833	233	17	graphakos	graphakos	ADJ
bam-10833	233	18	e	e	NOUN
bam-10833	233	19	,	,	PUNCT
bam-10833	233	20	valakis	valakis	PROPN
bam-10833	233	21	c	c	NOUN
bam-10833	233	22	,	,	PUNCT
bam-10833	233	23	maltezou	maltezou	VERB
bam-10833	233	24	hc	hc	NOUN
bam-10833	233	25	;	;	PUNCT
bam-10833	233	26	group	group	NOUN
bam-10833	233	27	for	for	ADP
bam-10833	233	28	the	the	DET
bam-10833	233	29	study	study	NOUN
bam-10833	233	30	of	of	ADP
bam-10833	233	31	kpc	kpc	NOUN
bam-10833	233	32	-	-	PUNCT
bam-10833	233	33	producing	produce	VERB
bam-10833	233	34	klebsiella	klebsiella	NOUN
bam-10833	233	35	pneumoniae	pneumoniae	ADJ
bam-10833	233	36	infections	infection	NOUN
bam-10833	233	37	in	in	ADP
bam-10833	233	38	intensive	intensive	ADJ
bam-10833	233	39	care	care	NOUN
bam-10833	233	40	units	unit	NOUN
bam-10833	233	41	.	.	PUNCT
bam-10833	234	1	infections	infection	NOUN
bam-10833	234	2	caused	cause	VERB
bam-10833	234	3	by	by	ADP
bam-10833	234	4	carbapenem	carbapenem	NOUN
bam-10833	234	5	-	-	PUNCT
bam-10833	234	6	resistant	resistant	ADJ
bam-10833	234	7	klebsiella	klebsiella	NOUN
bam-10833	234	8	pneumoniae	pneumoniae	ADJ
bam-10833	234	9	among	among	ADP
bam-10833	234	10	patients	patient	NOUN
bam-10833	234	11	in	in	ADP
bam-10833	234	12	intensive	intensive	ADJ
bam-10833	234	13	care	care	NOUN
bam-10833	234	14	units	unit	NOUN
bam-10833	234	15	in	in	ADP
bam-10833	234	16	greece	greece	PROPN
bam-10833	234	17	:	:	PUNCT
bam-10833	234	18	a	a	DET
bam-10833	234	19	multi	multi	ADJ
bam-10833	234	20	-	-	ADJ
bam-10833	234	21	centre	centre	ADJ
bam-10833	234	22	study	study	NOUN
bam-10833	234	23	on	on	ADP
bam-10833	234	24	clinical	clinical	ADJ
bam-10833	234	25	outcome	outcome	NOUN
bam-10833	234	26	and	and	CCONJ
bam-10833	234	27	therapeutic	therapeutic	ADJ
bam-10833	234	28	options	option	NOUN
bam-10833	234	29	.	.	PUNCT
bam-10833	235	1	clin	clin	PROPN
bam-10833	235	2	microbiol	microbiol	PROPN
bam-10833	235	3	infect	infect	PROPN
bam-10833	235	4	.	.	PUNCT
bam-10833	236	1	2014	2014	NUM
bam-10833	236	2	feb;20(2):o117	feb;20(2):o117	PROPN
bam-10833	236	3	-	-	PUNCT
bam-10833	236	4	23	23	NUM
bam-10833	236	5	.	.	PUNCT
bam-10833	237	1	doi	doi	NOUN
bam-10833	237	2	:	:	PUNCT
bam-10833	237	3	10.1111/14690691.12341	10.1111/14690691.12341	NUM
bam-10833	237	4	.	.	PUNCT
bam-10833	238	1	epub	epub	PROPN
bam-10833	238	2	2013	2013	NUM
bam-10833	238	3	aug	aug	PROPN
bam-10833	238	4	30	30	NUM
bam-10833	238	5	.	.	PUNCT
bam-10833	239	1	pmid	pmid	NOUN
bam-10833	239	2	:	:	PUNCT
bam-10833	239	3	23992130	23992130	NUM
bam-10833	239	4	.	.	PUNCT
bam-10833	240	1	25	25	NUM
bam-10833	240	2	.	.	PUNCT
bam-10833	241	1	ku	ku	PROPN
bam-10833	241	2	k	k	PROPN
bam-10833	241	3	,	,	PUNCT
bam-10833	241	4	pogue	pogue	PROPN
bam-10833	241	5	jm	jm	PROPN
bam-10833	241	6	,	,	PUNCT
bam-10833	241	7	moshos	moshos	PROPN
bam-10833	241	8	j	j	PROPN
bam-10833	241	9	,	,	PUNCT
bam-10833	241	10	bheemreddy	bheemreddy	PROPN
bam-10833	241	11	s	s	PROPN
bam-10833	241	12	,	,	PUNCT
bam-10833	241	13	wang	wang	PROPN
bam-10833	241	14	y	y	PROPN
bam-10833	241	15	,	,	PUNCT
bam-10833	241	16	bhargava	bhargava	PROPN
bam-10833	241	17	a	a	PROPN
bam-10833	241	18	,	,	PUNCT
bam-10833	241	19	campbell	campbell	PROPN
bam-10833	241	20	m	m	PROPN
bam-10833	241	21	,	,	PUNCT
bam-10833	241	22	khandker	khandker	NOUN
bam-10833	241	23	n	n	CCONJ
bam-10833	241	24	,	,	PUNCT
bam-10833	241	25	lephart	lephart	NOUN
bam-10833	241	26	pr	pr	PROPN
bam-10833	241	27	,	,	PUNCT
bam-10833	241	28	chopra	chopra	PROPN
bam-10833	241	29	t	t	PROPN
bam-10833	241	30	,	,	PUNCT
bam-10833	241	31	hayakawa	hayakawa	PROPN
bam-10833	241	32	k	k	PROPN
bam-10833	241	33	,	,	PUNCT
bam-10833	241	34	martin	martin	PROPN
bam-10833	241	35	et	et	PROPN
bam-10833	241	36	,	,	PUNCT
bam-10833	241	37	abreu	abreu	PROPN
bam-10833	241	38	-	-	PUNCT
bam-10833	241	39	lanfranco	lanfranco	PROPN
bam-10833	241	40	o	o	PROPN
bam-10833	241	41	,	,	PUNCT
bam-10833	241	42	dhar	dhar	PROPN
bam-10833	241	43	s	s	PROPN
bam-10833	241	44	,	,	PUNCT
bam-10833	241	45	kaye	kaye	PROPN
bam-10833	241	46	ks	ks	PROPN
bam-10833	241	47	,	,	PUNCT
bam-10833	241	48	marchaim	marchaim	PROPN
bam-10833	241	49	d.	d.	PROPN
bam-10833	241	50	retrospective	retrospective	ADJ
bam-10833	241	51	evaluation	evaluation	NOUN
bam-10833	241	52	of	of	ADP
bam-10833	241	53	colistin	colistin	NOUN
bam-10833	241	54	versus	versus	ADP
bam-10833	241	55	tigecycline	tigecycline	NOUN
bam-10833	241	56	for	for	ADP
bam-10833	241	57	the	the	DET
bam-10833	241	58	treatment	treatment	NOUN
bam-10833	241	59	of	of	ADP
bam-10833	241	60	acinetobacter	acinetobacter	ADJ
bam-10833	241	61	baumannii	baumannii	ADJ
bam-10833	241	62	and/or	and/or	CCONJ
bam-10833	241	63	carbapenem	carbapenem	NOUN
bam-10833	241	64	-	-	PUNCT
bam-10833	241	65	resistant	resistant	ADJ
bam-10833	241	66	enterobacteriaceae	enterobacteriaceae	NOUN
bam-10833	241	67	infections	infection	NOUN
bam-10833	241	68	.	.	PUNCT
bam-10833	241	69	am	be	AUX
bam-10833	241	70	j	j	PROPN
bam-10833	241	71	infect	infect	PROPN
bam-10833	241	72	control	control	NOUN
bam-10833	241	73	.	.	PUNCT
bam-10833	242	1	2012	2012	NUM
bam-10833	242	2	dec;40(10):983	dec;40(10):983	NOUN
bam-10833	242	3	-	-	SYM
bam-10833	242	4	7	7	PROPN
bam-10833	242	5	.	.	PUNCT
bam-10833	242	6	doi	doi	NOUN
bam-10833	242	7	:	:	PUNCT
bam-10833	242	8	10.1016	10.1016	NUM
bam-10833	242	9	/	/	SYM
bam-10833	242	10	j.ajic.2011.12.014	j.ajic.2011.12.014	PROPN
bam-10833	242	11	.	.	PUNCT
bam-10833	243	1	epub	epub	PROPN
bam-10833	243	2	2012	2012	NUM
bam-10833	243	3	mar	mar	PROPN
bam-10833	243	4	21	21	NUM
bam-10833	243	5	.	.	PUNCT
bam-10833	243	6	26	26	NUM
bam-10833	243	7	.	.	PUNCT
bam-10833	244	1	lópez	lópez	NOUN
bam-10833	244	2	-	-	PUNCT
bam-10833	244	3	cortés	cortés	PROPN
bam-10833	244	4	le	le	PROPN
bam-10833	244	5	,	,	PUNCT
bam-10833	244	6	cisneros	cisneros	PROPN
bam-10833	244	7	jm	jm	PROPN
bam-10833	244	8	,	,	PUNCT
bam-10833	244	9	fernández	fernández	PROPN
bam-10833	244	10	-	-	PUNCT
bam-10833	244	11	cuenca	cuenca	PROPN
bam-10833	244	12	f	f	PROPN
bam-10833	244	13	,	,	PUNCT
bam-10833	244	14	bou	bou	PROPN
bam-10833	244	15	g	g	PROPN
bam-10833	244	16	,	,	PUNCT
bam-10833	244	17	tomás	tomás	PROPN
bam-10833	244	18	m	m	NOUN
bam-10833	244	19	,	,	PUNCT
bam-10833	244	20	garnacho	garnacho	PROPN
bam-10833	244	21	-	-	PUNCT
bam-10833	244	22	montero	montero	PROPN
bam-10833	244	23	j	j	PROPN
bam-10833	244	24	,	,	PUNCT
bam-10833	244	25	pascual	pascual	PROPN
bam-10833	244	26	a	a	PRON
bam-10833	244	27	,	,	PUNCT
bam-10833	244	28	martínez	martínez	NOUN
bam-10833	244	29	-	-	PUNCT
bam-10833	244	30	martínez	martínez	PROPN
bam-10833	244	31	l	l	PROPN
bam-10833	244	32	,	,	PUNCT
bam-10833	244	33	vila	vila	PROPN
bam-10833	244	34	j	j	PROPN
bam-10833	244	35	,	,	PUNCT
bam-10833	244	36	pachón	pachón	PROPN
bam-10833	244	37	j	j	PROPN
bam-10833	244	38	,	,	PUNCT
bam-10833	244	39	rodríguez	rodríguez	PROPN
bam-10833	244	40	baño	baño	PROPN
bam-10833	244	41	j	j	PROPN
bam-10833	244	42	;	;	PUNCT
bam-10833	244	43	geih	geih	NOUN
bam-10833	244	44	/	/	SYM
bam-10833	244	45	reipi	reipi	ADJ
bam-10833	244	46	-	-	PUNCT
bam-10833	244	47	ab2010	ab2010	NOUN
bam-10833	244	48	group	group	NOUN
bam-10833	244	49	.	.	PUNCT
bam-10833	245	1	monotherapy	monotherapy	NOUN
bam-10833	245	2	versus	versus	ADP
bam-10833	245	3	combination	combination	NOUN
bam-10833	245	4	therapy	therapy	NOUN
bam-10833	245	5	for	for	ADP
bam-10833	245	6	sepsis	sepsis	NOUN
bam-10833	245	7	due	due	ADP
bam-10833	245	8	to	to	ADP
bam-10833	245	9	multidrug	multidrug	VERB
bam-10833	245	10	-	-	PUNCT
bam-10833	245	11	resistant	resistant	ADJ
bam-10833	245	12	acinetobacter	acinetobacter	ADJ
bam-10833	245	13	baumannii	baumannii	NOUN
bam-10833	245	14	:	:	PUNCT
bam-10833	245	15	analysis	analysis	NOUN
bam-10833	245	16	of	of	ADP
bam-10833	245	17	a	a	DET
bam-10833	245	18	multicentre	multicentre	NOUN
bam-10833	245	19	prospective	prospective	ADJ
bam-10833	245	20	cohort	cohort	NOUN
bam-10833	245	21	.	.	PUNCT
bam-10833	246	1	j	j	PROPN
bam-10833	246	2	antimicrob	antimicrob	PROPN
bam-10833	246	3	chemother	chemother	PROPN
bam-10833	246	4	.	.	PUNCT
bam-10833	247	1	2014	2014	NUM
bam-10833	247	2	intravenous	intravenous	ADJ
bam-10833	247	3	colistin	colistin	NOUN
bam-10833	247	4	monotherapy	monotherapy	NOUN
bam-10833	247	5	versus	versus	ADP
bam-10833	247	6	combination	combination	NOUN
bam-10833	247	7	therapy	therapy	NOUN
bam-10833	247	8	eur	eur	PROPN
bam-10833	247	9	j	j	PROPN
bam-10833	247	10	transl	transl	PROPN
bam-10833	247	11	myol	myol	ADV
bam-10833	247	12	32	32	NUM
bam-10833	247	13	(	(	PUNCT
bam-10833	247	14	4	4	NUM
bam-10833	247	15	):	):	PUNCT
bam-10833	247	16	10833	10833	NUM
bam-10833	247	17	,	,	PUNCT
bam-10833	247	18	2022	2022	NUM
bam-10833	247	19	doi	doi	NOUN
bam-10833	247	20	:	:	PUNCT
bam-10833	247	21	10.4081	10.4081	NUM
bam-10833	247	22	/	/	SYM
bam-10833	247	23	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	247	24	9	9	NUM
bam-10833	247	25	nov;69(11):3119	nov;69(11):3119	NOUN
bam-10833	247	26	-	-	PUNCT
bam-10833	247	27	26	26	NUM
bam-10833	247	28	.	.	PUNCT
bam-10833	248	1	doi	doi	NOUN
bam-10833	248	2	:	:	PUNCT
bam-10833	248	3	10.1093	10.1093	NUM
bam-10833	248	4	/	/	SYM
bam-10833	248	5	jac	jac	PROPN
bam-10833	248	6	/	/	SYM
bam-10833	248	7	dku233	dku233	PROPN
bam-10833	248	8	.	.	PUNCT
bam-10833	249	1	epub	epub	PROPN
bam-10833	249	2	2014	2014	NUM
bam-10833	249	3	jun	jun	PROPN
bam-10833	249	4	25	25	NUM
bam-10833	249	5	.	.	PROPN
bam-10833	249	6	27	27	NUM
bam-10833	249	7	.	.	PUNCT
bam-10833	250	1	makris	makris	PROPN
bam-10833	250	2	d	d	PROPN
bam-10833	250	3	,	,	PUNCT
bam-10833	250	4	petinaki	petinaki	NOUN
bam-10833	250	5	e	e	NOUN
bam-10833	250	6	,	,	PUNCT
bam-10833	250	7	tsolaki	tsolaki	NOUN
bam-10833	250	8	v	v	NOUN
bam-10833	250	9	,	,	PUNCT
bam-10833	250	10	manoulakas	manoulakas	PROPN
bam-10833	250	11	e	e	PROPN
bam-10833	250	12	,	,	PUNCT
bam-10833	250	13	mantzarlis	mantzarlis	PROPN
bam-10833	250	14	k	k	PROPN
bam-10833	250	15	,	,	PUNCT
bam-10833	250	16	apostolopoulou	apostolopoulou	PROPN
bam-10833	250	17	o	o	NOUN
bam-10833	250	18	,	,	PUNCT
bam-10833	250	19	sfyras	sfyras	PROPN
bam-10833	250	20	d	d	PROPN
bam-10833	250	21	,	,	PUNCT
bam-10833	250	22	zakynthinos	zakynthinos	PROPN
bam-10833	250	23	e.	e.	PROPN
bam-10833	250	24	colistin	colistin	PROPN
bam-10833	250	25	versus	versus	ADP
bam-10833	250	26	colistin	colistin	PROPN
bam-10833	250	27	combined	combine	VERB
bam-10833	250	28	with	with	ADP
bam-10833	250	29	ampicillin	ampicillin	NOUN
bam-10833	250	30	-	-	NOUN
bam-10833	250	31	sulbactam	sulbactam	NOUN
bam-10833	250	32	for	for	ADP
bam-10833	250	33	multiresistant	multiresistant	ADJ
bam-10833	250	34	acinetobacter	acinetobacter	ADJ
bam-10833	250	35	baumannii	baumannii	ADJ
bam-10833	250	36	ventilator	ventilator	NOUN
bam-10833	250	37	-	-	PUNCT
bam-10833	250	38	associated	associate	VERB
bam-10833	250	39	pneumonia	pneumonia	NOUN
bam-10833	250	40	treatment	treatment	NOUN
bam-10833	250	41	:	:	PUNCT
bam-10833	250	42	an	an	DET
bam-10833	250	43	open	open	ADJ
bam-10833	250	44	-	-	PUNCT
bam-10833	250	45	label	label	NOUN
bam-10833	250	46	prospective	prospective	ADJ
bam-10833	250	47	study	study	NOUN
bam-10833	250	48	.	.	PUNCT
bam-10833	251	1	indian	indian	PROPN
bam-10833	251	2	j	j	PROPN
bam-10833	251	3	crit	crit	PROPN
bam-10833	251	4	care	care	PROPN
bam-10833	251	5	med	me	VERB
bam-10833	251	6	.	.	PUNCT
bam-10833	252	1	2018	2018	NUM
bam-10833	252	2	feb;22(2):6777	feb;22(2):6777	PROPN
bam-10833	252	3	.	.	PROPN
bam-10833	252	4	doi	doi	PROPN
bam-10833	252	5	:	:	PUNCT
bam-10833	252	6	10.4103	10.4103	NUM
bam-10833	252	7	/	/	SYM
bam-10833	252	8	ijccm.ijccm_302_17	ijccm.ijccm_302_17	PROPN
bam-10833	252	9	.	.	PUNCT
bam-10833	253	1	28	28	NUM
bam-10833	253	2	.	.	PUNCT
bam-10833	254	1	mouloudi	mouloudi	PROPN
bam-10833	254	2	e	e	PROPN
bam-10833	254	3	,	,	PUNCT
bam-10833	254	4	protonotariou	protonotariou	NOUN
bam-10833	254	5	e	e	PROPN
bam-10833	254	6	,	,	PUNCT
bam-10833	254	7	zagorianou	zagorianou	PROPN
bam-10833	254	8	a	a	NOUN
bam-10833	254	9	,	,	PUNCT
bam-10833	254	10	iosifidis	iosifidis	PROPN
bam-10833	254	11	e	e	NOUN
bam-10833	254	12	,	,	PUNCT
bam-10833	254	13	karapanagiotou	karapanagiotou	PROPN
bam-10833	254	14	a	a	PROPN
bam-10833	254	15	,	,	PUNCT
bam-10833	254	16	giasnetsova	giasnetsova	PROPN
bam-10833	254	17	t	t	PROPN
bam-10833	254	18	,	,	PUNCT
bam-10833	254	19	tsioka	tsioka	NOUN
bam-10833	254	20	a	a	PRON
bam-10833	254	21	,	,	PUNCT
bam-10833	254	22	roilides	roilide	NOUN
bam-10833	254	23	e	e	NOUN
bam-10833	254	24	,	,	PUNCT
bam-10833	254	25	sofianou	sofianou	NOUN
bam-10833	254	26	d	d	PROPN
bam-10833	254	27	,	,	PUNCT
bam-10833	254	28	gritsigerogianni	gritsigerogianni	PROPN
bam-10833	254	29	n.	n.	NOUN
bam-10833	254	30	bloodstream	bloodstream	NOUN
bam-10833	254	31	infections	infection	NOUN
bam-10833	254	32	caused	cause	VERB
bam-10833	254	33	by	by	ADP
bam-10833	254	34	metallo	metallo	PROPN
bam-10833	254	35	-	-	PUNCT
bam-10833	254	36	β	β	NOUN
bam-10833	254	37	-	-	PUNCT
bam-10833	254	38	lactamase	lactamase	ADJ
bam-10833	254	39	/	/	SYM
bam-10833	254	40	klebsiella	klebsiella	NOUN
bam-10833	254	41	pneumoniae	pneumoniae	ADJ
bam-10833	254	42	carbapenemase	carbapenemase	NOUN
bam-10833	254	43	-	-	PUNCT
bam-10833	254	44	producing	produce	VERB
bam-10833	254	45	k.	k.	NOUN
bam-10833	254	46	pneumoniae	pneumoniae	ADJ
bam-10833	254	47	among	among	ADP
bam-10833	254	48	intensive	intensive	ADJ
bam-10833	254	49	care	care	NOUN
bam-10833	254	50	unit	unit	NOUN
bam-10833	254	51	patients	patient	NOUN
bam-10833	254	52	in	in	ADP
bam-10833	254	53	greece	greece	PROPN
bam-10833	254	54	:	:	PUNCT
bam-10833	254	55	risk	risk	NOUN
bam-10833	254	56	factors	factor	NOUN
bam-10833	254	57	for	for	ADP
bam-10833	254	58	infection	infection	NOUN
bam-10833	254	59	and	and	CCONJ
bam-10833	254	60	impact	impact	NOUN
bam-10833	254	61	of	of	ADP
bam-10833	254	62	type	type	NOUN
bam-10833	254	63	of	of	ADP
bam-10833	254	64	resistance	resistance	NOUN
bam-10833	254	65	on	on	ADP
bam-10833	254	66	outcomes	outcome	NOUN
bam-10833	254	67	.	.	PUNCT
bam-10833	255	1	infect	infect	VERB
bam-10833	255	2	control	control	PROPN
bam-10833	255	3	hosp	hosp	PROPN
bam-10833	255	4	epidemiol	epidemiol	PROPN
bam-10833	255	5	.	.	PUNCT
bam-10833	256	1	2010	2010	NUM
bam-10833	256	2	dec;31(12):1250	dec;31(12):1250	PROPN
bam-10833	256	3	-	-	PUNCT
bam-10833	256	4	6	6	NUM
bam-10833	256	5	.	.	PUNCT
bam-10833	256	6	doi	doi	NOUN
bam-10833	256	7	:	:	PUNCT
bam-10833	256	8	10.1086/657135	10.1086/657135	NUM
bam-10833	256	9	.	.	X
bam-10833	256	10	epub	epub	PROPN
bam-10833	256	11	2010	2010	NUM
bam-10833	256	12	oct	oct	NOUN
bam-10833	256	13	25	25	NUM
bam-10833	256	14	.	.	PROPN
bam-10833	256	15	29	29	NUM
bam-10833	256	16	.	.	PUNCT
bam-10833	257	1	navarro	navarro	PROPN
bam-10833	257	2	-	-	PUNCT
bam-10833	257	3	san	san	PROPN
bam-10833	257	4	francisco	francisco	PROPN
bam-10833	257	5	c	c	PROPN
bam-10833	257	6	,	,	PUNCT
bam-10833	257	7	mora	mora	PROPN
bam-10833	257	8	-	-	PUNCT
bam-10833	257	9	rillo	rillo	PROPN
bam-10833	257	10	m	m	PROPN
bam-10833	257	11	,	,	PUNCT
bam-10833	257	12	romerogómez	romerogómez	PROPN
bam-10833	257	13	mp	mp	PROPN
bam-10833	257	14	,	,	PUNCT
bam-10833	257	15	moreno	moreno	PROPN
bam-10833	257	16	-	-	PUNCT
bam-10833	257	17	ramos	ramos	PROPN
bam-10833	257	18	f	f	PROPN
bam-10833	257	19	,	,	PUNCT
bam-10833	257	20	rico	rico	PROPN
bam-10833	257	21	-	-	PUNCT
bam-10833	257	22	nieto	nieto	PROPN
bam-10833	257	23	a	a	PROPN
bam-10833	257	24	,	,	PUNCT
bam-10833	257	25	ruiz	ruiz	NOUN
bam-10833	257	26	-	-	PUNCT
bam-10833	257	27	carrascoso	carrascoso	NOUN
bam-10833	257	28	g	g	NOUN
bam-10833	257	29	,	,	PUNCT
bam-10833	257	30	gómez	gómez	NOUN
bam-10833	257	31	-	-	PUNCT
bam-10833	257	32	gil	gil	NOUN
bam-10833	257	33	r	r	NOUN
bam-10833	257	34	,	,	PUNCT
bam-10833	257	35	arribas	arribas	ADJ
bam-10833	257	36	-	-	PUNCT
bam-10833	257	37	lópez	lópez	PROPN
bam-10833	257	38	jr	jr	PROPN
bam-10833	257	39	,	,	PUNCT
bam-10833	257	40	mingorance	mingorance	PROPN
bam-10833	257	41	j	j	PROPN
bam-10833	257	42	,	,	PUNCT
bam-10833	257	43	paño	paño	ADJ
bam-10833	257	44	-	-	PUNCT
bam-10833	257	45	pardo	pardo	PROPN
bam-10833	257	46	jr	jr	PROPN
bam-10833	257	47	.	.	PROPN
bam-10833	257	48	bacteraemia	bacteraemia	PROPN
bam-10833	257	49	due	due	ADP
bam-10833	257	50	to	to	ADP
bam-10833	257	51	oxa-48	oxa-48	NOUN
bam-10833	257	52	-	-	PUNCT
bam-10833	257	53	carbapenemase	carbapenemase	NOUN
bam-10833	257	54	-	-	PUNCT
bam-10833	257	55	producing	produce	VERB
bam-10833	257	56	enterobacteriaceae	enterobacteriaceae	NOUN
bam-10833	257	57	:	:	PUNCT
bam-10833	257	58	a	a	DET
bam-10833	257	59	major	major	ADJ
bam-10833	257	60	clinical	clinical	ADJ
bam-10833	257	61	challenge	challenge	NOUN
bam-10833	257	62	.	.	PUNCT
bam-10833	258	1	clin	clin	PROPN
bam-10833	258	2	microbiol	microbiol	PROPN
bam-10833	258	3	infect	infect	PROPN
bam-10833	258	4	.	.	PUNCT
bam-10833	259	1	2013	2013	NUM
bam-10833	259	2	feb;19(2):e72	feb;19(2):e72	NUM
bam-10833	259	3	-	-	SYM
bam-10833	259	4	9	9	NUM
bam-10833	259	5	.	.	PUNCT
bam-10833	259	6	doi	doi	NOUN
bam-10833	259	7	:	:	PUNCT
bam-10833	259	8	10.1111/1469	10.1111/1469	NUM
bam-10833	259	9	-	-	SYM
bam-10833	259	10	0691.12091	0691.12091	PROPN
bam-10833	259	11	.	.	PUNCT
bam-10833	260	1	epub	epub	PROPN
bam-10833	260	2	2012	2012	NUM
bam-10833	260	3	dec	dec	PROPN
bam-10833	260	4	12	12	NUM
bam-10833	260	5	.	.	PUNCT
bam-10833	260	6	30	30	NUM
bam-10833	260	7	.	.	PUNCT
bam-10833	261	1	nutman	nutman	PROPN
bam-10833	261	2	a	a	PRON
bam-10833	261	3	,	,	PUNCT
bam-10833	261	4	carmeli	carmeli	PROPN
bam-10833	261	5	y.	y.	PROPN
bam-10833	261	6	re	re	PROPN
bam-10833	261	7	:	:	PUNCT
bam-10833	261	8	'	'	PUNCT
bam-10833	261	9	colistin	colistin	NOUN
bam-10833	261	10	plus	plus	CCONJ
bam-10833	261	11	meropenem	meropenem	PROPN
bam-10833	261	12	for	for	ADP
bam-10833	261	13	carbapenem	carbapenem	NOUN
bam-10833	261	14	-	-	PUNCT
bam-10833	261	15	resistant	resistant	ADJ
bam-10833	261	16	gramnegative	gramnegative	ADJ
bam-10833	261	17	infections	infection	NOUN
bam-10833	261	18	:	:	PUNCT
bam-10833	261	19	in	in	ADP
bam-10833	261	20	vitro	vitro	X
bam-10833	261	21	synergism	synergism	NOUN
bam-10833	261	22	is	be	AUX
bam-10833	261	23	not	not	PART
bam-10833	261	24	associated	associate	VERB
bam-10833	261	25	with	with	ADP
bam-10833	261	26	better	well	ADJ
bam-10833	261	27	clinical	clinical	ADJ
bam-10833	261	28	outcomes'-author	outcomes'-author	NOUN
bam-10833	261	29	's	's	PART
bam-10833	261	30	reply	reply	NOUN
bam-10833	261	31	.	.	PUNCT
bam-10833	262	1	clin	clin	PROPN
bam-10833	262	2	microbiol	microbiol	PROPN
bam-10833	262	3	infect	infect	PROPN
bam-10833	262	4	.	.	PUNCT
bam-10833	263	1	2020	2020	NUM
bam-10833	263	2	sep;26(9):1275	sep;26(9):1275	PROPN
bam-10833	263	3	.	.	PUNCT
bam-10833	263	4	doi	doi	PROPN
bam-10833	263	5	:	:	PUNCT
bam-10833	263	6	10.1016	10.1016	NUM
bam-10833	263	7	/	/	SYM
bam-10833	263	8	j.cmi.2020.05.010	j.cmi.2020.05.010	PROPN
bam-10833	263	9	.	.	PUNCT
bam-10833	264	1	epub	epub	PROPN
bam-10833	264	2	2020	2020	NUM
bam-10833	264	3	may	may	AUX
bam-10833	264	4	25	25	NUM
bam-10833	264	5	.	.	PUNCT
bam-10833	265	1	31	31	NUM
bam-10833	265	2	.	.	PUNCT
bam-10833	266	1	özvatan	özvatan	PROPN
bam-10833	266	2	t	t	PROPN
bam-10833	266	3	,	,	PUNCT
bam-10833	266	4	akalın	akalın	PROPN
bam-10833	266	5	h	h	NOUN
bam-10833	266	6	,	,	PUNCT
bam-10833	266	7	sınırtaş	sınırtaş	PROPN
bam-10833	266	8	m	m	PROPN
bam-10833	266	9	,	,	PUNCT
bam-10833	266	10	ocakoğlu	ocakoğlu	VERB
bam-10833	266	11	g	g	PROPN
bam-10833	266	12	,	,	PUNCT
bam-10833	266	13	yılmaz	yılmaz	PROPN
bam-10833	266	14	e	e	PROPN
bam-10833	266	15	,	,	PUNCT
bam-10833	266	16	heper	heper	PROPN
bam-10833	266	17	y	y	PROPN
bam-10833	266	18	,	,	PUNCT
bam-10833	266	19	kelebek	kelebek	PROPN
bam-10833	266	20	n	n	CCONJ
bam-10833	266	21	,	,	PUNCT
bam-10833	266	22	i̇şçimen	i̇şçiman	NOUN
bam-10833	266	23	r	r	NOUN
bam-10833	266	24	,	,	PUNCT
bam-10833	266	25	kahveci	kahveci	PROPN
bam-10833	266	26	f.	f.	PROPN
bam-10833	266	27	nosocomial	nosocomial	PROPN
bam-10833	266	28	acinetobacter	acinetobacter	ADJ
bam-10833	266	29	pneumonia	pneumonia	NOUN
bam-10833	266	30	:	:	PUNCT
bam-10833	267	1	treatment	treatment	NOUN
bam-10833	267	2	and	and	CCONJ
bam-10833	267	3	prognostic	prognostic	ADJ
bam-10833	267	4	factors	factor	NOUN
bam-10833	267	5	in	in	ADP
bam-10833	267	6	356	356	NUM
bam-10833	267	7	cases	case	NOUN
bam-10833	267	8	.	.	PUNCT
bam-10833	268	1	respirology	respirology	NOUN
bam-10833	268	2	.	.	PUNCT
bam-10833	269	1	2016	2016	NUM
bam-10833	269	2	feb;21(2):363	feb;21(2):363	PROPN
bam-10833	269	3	-	-	SYM
bam-10833	269	4	9	9	NUM
bam-10833	269	5	.	.	PUNCT
bam-10833	269	6	doi	doi	NOUN
bam-10833	269	7	:	:	PUNCT
bam-10833	269	8	10.1111	10.1111	NUM
bam-10833	269	9	/	/	SYM
bam-10833	269	10	resp.12698	resp.12698	PROPN
bam-10833	269	11	.	.	PUNCT
bam-10833	270	1	epub	epub	PROPN
bam-10833	270	2	2015	2015	NUM
bam-10833	270	3	dec	dec	PROPN
bam-10833	270	4	3	3	NUM
bam-10833	270	5	.	.	NOUN
bam-10833	270	6	32	32	NUM
bam-10833	270	7	.	.	PUNCT
bam-10833	271	1	papadimitriou	papadimitriou	ADJ
bam-10833	271	2	-	-	PUNCT
bam-10833	271	3	olivgeris	olivgeris	NOUN
bam-10833	271	4	m	m	NOUN
bam-10833	271	5	,	,	PUNCT
bam-10833	271	6	marangos	marangos	PROPN
bam-10833	271	7	m	m	PROPN
bam-10833	271	8	,	,	PUNCT
bam-10833	271	9	christofidou	christofidou	NOUN
bam-10833	271	10	m	m	PROPN
bam-10833	271	11	,	,	PUNCT
bam-10833	271	12	fligou	fligou	PROPN
bam-10833	271	13	f	f	PROPN
bam-10833	271	14	,	,	PUNCT
bam-10833	271	15	bartzavali	bartzavali	PROPN
bam-10833	271	16	c	c	NOUN
bam-10833	271	17	,	,	PUNCT
bam-10833	271	18	panteli	panteli	NOUN
bam-10833	271	19	es	es	NOUN
bam-10833	271	20	,	,	PUNCT
bam-10833	271	21	vamvakopoulou	vamvakopoulou	ADJ
bam-10833	271	22	s	s	SYM
bam-10833	271	23	,	,	PUNCT
bam-10833	271	24	filos	filos	PROPN
bam-10833	271	25	ks	ks	PROPN
bam-10833	271	26	,	,	PUNCT
bam-10833	271	27	anastassiou	anastassiou	PROPN
bam-10833	271	28	ed	ed	NOUN
bam-10833	271	29	.	.	PUNCT
bam-10833	272	1	risk	risk	NOUN
bam-10833	272	2	factors	factor	NOUN
bam-10833	272	3	for	for	ADP
bam-10833	272	4	infection	infection	NOUN
bam-10833	272	5	and	and	CCONJ
bam-10833	272	6	predictors	predictor	NOUN
bam-10833	272	7	of	of	ADP
bam-10833	272	8	mortality	mortality	NOUN
bam-10833	272	9	among	among	ADP
bam-10833	272	10	patients	patient	NOUN
bam-10833	272	11	with	with	ADP
bam-10833	272	12	kpc	kpc	NOUN
bam-10833	272	13	-	-	PUNCT
bam-10833	272	14	producing	produce	VERB
bam-10833	272	15	klebsiella	klebsiella	NOUN
bam-10833	272	16	pneumoniae	pneumoniae	ADJ
bam-10833	272	17	bloodstream	bloodstream	NOUN
bam-10833	272	18	infections	infection	NOUN
bam-10833	272	19	in	in	ADP
bam-10833	272	20	the	the	DET
bam-10833	272	21	intensive	intensive	ADJ
bam-10833	272	22	care	care	NOUN
bam-10833	272	23	unit	unit	NOUN
bam-10833	272	24	.	.	PUNCT
bam-10833	273	1	scand	scand	PROPN
bam-10833	273	2	j	j	PROPN
bam-10833	273	3	infect	infect	PROPN
bam-10833	273	4	dis	dis	PROPN
bam-10833	273	5	.	.	PUNCT
bam-10833	273	6	2014	2014	NUM
bam-10833	273	7	sep;46(9):642	sep;46(9):642	PROPN
bam-10833	273	8	-	-	PUNCT
bam-10833	273	9	8	8	NUM
bam-10833	273	10	.	.	PUNCT
bam-10833	274	1	doi	doi	NOUN
bam-10833	274	2	:	:	PUNCT
bam-10833	274	3	10.3109/00365548.2014.923106	10.3109/00365548.2014.923106	X
bam-10833	274	4	.	.	PUNCT
bam-10833	275	1	epub	epub	PROPN
bam-10833	275	2	2014	2014	NUM
bam-10833	275	3	jul	jul	PROPN
bam-10833	275	4	14	14	NUM
bam-10833	275	5	.	.	PUNCT
bam-10833	276	1	33	33	NUM
bam-10833	276	2	.	.	PUNCT
bam-10833	277	1	parchem	parchem	PROPN
bam-10833	277	2	nl	nl	PROPN
bam-10833	277	3	,	,	PUNCT
bam-10833	277	4	bauer	bauer	PROPN
bam-10833	277	5	ka	ka	PROPN
bam-10833	277	6	,	,	PUNCT
bam-10833	277	7	cook	cook	VERB
bam-10833	277	8	ch	ch	PROPN
bam-10833	277	9	,	,	PUNCT
bam-10833	277	10	mangino	mangino	PROPN
bam-10833	277	11	je	je	PROPN
bam-10833	277	12	,	,	PUNCT
bam-10833	277	13	jones	jones	PROPN
bam-10833	277	14	cd	cd	PROPN
bam-10833	277	15	,	,	PUNCT
bam-10833	277	16	porter	porter	PROPN
bam-10833	277	17	k	k	PROPN
bam-10833	277	18	,	,	PUNCT
bam-10833	277	19	murphy	murphy	PROPN
bam-10833	277	20	cv	cv	PROPN
bam-10833	277	21	.	.	PROPN
bam-10833	277	22	colistin	colistin	PROPN
bam-10833	277	23	combination	combination	NOUN
bam-10833	277	24	therapy	therapy	NOUN
bam-10833	277	25	improves	improve	VERB
bam-10833	277	26	microbiologic	microbiologic	ADJ
bam-10833	277	27	cure	cure	NOUN
bam-10833	277	28	in	in	ADP
bam-10833	277	29	critically	critically	ADV
bam-10833	277	30	ill	ill	ADJ
bam-10833	277	31	patients	patient	NOUN
bam-10833	277	32	with	with	ADP
bam-10833	277	33	multi	multi	ADJ
bam-10833	277	34	-	-	ADJ
bam-10833	277	35	drug	drug	ADJ
bam-10833	277	36	resistant	resistant	ADJ
bam-10833	277	37	gram	gram	NOUN
bam-10833	277	38	-	-	PUNCT
bam-10833	277	39	negative	negative	ADJ
bam-10833	277	40	pneumonia	pneumonia	NOUN
bam-10833	277	41	.	.	PUNCT
bam-10833	278	1	eur	eur	PROPN
bam-10833	278	2	j	j	PROPN
bam-10833	278	3	clin	clin	PROPN
bam-10833	278	4	microbiol	microbiol	PROPN
bam-10833	278	5	infect	infect	VERB
bam-10833	278	6	dis	dis	PROPN
bam-10833	278	7	.	.	PUNCT
bam-10833	279	1	2016	2016	NUM
bam-10833	279	2	sep;35(9):1433	sep;35(9):1433	NOUN
bam-10833	279	3	-	-	PUNCT
bam-10833	279	4	9	9	NUM
bam-10833	279	5	.	.	PUNCT
bam-10833	279	6	doi	doi	NOUN
bam-10833	279	7	:	:	PUNCT
bam-10833	279	8	10.1007	10.1007	NUM
bam-10833	279	9	/	/	SYM
bam-10833	279	10	s10096	s10096	NOUN
bam-10833	279	11	-	-	PUNCT
bam-10833	279	12	016	016	NUM
bam-10833	279	13	-	-	PUNCT
bam-10833	279	14	2681	2681	NUM
bam-10833	279	15	-	-	SYM
bam-10833	279	16	1	1	NUM
bam-10833	279	17	.	.	PUNCT
bam-10833	280	1	epub	epub	NOUN
bam-10833	280	2	2016	2016	NUM
bam-10833	280	3	may	may	AUX
bam-10833	280	4	26	26	NUM
bam-10833	280	5	.	.	PUNCT
bam-10833	281	1	34	34	NUM
bam-10833	281	2	.	.	PUNCT
bam-10833	281	3	park	park	PROPN
bam-10833	281	4	hj	hj	PROPN
bam-10833	281	5	,	,	PUNCT
bam-10833	281	6	cho	cho	PROPN
bam-10833	281	7	jh	jh	PROPN
bam-10833	281	8	,	,	PUNCT
bam-10833	281	9	kim	kim	PROPN
bam-10833	281	10	hj	hj	PROPN
bam-10833	281	11	,	,	PUNCT
bam-10833	281	12	han	han	PROPN
bam-10833	281	13	sh	sh	PROPN
bam-10833	281	14	,	,	PUNCT
bam-10833	281	15	jeong	jeong	PROPN
bam-10833	281	16	sh	sh	PROPN
bam-10833	281	17	,	,	PUNCT
bam-10833	281	18	byun	byun	PROPN
bam-10833	281	19	mk	mk	PROPN
bam-10833	281	20	.	.	PROPN
bam-10833	281	21	colistin	colistin	PROPN
bam-10833	281	22	monotherapy	monotherapy	NOUN
bam-10833	281	23	versus	versus	ADP
bam-10833	281	24	colistin	colistin	PROPN
bam-10833	281	25	/	/	SYM
bam-10833	281	26	rifampicin	rifampicin	VERB
bam-10833	281	27	combination	combination	NOUN
bam-10833	281	28	therapy	therapy	NOUN
bam-10833	281	29	in	in	ADP
bam-10833	281	30	pneumonia	pneumonia	NOUN
bam-10833	281	31	caused	cause	VERB
bam-10833	281	32	by	by	ADP
bam-10833	281	33	colistin	colistin	NOUN
bam-10833	281	34	-	-	PUNCT
bam-10833	281	35	resistant	resistant	ADJ
bam-10833	281	36	acinetobacter	acinetobacter	ADJ
bam-10833	281	37	baumannii	baumannii	PROPN
bam-10833	281	38	:	:	PUNCT
bam-10833	281	39	a	a	DET
bam-10833	281	40	randomised	randomised	ADJ
bam-10833	281	41	controlled	control	VERB
bam-10833	281	42	trial	trial	NOUN
bam-10833	281	43	.	.	PUNCT
bam-10833	282	1	j	j	PROPN
bam-10833	282	2	glob	glob	PROPN
bam-10833	282	3	antimicrob	antimicrob	PROPN
bam-10833	282	4	resist	resist	VERB
bam-10833	282	5	.	.	PUNCT
bam-10833	283	1	2019	2019	NUM
bam-10833	283	2	jun;17:6671	jun;17:6671	NOUN
bam-10833	283	3	.	.	PUNCT
bam-10833	284	1	doi	doi	NOUN
bam-10833	284	2	:	:	PUNCT
bam-10833	284	3	10.1016	10.1016	NUM
bam-10833	284	4	/	/	SYM
bam-10833	284	5	j.jgar.2018.11.016	j.jgar.2018.11.016	PROPN
bam-10833	284	6	.	.	PUNCT
bam-10833	285	1	epub	epub	PROPN
bam-10833	285	2	2018	2018	NUM
bam-10833	285	3	nov	nov	PROPN
bam-10833	285	4	23	23	NUM
bam-10833	285	5	.	.	PUNCT
bam-10833	286	1	35	35	NUM
bam-10833	286	2	.	.	PUNCT
bam-10833	287	1	park	park	PROPN
bam-10833	287	2	jj	jj	PROPN
bam-10833	287	3	,	,	PUNCT
bam-10833	287	4	seo	seo	PROPN
bam-10833	287	5	yb	yb	PROPN
bam-10833	287	6	,	,	PUNCT
bam-10833	287	7	lee	lee	PROPN
bam-10833	287	8	j	j	PROPN
bam-10833	287	9	,	,	PUNCT
bam-10833	287	10	choi	choi	PROPN
bam-10833	287	11	yk	yk	PROPN
bam-10833	287	12	,	,	PUNCT
bam-10833	287	13	jeon	jeon	PROPN
bam-10833	287	14	j.	j.	PROPN
bam-10833	287	15	colistin	colistin	PROPN
bam-10833	287	16	monotherapy	monotherapy	NOUN
bam-10833	287	17	versus	versus	ADP
bam-10833	287	18	colistin	colistin	NOUN
bam-10833	287	19	-	-	PUNCT
bam-10833	287	20	based	base	VERB
bam-10833	287	21	combination	combination	NOUN
bam-10833	287	22	therapy	therapy	NOUN
bam-10833	287	23	for	for	ADP
bam-10833	287	24	treatment	treatment	NOUN
bam-10833	287	25	of	of	ADP
bam-10833	287	26	bacteremia	bacteremia	NOUN
bam-10833	287	27	in	in	ADP
bam-10833	287	28	burn	burn	NOUN
bam-10833	287	29	patients	patient	NOUN
bam-10833	287	30	due	due	ADP
bam-10833	287	31	to	to	ADP
bam-10833	287	32	carbapenem	carbapenem	NOUN
bam-10833	287	33	-	-	PUNCT
bam-10833	287	34	resistant	resistant	ADJ
bam-10833	287	35	gram	gram	NOUN
bam-10833	287	36	negative	negative	ADJ
bam-10833	287	37	bacteria	bacteria	NOUN
bam-10833	287	38	.	.	PUNCT
bam-10833	288	1	burns	burn	NOUN
bam-10833	288	2	.	.	PUNCT
bam-10833	289	1	2020	2020	NUM
bam-10833	289	2	dec;46(8):1848	dec;46(8):1848	PROPN
bam-10833	289	3	-	-	PUNCT
bam-10833	289	4	1856	1856	NUM
bam-10833	289	5	.	.	PUNCT
bam-10833	290	1	doi	doi	NOUN
bam-10833	290	2	:	:	PUNCT
bam-10833	290	3	10.1016	10.1016	NUM
bam-10833	290	4	/	/	SYM
bam-10833	290	5	j.burns.2020.06.014	j.burns.2020.06.014	PROPN
bam-10833	290	6	.	.	PUNCT
bam-10833	291	1	epub	epub	PROPN
bam-10833	291	2	2020	2020	NUM
bam-10833	291	3	jun	jun	PROPN
bam-10833	291	4	21	21	NUM
bam-10833	291	5	.	.	PUNCT
bam-10833	292	1	36	36	NUM
bam-10833	292	2	.	.	PUNCT
bam-10833	293	1	park	park	PROPN
bam-10833	293	2	sy	sy	PROPN
bam-10833	293	3	,	,	PUNCT
bam-10833	293	4	si	si	PROPN
bam-10833	293	5	hj	hj	PROPN
bam-10833	293	6	,	,	PUNCT
bam-10833	293	7	eom	eom	PROPN
bam-10833	293	8	js	js	PROPN
bam-10833	293	9	,	,	PUNCT
bam-10833	293	10	lee	lee	PROPN
bam-10833	293	11	js	js	PROPN
bam-10833	293	12	.	.	PUNCT
bam-10833	294	1	survival	survival	PROPN
bam-10833	294	2	of	of	ADP
bam-10833	294	3	carbapenem	carbapenem	NOUN
bam-10833	294	4	-	-	PUNCT
bam-10833	294	5	resistant	resistant	ADJ
bam-10833	294	6	acinetobacter	acinetobacter	ADJ
bam-10833	294	7	baumannii	baumannii	ADJ
bam-10833	294	8	bacteremia	bacteremia	NOUN
bam-10833	294	9	:	:	PUNCT
bam-10833	294	10	colistin	colistin	NOUN
bam-10833	294	11	monotherapy	monotherapy	NOUN
bam-10833	294	12	versus	versus	ADP
bam-10833	294	13	colistin	colistin	PROPN
bam-10833	294	14	plus	plus	CCONJ
bam-10833	294	15	meropenem	meropenem	PROPN
bam-10833	294	16	.	.	PUNCT
bam-10833	295	1	j	j	PROPN
bam-10833	295	2	int	int	PROPN
bam-10833	295	3	med	med	PROPN
bam-10833	295	4	res	re	NOUN
bam-10833	295	5	.	.	PROPN
bam-10833	295	6	2019	2019	NUM
bam-10833	295	7	dec;47(12):5977	dec;47(12):5977	PROPN
bam-10833	295	8	-	-	PUNCT
bam-10833	295	9	5985	5985	NUM
bam-10833	295	10	.	.	PUNCT
bam-10833	296	1	doi	doi	NOUN
bam-10833	296	2	:	:	PUNCT
bam-10833	296	3	10.1177/03000	10.1177/03000	NUM
bam-10833	296	4	60519879336	60519879336	NUM
bam-10833	296	5	.	.	PUNCT
bam-10833	297	1	epub	epub	NOUN
bam-10833	297	2	2019	2019	NUM
bam-10833	297	3	oct	oct	NOUN
bam-10833	297	4	15	15	NUM
bam-10833	297	5	.	.	PUNCT
bam-10833	298	1	37	37	NUM
bam-10833	298	2	.	.	PUNCT
bam-10833	299	1	paul	paul	PROPN
bam-10833	299	2	m	m	PROPN
bam-10833	299	3	,	,	PUNCT
bam-10833	299	4	daikos	daikos	PROPN
bam-10833	299	5	gl	gl	PROPN
bam-10833	299	6	,	,	PUNCT
bam-10833	299	7	durante	durante	PROPN
bam-10833	299	8	-	-	PUNCT
bam-10833	299	9	mangoni	mangoni	PROPN
bam-10833	299	10	e	e	PROPN
bam-10833	299	11	,	,	PUNCT
bam-10833	299	12	yahav	yahav	NOUN
bam-10833	299	13	d	d	PROPN
bam-10833	299	14	,	,	PUNCT
bam-10833	299	15	carmeli	carmeli	PROPN
bam-10833	299	16	y	y	PROPN
bam-10833	299	17	,	,	PUNCT
bam-10833	299	18	benattar	benattar	PROPN
bam-10833	299	19	yd	yd	PROPN
bam-10833	299	20	,	,	PUNCT
bam-10833	299	21	skiada	skiada	NOUN
bam-10833	299	22	a	a	X
bam-10833	299	23	,	,	PUNCT
bam-10833	299	24	andini	andini	ADJ
bam-10833	299	25	r	r	NOUN
bam-10833	299	26	,	,	PUNCT
bam-10833	299	27	eliakim	eliakim	ADJ
bam-10833	299	28	-	-	PUNCT
bam-10833	299	29	raz	raz	PROPN
bam-10833	299	30	n	n	NOUN
bam-10833	299	31	,	,	PUNCT
bam-10833	299	32	nutman	nutman	NOUN
bam-10833	299	33	a	a	PRON
bam-10833	299	34	,	,	PUNCT
bam-10833	299	35	zusman	zusman	ADJ
bam-10833	299	36	o	o	NOUN
bam-10833	299	37	,	,	PUNCT
bam-10833	299	38	antoniadou	antoniadou	PROPN
bam-10833	299	39	a	a	PRON
bam-10833	299	40	,	,	PUNCT
bam-10833	299	41	pafundi	pafundi	PROPN
bam-10833	299	42	pc	pc	PROPN
bam-10833	299	43	,	,	PUNCT
bam-10833	299	44	adler	adler	PROPN
bam-10833	299	45	a	a	PROPN
bam-10833	299	46	,	,	PUNCT
bam-10833	299	47	dickstein	dickstein	ADV
bam-10833	299	48	y	y	PROPN
bam-10833	299	49	,	,	PUNCT
bam-10833	299	50	pavleas	pavlea	NOUN
bam-10833	299	51	i	i	PRON
bam-10833	299	52	,	,	PUNCT
bam-10833	299	53	zampino	zampino	ADJ
bam-10833	299	54	r	r	NOUN
bam-10833	299	55	,	,	PUNCT
bam-10833	299	56	daitch	daitch	VERB
bam-10833	299	57	v	v	NOUN
bam-10833	299	58	,	,	PUNCT
bam-10833	299	59	bitterman	bitterman	NOUN
bam-10833	299	60	r	r	NOUN
bam-10833	299	61	,	,	PUNCT
bam-10833	299	62	zayyad	zayyad	PROPN
bam-10833	299	63	h	h	PROPN
bam-10833	299	64	,	,	PUNCT
bam-10833	299	65	koppel	koppel	PROPN
bam-10833	299	66	f	f	PROPN
bam-10833	299	67	,	,	PUNCT
bam-10833	299	68	levi	levi	PROPN
bam-10833	299	69	i	i	PRON
bam-10833	299	70	,	,	PUNCT
bam-10833	299	71	babich	babich	PROPN
bam-10833	299	72	t	t	PROPN
bam-10833	299	73	,	,	PUNCT
bam-10833	299	74	friberg	friberg	PROPN
bam-10833	299	75	le	le	PROPN
bam-10833	299	76	,	,	PUNCT
bam-10833	299	77	mouton	mouton	PROPN
bam-10833	299	78	jw	jw	PROPN
bam-10833	299	79	,	,	PUNCT
bam-10833	299	80	theuretzbacher	theuretzbacher	ADJ
bam-10833	299	81	u	u	NOUN
bam-10833	299	82	,	,	PUNCT
bam-10833	299	83	leibovici	leibovici	PROPN
bam-10833	299	84	l.	l.	PROPN
bam-10833	299	85	colistin	colistin	PROPN
bam-10833	299	86	alone	alone	ADV
bam-10833	299	87	versus	versus	ADP
bam-10833	299	88	colistin	colistin	PROPN
bam-10833	299	89	plus	plus	CCONJ
bam-10833	299	90	meropenem	meropenem	PROPN
bam-10833	299	91	for	for	ADP
bam-10833	299	92	treatment	treatment	NOUN
bam-10833	299	93	of	of	ADP
bam-10833	299	94	severe	severe	ADJ
bam-10833	299	95	infections	infection	NOUN
bam-10833	299	96	caused	cause	VERB
bam-10833	299	97	by	by	ADP
bam-10833	299	98	carbapenem	carbapenem	NOUN
bam-10833	299	99	-	-	PUNCT
bam-10833	299	100	resistant	resistant	ADJ
bam-10833	299	101	gram	gram	NOUN
bam-10833	299	102	-	-	PUNCT
bam-10833	299	103	negative	negative	ADJ
bam-10833	299	104	bacteria	bacteria	NOUN
bam-10833	299	105	:	:	PUNCT
bam-10833	299	106	an	an	DET
bam-10833	299	107	open	open	ADJ
bam-10833	299	108	-	-	PUNCT
bam-10833	299	109	label	label	NOUN
bam-10833	299	110	,	,	PUNCT
bam-10833	299	111	randomised	randomise	VERB
bam-10833	299	112	controlled	control	VERB
bam-10833	299	113	trial	trial	NOUN
bam-10833	299	114	.	.	PUNCT
bam-10833	300	1	lancet	lancet	PROPN
bam-10833	300	2	infect	infect	PROPN
bam-10833	300	3	dis	dis	PROPN
bam-10833	300	4	.	.	PUNCT
bam-10833	301	1	2018	2018	NUM
bam-10833	301	2	apr;18(4):391	apr;18(4):391	PROPN
bam-10833	301	3	-	-	PUNCT
bam-10833	301	4	400	400	NUM
bam-10833	301	5	.	.	PUNCT
bam-10833	302	1	doi	doi	NOUN
bam-10833	302	2	:	:	PUNCT
bam-10833	302	3	10	10	NUM
bam-10833	302	4	.	.	X
bam-10833	303	1	1016	1016	NUM
bam-10833	303	2	/	/	SYM
bam-10833	303	3	s1473	s1473	NOUN
bam-10833	303	4	-	-	PUNCT
bam-10833	303	5	3099(18)30099	3099(18)30099	NUM
bam-10833	303	6	-	-	PUNCT
bam-10833	303	7	9	9	NUM
bam-10833	303	8	.	.	PUNCT
bam-10833	304	1	epub	epub	PROPN
bam-10833	304	2	2018	2018	NUM
bam-10833	304	3	feb	feb	NOUN
bam-10833	304	4	16	16	NUM
bam-10833	304	5	.	.	PUNCT
bam-10833	305	1	38	38	NUM
bam-10833	305	2	.	.	PUNCT
bam-10833	306	1	petrosillo	petrosillo	PROPN
bam-10833	306	2	n	n	CCONJ
bam-10833	306	3	,	,	PUNCT
bam-10833	306	4	giannella	giannella	PROPN
bam-10833	306	5	m	m	PROPN
bam-10833	306	6	,	,	PUNCT
bam-10833	306	7	antonelli	antonelli	PROPN
bam-10833	306	8	m	m	PROPN
bam-10833	306	9	,	,	PUNCT
bam-10833	306	10	antonini	antonini	PROPN
bam-10833	306	11	m	m	PROPN
bam-10833	306	12	,	,	PUNCT
bam-10833	306	13	barsic	barsic	ADJ
bam-10833	306	14	b	b	NOUN
bam-10833	306	15	,	,	PUNCT
bam-10833	306	16	belancic	belancic	PROPN
bam-10833	306	17	l	l	NOUN
bam-10833	306	18	,	,	PUNCT
bam-10833	306	19	inkaya	inkaya	VERB
bam-10833	306	20	a	a	DET
bam-10833	306	21	c	c	NOUN
bam-10833	306	22	,	,	PUNCT
bam-10833	306	23	de	de	PROPN
bam-10833	306	24	pascale	pascale	PROPN
bam-10833	306	25	g	g	PROPN
bam-10833	306	26	,	,	PUNCT
bam-10833	306	27	grilli	grilli	PROPN
bam-10833	306	28	e	e	PROPN
bam-10833	306	29	,	,	PUNCT
bam-10833	306	30	tumbarello	tumbarello	PROPN
bam-10833	306	31	m	m	PROPN
bam-10833	306	32	,	,	PUNCT
bam-10833	306	33	akova	akova	PROPN
bam-10833	306	34	m.	m.	NOUN
bam-10833	306	35	clinical	clinical	ADJ
bam-10833	306	36	experience	experience	NOUN
bam-10833	306	37	of	of	ADP
bam-10833	306	38	colistin	colistin	NOUN
bam-10833	306	39	-	-	PUNCT
bam-10833	306	40	glycopeptide	glycopeptide	NOUN
bam-10833	306	41	combination	combination	NOUN
bam-10833	306	42	in	in	ADP
bam-10833	306	43	critically	critically	ADV
bam-10833	306	44	ill	ill	ADJ
bam-10833	306	45	patients	patient	NOUN
bam-10833	306	46	infected	infect	VERB
bam-10833	306	47	with	with	ADP
bam-10833	306	48	gram	gram	NOUN
bam-10833	306	49	-	-	PUNCT
bam-10833	306	50	negative	negative	ADJ
bam-10833	306	51	bacteria	bacteria	NOUN
bam-10833	306	52	.	.	PUNCT
bam-10833	307	1	antimicrob	antimicrob	PROPN
bam-10833	307	2	agents	agents	PROPN
bam-10833	307	3	chemother	chemother	PROPN
bam-10833	307	4	.	.	PUNCT
bam-10833	308	1	2014;58(2):851	2014;58(2):851	NOUN
bam-10833	308	2	-	-	SYM
bam-10833	308	3	8	8	NUM
bam-10833	308	4	.	.	PUNCT
bam-10833	309	1	doi	doi	NOUN
bam-10833	309	2	:	:	PUNCT
bam-10833	309	3	10.1128	10.1128	NUM
bam-10833	309	4	/	/	SYM
bam-10833	309	5	aac.00871	aac.00871	PROPN
bam-10833	309	6	-	-	PUNCT
bam-10833	309	7	13	13	NUM
bam-10833	309	8	.	.	PUNCT
bam-10833	310	1	epub	epub	PROPN
bam-10833	310	2	2013	2013	NUM
bam-10833	310	3	nov	nov	PROPN
bam-10833	310	4	25	25	NUM
bam-10833	310	5	.	.	PROPN
bam-10833	310	6	39	39	NUM
bam-10833	310	7	.	.	PUNCT
bam-10833	311	1	pintado	pintado	PROPN
bam-10833	311	2	v	v	NOUN
bam-10833	311	3	,	,	PUNCT
bam-10833	311	4	san	san	PROPN
bam-10833	311	5	miguel	miguel	PROPN
bam-10833	311	6	lg	lg	PROPN
bam-10833	311	7	,	,	PUNCT
bam-10833	311	8	grill	grill	NOUN
bam-10833	311	9	f	f	NOUN
bam-10833	311	10	,	,	PUNCT
bam-10833	311	11	mejía	mejía	PROPN
bam-10833	311	12	b	b	PROPN
bam-10833	311	13	,	,	PUNCT
bam-10833	311	14	cobo	cobo	PROPN
bam-10833	311	15	j	j	PROPN
bam-10833	311	16	,	,	PUNCT
bam-10833	311	17	fortún	fortún	PROPN
bam-10833	311	18	j	j	PROPN
bam-10833	311	19	,	,	PUNCT
bam-10833	311	20	martín	martín	NOUN
bam-10833	311	21	-	-	PUNCT
bam-10833	311	22	dávila	dávila	NOUN
bam-10833	311	23	p	p	X
bam-10833	311	24	,	,	PUNCT
bam-10833	311	25	moreno	moreno	PROPN
bam-10833	311	26	s.	s.	PROPN
bam-10833	311	27	intravenous	intravenous	PROPN
bam-10833	311	28	colistin	colistin	PROPN
bam-10833	311	29	sulphomethate	sulphomethate	VERB
bam-10833	311	30	sodium	sodium	NOUN
bam-10833	311	31	for	for	ADP
bam-10833	311	32	therapy	therapy	NOUN
bam-10833	311	33	of	of	ADP
bam-10833	311	34	infections	infection	NOUN
bam-10833	311	35	due	due	ADP
bam-10833	311	36	to	to	ADP
bam-10833	311	37	multidrug	multidrug	VERB
bam-10833	311	38	-	-	PUNCT
bam-10833	311	39	resistant	resistant	ADJ
bam-10833	311	40	gram	gram	NOUN
bam-10833	311	41	-	-	PUNCT
bam-10833	311	42	negative	negative	ADJ
bam-10833	311	43	bacteria	bacteria	NOUN
bam-10833	311	44	.	.	PUNCT
bam-10833	312	1	j	j	PROPN
bam-10833	312	2	infect	infect	PROPN
bam-10833	312	3	.	.	PUNCT
bam-10833	313	1	2008	2008	NUM
bam-10833	313	2	mar;56(3):185	mar;56(3):185	NUM
bam-10833	313	3	-	-	SYM
bam-10833	313	4	90	90	NUM
bam-10833	313	5	.	.	PUNCT
bam-10833	314	1	doi	doi	NOUN
bam-10833	314	2	:	:	PUNCT
bam-10833	314	3	10.1016	10.1016	NUM
bam-10833	314	4	/	/	SYM
bam-10833	314	5	j.jinf.2008.01.003	j.jinf.2008.01.003	PROPN
bam-10833	314	6	.	.	PUNCT
bam-10833	315	1	epub	epub	PROPN
bam-10833	315	2	2008	2008	NUM
bam-10833	315	3	feb	feb	NOUN
bam-10833	315	4	15	15	NUM
bam-10833	315	5	.	.	NOUN
bam-10833	315	6	40	40	NUM
bam-10833	315	7	.	.	PUNCT
bam-10833	316	1	porwal	porwal	NOUN
bam-10833	316	2	r	r	NOUN
bam-10833	316	3	,	,	PUNCT
bam-10833	316	4	gopalakrishnan	gopalakrishnan	NOUN
bam-10833	316	5	r	r	NOUN
bam-10833	316	6	,	,	PUNCT
bam-10833	316	7	rajesh	rajesh	PROPN
bam-10833	316	8	nj	nj	PROPN
bam-10833	316	9	,	,	PUNCT
bam-10833	316	10	ramasubramanian	ramasubramanian	PROPN
bam-10833	316	11	v.	v.	ADP
bam-10833	316	12	carbapenem	carbapenem	PROPN
bam-10833	316	13	resistant	resistant	ADJ
bam-10833	316	14	gramnegative	gramnegative	ADJ
bam-10833	316	15	bacteremia	bacteremia	NOUN
bam-10833	316	16	in	in	ADP
bam-10833	316	17	an	an	DET
bam-10833	316	18	indian	indian	ADJ
bam-10833	316	19	intensive	intensive	ADJ
bam-10833	316	20	care	care	NOUN
bam-10833	316	21	unit	unit	NOUN
bam-10833	316	22	:	:	PUNCT
bam-10833	316	23	a	a	DET
bam-10833	316	24	review	review	NOUN
bam-10833	316	25	of	of	ADP
bam-10833	316	26	the	the	DET
bam-10833	316	27	clinical	clinical	ADJ
bam-10833	316	28	profile	profile	NOUN
bam-10833	316	29	and	and	CCONJ
bam-10833	316	30	treatment	treatment	NOUN
bam-10833	316	31	outcome	outcome	NOUN
bam-10833	316	32	of	of	ADP
bam-10833	316	33	50	50	NUM
bam-10833	316	34	patients	patient	NOUN
bam-10833	316	35	.	.	PUNCT
bam-10833	317	1	indian	indian	PROPN
bam-10833	317	2	j	j	PROPN
bam-10833	317	3	crit	crit	PROPN
bam-10833	317	4	care	care	PROPN
bam-10833	317	5	med	me	VERB
bam-10833	317	6	.	.	PUNCT
bam-10833	318	1	2014	2014	NUM
bam-10833	319	1	nov;18(11):750	nov;18(11):750	PROPN
bam-10833	319	2	-	-	SYM
bam-10833	319	3	3	3	NUM
bam-10833	319	4	.	.	PUNCT
bam-10833	319	5	doi	doi	NOUN
bam-10833	319	6	:	:	PUNCT
bam-10833	319	7	10.4103/09725229.144021	10.4103/09725229.144021	NUM
bam-10833	319	8	.	.	PUNCT
bam-10833	320	1	intravenous	intravenous	ADJ
bam-10833	320	2	colistin	colistin	PROPN
bam-10833	320	3	monotherapy	monotherapy	NOUN
bam-10833	320	4	versus	versus	ADP
bam-10833	320	5	combination	combination	NOUN
bam-10833	320	6	therapy	therapy	NOUN
bam-10833	320	7	eur	eur	PROPN
bam-10833	320	8	j	j	PROPN
bam-10833	320	9	transl	transl	PROPN
bam-10833	320	10	myol	myol	ADV
bam-10833	320	11	32	32	NUM
bam-10833	320	12	(	(	PUNCT
bam-10833	320	13	4	4	NUM
bam-10833	320	14	):	):	PUNCT
bam-10833	320	15	10833	10833	NUM
bam-10833	320	16	,	,	PUNCT
bam-10833	320	17	2022	2022	NUM
bam-10833	320	18	doi	doi	NOUN
bam-10833	320	19	:	:	PUNCT
bam-10833	320	20	10.4081	10.4081	NUM
bam-10833	320	21	/	/	SYM
bam-10833	320	22	ejtm.2022.10833	ejtm.2022.10833	VERB
bam-10833	320	23	10	10	NUM
bam-10833	320	24	41	41	NUM
bam-10833	320	25	.	.	PUNCT
bam-10833	321	1	shi	shi	PROPN
bam-10833	321	2	h	h	PROPN
bam-10833	321	3	,	,	PUNCT
bam-10833	321	4	lee	lee	PROPN
bam-10833	321	5	js	js	PROPN
bam-10833	321	6	,	,	PUNCT
bam-10833	321	7	park	park	NOUN
bam-10833	321	8	sy	sy	PROPN
bam-10833	321	9	,	,	PUNCT
bam-10833	321	10	ko	ko	PROPN
bam-10833	321	11	y	y	PROPN
bam-10833	321	12	,	,	PUNCT
bam-10833	321	13	eom	eom	PROPN
bam-10833	321	14	js	js	PROPN
bam-10833	321	15	.	.	PROPN
bam-10833	321	16	colistin	colistin	PROPN
bam-10833	321	17	plus	plus	CCONJ
bam-10833	321	18	carbapenem	carbapenem	PROPN
bam-10833	321	19	versus	versus	ADP
bam-10833	321	20	colistin	colistin	PROPN
bam-10833	321	21	monotherapy	monotherapy	NOUN
bam-10833	321	22	in	in	ADP
bam-10833	321	23	the	the	DET
bam-10833	321	24	treatment	treatment	NOUN
bam-10833	321	25	of	of	ADP
bam-10833	321	26	carbapenem	carbapenem	NOUN
bam-10833	321	27	-	-	PUNCT
bam-10833	321	28	resistant	resistant	ADJ
bam-10833	321	29	acinetobacter	acinetobacter	ADJ
bam-10833	321	30	baumannii	baumannii	ADJ
bam-10833	321	31	pneumonia	pneumonia	NOUN
bam-10833	321	32	.	.	PUNCT
bam-10833	322	1	infect	infect	VERB
bam-10833	322	2	drug	drug	NOUN
bam-10833	322	3	resist	resist	NOUN
bam-10833	322	4	.	.	PUNCT
bam-10833	323	1	2019	2019	NUM
bam-10833	323	2	dec	dec	PROPN
bam-10833	323	3	23;12:3925	23;12:3925	NUM
bam-10833	323	4	-	-	SYM
bam-10833	323	5	3934	3934	NUM
bam-10833	323	6	.	.	PUNCT
bam-10833	324	1	doi	doi	NOUN
bam-10833	324	2	:	:	PUNCT
bam-10833	324	3	10.2147	10.2147	NUM
bam-10833	324	4	/	/	SYM
bam-10833	324	5	idr.s234211	idr.s234211	NOUN
bam-10833	324	6	.	.	PUNCT
bam-10833	325	1	42	42	NUM
bam-10833	325	2	.	.	PUNCT
bam-10833	326	1	simsek	simsek	PROPN
bam-10833	326	2	f	f	NOUN
bam-10833	326	3	,	,	PUNCT
bam-10833	326	4	gedik	gedik	NOUN
bam-10833	326	5	h	h	NOUN
bam-10833	326	6	,	,	PUNCT
bam-10833	326	7	yildirmak	yildirmak	PROPN
bam-10833	326	8	mt	mt	PROPN
bam-10833	326	9	,	,	PUNCT
bam-10833	326	10	iris	iris	NOUN
bam-10833	326	11	ne	ne	PROPN
bam-10833	326	12	,	,	PUNCT
bam-10833	326	13	türkmen	türkmen	VERB
bam-10833	326	14	a	a	PRON
bam-10833	326	15	,	,	PUNCT
bam-10833	326	16	ersoy	ersoy	NOUN
bam-10833	326	17	a	a	PRON
bam-10833	326	18	,	,	PUNCT
bam-10833	326	19	ersöz	ersöz	PROPN
bam-10833	326	20	m	m	PROPN
bam-10833	326	21	,	,	PUNCT
bam-10833	326	22	gücüyener	gücüyener	NOUN
bam-10833	326	23	a.	a.	NOUN
bam-10833	326	24	colistin	colistin	PROPN
bam-10833	326	25	against	against	ADP
bam-10833	326	26	colistin	colistin	NOUN
bam-10833	326	27	-	-	PUNCT
bam-10833	326	28	only	only	ADV
bam-10833	326	29	-	-	PUNCT
bam-10833	326	30	susceptible	susceptible	ADJ
bam-10833	326	31	acinetobacter	acinetobacter	ADJ
bam-10833	326	32	baumannii	baumannii	ADJ
bam-10833	326	33	-	-	PUNCT
bam-10833	326	34	related	relate	VERB
bam-10833	326	35	infections	infection	NOUN
bam-10833	326	36	:	:	PUNCT
bam-10833	326	37	monotherapy	monotherapy	NOUN
bam-10833	326	38	or	or	CCONJ
bam-10833	326	39	combination	combination	NOUN
bam-10833	326	40	therapy	therapy	NOUN
bam-10833	326	41	?	?	PUNCT
bam-10833	327	1	indian	indian	PROPN
bam-10833	327	2	j	j	PROPN
bam-10833	327	3	med	med	PROPN
bam-10833	327	4	microbiol	microbiol	PROPN
bam-10833	327	5	.	.	PUNCT
bam-10833	328	1	2012	2012	NUM
bam-10833	328	2	oct	oct	NOUN
bam-10833	328	3	-	-	PUNCT
bam-10833	328	4	dec;30(4):448	dec;30(4):448	ADP
bam-10833	328	5	-	-	PUNCT
bam-10833	328	6	52	52	NUM
bam-10833	328	7	.	.	PUNCT
bam-10833	329	1	doi	doi	NOUN
bam-10833	329	2	:	:	PUNCT
bam-10833	329	3	10.4103/0255	10.4103/0255	NUM
bam-10833	329	4	-	-	PUNCT
bam-10833	329	5	0857.103767	0857.103767	NOUN
bam-10833	329	6	.	.	PUNCT
bam-10833	330	1	43	43	NUM
bam-10833	330	2	.	.	PUNCT
bam-10833	331	1	sirijatuphat	sirijatuphat	PRON
bam-10833	331	2	r	r	NOUN
bam-10833	331	3	,	,	PUNCT
bam-10833	331	4	thamlikitkul	thamlikitkul	PROPN
bam-10833	331	5	v.	v.	ADP
bam-10833	331	6	preliminary	preliminary	ADJ
bam-10833	331	7	study	study	NOUN
bam-10833	331	8	of	of	ADP
bam-10833	331	9	colistin	colistin	PROPN
bam-10833	331	10	versus	versus	ADP
bam-10833	331	11	colistin	colistin	PROPN
bam-10833	331	12	plus	plus	CCONJ
bam-10833	331	13	fosfomycin	fosfomycin	PROPN
bam-10833	331	14	for	for	ADP
bam-10833	331	15	treatment	treatment	NOUN
bam-10833	331	16	of	of	ADP
bam-10833	331	17	carbapenem	carbapenem	NOUN
bam-10833	331	18	-	-	PUNCT
bam-10833	331	19	resistant	resistant	ADJ
bam-10833	331	20	acinetobacter	acinetobacter	ADJ
bam-10833	331	21	baumannii	baumannii	ADJ
bam-10833	331	22	infections	infection	NOUN
bam-10833	331	23	.	.	PUNCT
bam-10833	332	1	antimicrob	antimicrob	PROPN
bam-10833	332	2	agents	agents	PROPN
bam-10833	332	3	chemother	chemother	PROPN
bam-10833	332	4	.	.	PUNCT
bam-10833	333	1	2014	2014	NUM
bam-10833	334	1	sep;58(9):5598	sep;58(9):5598	ADJ
bam-10833	334	2	-	-	PUNCT
bam-10833	334	3	601	601	NUM
bam-10833	334	4	.	.	PUNCT
bam-10833	335	1	doi	doi	NOUN
bam-10833	335	2	:	:	PUNCT
bam-10833	335	3	10.1128	10.1128	NUM
bam-10833	335	4	/	/	SYM
bam-10833	335	5	aac.02435	aac.02435	NUM
bam-10833	335	6	-	-	SYM
bam-10833	335	7	13	13	NUM
bam-10833	335	8	.	.	PUNCT
bam-10833	336	1	epub	epub	PROPN
bam-10833	336	2	2014	2014	NUM
bam-10833	336	3	jun	jun	PROPN
bam-10833	336	4	30	30	NUM
bam-10833	336	5	.	.	PUNCT
bam-10833	336	6	44	44	NUM
bam-10833	336	7	.	.	PUNCT
bam-10833	337	1	souli	souli	PROPN
bam-10833	337	2	m	m	PROPN
bam-10833	337	3	,	,	PUNCT
bam-10833	337	4	kontopidou	kontopidou	VERB
bam-10833	337	5	fv	fv	NOUN
bam-10833	337	6	,	,	PUNCT
bam-10833	337	7	papadomichelakis	papadomichelakis	PROPN
bam-10833	337	8	e	e	NOUN
bam-10833	337	9	,	,	PUNCT
bam-10833	337	10	galani	galani	PROPN
bam-10833	337	11	i	i	PROPN
bam-10833	337	12	,	,	PUNCT
bam-10833	337	13	armaganidis	armaganidis	PROPN
bam-10833	337	14	a	a	DET
bam-10833	337	15	,	,	PUNCT
bam-10833	337	16	giamarellou	giamarellou	PROPN
bam-10833	337	17	h.	h.	PROPN
bam-10833	337	18	clinical	clinical	ADJ
bam-10833	337	19	experience	experience	NOUN
bam-10833	337	20	of	of	ADP
bam-10833	337	21	serious	serious	ADJ
bam-10833	337	22	infections	infection	NOUN
bam-10833	337	23	caused	cause	VERB
bam-10833	337	24	by	by	ADP
bam-10833	337	25	enterobacteriaceae	enterobacteriaceae	PROPN
bam-10833	337	26	producing	produce	VERB
bam-10833	337	27	vim-1	vim-1	X
bam-10833	337	28	metallo	metallo	NOUN
bam-10833	337	29	-	-	PUNCT
bam-10833	337	30	betalactamase	betalactamase	NOUN
bam-10833	337	31	in	in	ADP
bam-10833	337	32	a	a	DET
bam-10833	337	33	greek	greek	ADJ
bam-10833	337	34	university	university	NOUN
bam-10833	337	35	hospital	hospital	NOUN
bam-10833	337	36	.	.	PUNCT
bam-10833	338	1	clin	clin	PROPN
bam-10833	338	2	infect	infect	PROPN
bam-10833	338	3	dis	dis	PROPN
bam-10833	338	4	.	.	PUNCT
bam-10833	338	5	2008	2008	NUM
bam-10833	338	6	mar	mar	PROPN
bam-10833	338	7	15;46(6):847	15;46(6):847	PROPN
bam-10833	338	8	-	-	SYM
bam-10833	338	9	54	54	NUM
bam-10833	338	10	.	.	PUNCT
bam-10833	339	1	doi	doi	NOUN
bam-10833	339	2	:	:	PUNCT
bam-10833	339	3	10.1086/528719	10.1086/528719	NUM
bam-10833	339	4	.	.	PUNCT
bam-10833	340	1	45	45	NUM
bam-10833	340	2	.	.	PUNCT
bam-10833	340	3	tumbarello	tumbarello	PROPN
bam-10833	340	4	m	m	PROPN
bam-10833	340	5	,	,	PUNCT
bam-10833	340	6	viale	viale	NOUN
bam-10833	340	7	p	p	NOUN
bam-10833	340	8	,	,	PUNCT
bam-10833	340	9	viscoli	viscoli	NOUN
bam-10833	340	10	c	c	NOUN
bam-10833	340	11	,	,	PUNCT
bam-10833	340	12	trecarichi	trecarichi	VERB
bam-10833	340	13	em	em	PRON
bam-10833	340	14	,	,	PUNCT
bam-10833	340	15	tumietto	tumietto	ADJ
bam-10833	340	16	f	f	X
bam-10833	340	17	,	,	PUNCT
bam-10833	340	18	marchese	marchese	PROPN
bam-10833	340	19	a	a	NOUN
bam-10833	340	20	,	,	PUNCT
bam-10833	340	21	spanu	spanu	PROPN
bam-10833	340	22	t	t	PROPN
bam-10833	340	23	,	,	PUNCT
bam-10833	340	24	ambretti	ambretti	PROPN
bam-10833	340	25	s	s	PROPN
bam-10833	340	26	,	,	PUNCT
bam-10833	340	27	ginocchio	ginocchio	PROPN
bam-10833	340	28	f	f	PROPN
bam-10833	340	29	,	,	PUNCT
bam-10833	340	30	cristini	cristini	PROPN
bam-10833	340	31	f	f	PROPN
bam-10833	340	32	,	,	PUNCT
bam-10833	340	33	losito	losito	PROPN
bam-10833	340	34	ar	ar	PROPN
bam-10833	340	35	,	,	PUNCT
bam-10833	340	36	tedeschi	tedeschi	PROPN
bam-10833	340	37	s	s	PROPN
bam-10833	340	38	,	,	PUNCT
bam-10833	340	39	cauda	cauda	NOUN
bam-10833	340	40	r	r	NOUN
bam-10833	340	41	,	,	PUNCT
bam-10833	340	42	bassetti	bassetti	NOUN
bam-10833	340	43	m.	m.	NOUN
bam-10833	340	44	predictors	predictor	NOUN
bam-10833	340	45	of	of	ADP
bam-10833	340	46	mortality	mortality	NOUN
bam-10833	340	47	in	in	ADP
bam-10833	340	48	bloodstream	bloodstream	NOUN
bam-10833	340	49	infections	infection	NOUN
bam-10833	340	50	caused	cause	VERB
bam-10833	340	51	by	by	ADP
bam-10833	340	52	klebsiella	klebsiella	NOUN
bam-10833	340	53	pneumoniae	pneumoniae	ADJ
bam-10833	340	54	carbapenemase	carbapenemase	NOUN
bam-10833	340	55	-	-	PUNCT
bam-10833	340	56	producing	produce	VERB
bam-10833	340	57	k.	k.	NOUN
bam-10833	340	58	pneumoniae	pneumoniae	NOUN
bam-10833	340	59	:	:	PUNCT
bam-10833	340	60	importance	importance	NOUN
bam-10833	340	61	of	of	ADP
bam-10833	340	62	combination	combination	NOUN
bam-10833	340	63	therapy	therapy	NOUN
bam-10833	340	64	.	.	PUNCT
bam-10833	341	1	clin	clin	PROPN
bam-10833	341	2	infect	infect	PROPN
bam-10833	341	3	dis	dis	PROPN
bam-10833	341	4	.	.	PUNCT
bam-10833	342	1	2012	2012	NUM
bam-10833	342	2	oct;55(7):943	oct;55(7):943	NOUN
bam-10833	342	3	-	-	PUNCT
bam-10833	342	4	50	50	NUM
bam-10833	342	5	.	.	PUNCT
bam-10833	343	1	doi	doi	NOUN
bam-10833	343	2	:	:	PUNCT
bam-10833	343	3	10.1093	10.1093	NUM
bam-10833	343	4	/	/	SYM
bam-10833	343	5	cid	cid	PROPN
bam-10833	343	6	/	/	SYM
bam-10833	343	7	cis588	cis588	PROPN
bam-10833	343	8	.	.	PUNCT
bam-10833	344	1	epub	epub	PROPN
bam-10833	344	2	2012	2012	NUM
bam-10833	344	3	jul	jul	PROPN
bam-10833	344	4	2	2	NUM
bam-10833	344	5	.	.	PROPN
bam-10833	344	6	46	46	NUM
bam-10833	344	7	.	.	PUNCT
bam-10833	345	1	yilmaz	yilmaz	PROPN
bam-10833	345	2	gr	gr	PROPN
bam-10833	345	3	,	,	PUNCT
bam-10833	345	4	guven	guven	PROPN
bam-10833	345	5	t	t	PROPN
bam-10833	345	6	,	,	PUNCT
bam-10833	345	7	guner	guner	NOUN
bam-10833	345	8	r	r	NOUN
bam-10833	345	9	,	,	PUNCT
bam-10833	345	10	kocak	kocak	ADJ
bam-10833	345	11	tufan	tufan	PROPN
bam-10833	345	12	z	z	PROPN
bam-10833	345	13	,	,	PUNCT
bam-10833	345	14	izdes	izdes	PROPN
bam-10833	345	15	s	s	PROPN
bam-10833	345	16	,	,	PUNCT
bam-10833	345	17	tasyaran	tasyaran	PROPN
bam-10833	345	18	ma	ma	PROPN
bam-10833	345	19	,	,	PUNCT
bam-10833	345	20	acikgoz	acikgoz	PROPN
bam-10833	345	21	zc	zc	PROPN
bam-10833	345	22	.	.	PROPN
bam-10833	345	23	colistin	colistin	PROPN
bam-10833	345	24	alone	alone	ADV
bam-10833	345	25	or	or	CCONJ
bam-10833	345	26	combined	combine	VERB
bam-10833	345	27	with	with	ADP
bam-10833	345	28	sulbactam	sulbactam	NOUN
bam-10833	345	29	or	or	CCONJ
bam-10833	345	30	carbapenem	carbapenem	NOUN
bam-10833	345	31	against	against	ADP
bam-10833	345	32	a.	a.	NOUN
bam-10833	345	33	baumannii	baumannii	PROPN
bam-10833	345	34	in	in	ADP
bam-10833	345	35	ventilator	ventilator	NOUN
bam-10833	345	36	-	-	PUNCT
bam-10833	345	37	associated	associate	VERB
bam-10833	345	38	pneumonia	pneumonia	NOUN
bam-10833	345	39	.	.	PUNCT
bam-10833	346	1	j	j	PROPN
bam-10833	346	2	infect	infect	PROPN
bam-10833	346	3	dev	dev	PROPN
bam-10833	346	4	ctries	ctrie	NOUN
bam-10833	346	5	.	.	PUNCT
bam-10833	347	1	2015	2015	NUM
bam-10833	347	2	may	may	AUX
bam-10833	347	3	18;9(5):476	18;9(5):476	NUM
bam-10833	347	4	-	-	PUNCT
bam-10833	347	5	85	85	NUM
bam-10833	347	6	.	.	PUNCT
bam-10833	348	1	doi	doi	NOUN
bam-10833	348	2	:	:	PUNCT
bam-10833	348	3	10.3855	10.3855	NUM
bam-10833	348	4	/	/	SYM
bam-10833	348	5	jidc.6195	jidc.6195	NOUN
bam-10833	348	6	.	.	PROPN
bam-10833	348	7	47	47	NUM
bam-10833	348	8	.	.	PUNCT
bam-10833	349	1	zarkotou	zarkotou	PROPN
bam-10833	349	2	o	o	PROPN
bam-10833	349	3	,	,	PUNCT
bam-10833	349	4	pournaras	pournaras	PROPN
bam-10833	349	5	s	s	PART
bam-10833	349	6	,	,	PUNCT
bam-10833	349	7	tselioti	tselioti	PROPN
bam-10833	349	8	p	p	X
bam-10833	349	9	,	,	PUNCT
bam-10833	349	10	dragoumanos	dragoumano	VERB
bam-10833	349	11	v	v	NOUN
bam-10833	349	12	,	,	PUNCT
bam-10833	349	13	pitiriga	pitiriga	ADJ
bam-10833	349	14	v	v	NOUN
bam-10833	349	15	,	,	PUNCT
bam-10833	349	16	ranellou	ranellou	PROPN
bam-10833	349	17	k	k	PROPN
bam-10833	349	18	,	,	PUNCT
bam-10833	349	19	prekates	prekate	VERB
bam-10833	349	20	a	a	DET
bam-10833	349	21	,	,	PUNCT
bam-10833	349	22	themelidigalaki	themelidigalaki	NOUN
bam-10833	349	23	k	k	NOUN
bam-10833	349	24	,	,	PUNCT
bam-10833	349	25	tsakris	tsakris	ADJ
bam-10833	349	26	a.	a.	NOUN
bam-10833	349	27	predictors	predictor	NOUN
bam-10833	349	28	of	of	ADP
bam-10833	349	29	mortality	mortality	NOUN
bam-10833	349	30	in	in	ADP
bam-10833	349	31	patients	patient	NOUN
bam-10833	349	32	with	with	ADP
bam-10833	349	33	bloodstream	bloodstream	NOUN
bam-10833	349	34	infections	infection	NOUN
bam-10833	349	35	caused	cause	VERB
bam-10833	349	36	by	by	ADP
bam-10833	349	37	kpc	kpc	NOUN
bam-10833	349	38	-	-	PUNCT
bam-10833	349	39	producing	produce	VERB
bam-10833	349	40	klebsiella	klebsiella	NOUN
bam-10833	349	41	pneumoniae	pneumoniae	ADJ
bam-10833	349	42	and	and	CCONJ
bam-10833	349	43	impact	impact	NOUN
bam-10833	349	44	of	of	ADP
bam-10833	349	45	appropriate	appropriate	ADJ
bam-10833	349	46	antimicrobial	antimicrobial	ADJ
bam-10833	349	47	treatment	treatment	NOUN
bam-10833	349	48	.	.	PUNCT
bam-10833	350	1	clin	clin	PROPN
bam-10833	350	2	microbiol	microbiol	PROPN
bam-10833	350	3	infect	infect	PROPN
bam-10833	350	4	.	.	PUNCT
bam-10833	351	1	2011	2011	NUM
bam-10833	351	2	dec;17(12):1798	dec;17(12):1798	NOUN
bam-10833	351	3	-	-	PUNCT
bam-10833	351	4	803	803	NUM
bam-10833	351	5	.	.	PUNCT
bam-10833	352	1	doi	doi	NOUN
bam-10833	352	2	:	:	PUNCT
bam-10833	352	3	10.1111	10.1111	NUM
bam-10833	352	4	/	/	SYM
bam-10833	352	5	j.1469	j.1469	PROPN
bam-10833	352	6	-	-	PUNCT
bam-10833	352	7	0691.2011.03514.x	0691.2011.03514.x	PROPN
bam-10833	352	8	.	.	PUNCT
bam-10833	353	1	epub	epub	PROPN
bam-10833	353	2	2011	2011	NUM
bam-10833	353	3	may	may	AUX
bam-10833	353	4	20	20	NUM
bam-10833	353	5	.	.	PUNCT
bam-10833	353	6	48	48	NUM
bam-10833	353	7	.	.	PUNCT
bam-10833	354	1	zusman	zusman	ADJ
bam-10833	354	2	o	o	PROPN
bam-10833	354	3	,	,	PUNCT
bam-10833	354	4	altunin	altunin	PROPN
bam-10833	354	5	s	s	PROPN
bam-10833	354	6	,	,	PUNCT
bam-10833	354	7	koppel	koppel	PROPN
bam-10833	354	8	f	f	PROPN
bam-10833	354	9	,	,	PUNCT
bam-10833	354	10	dishon	dishon	PROPN
bam-10833	354	11	benattar	benattar	PROPN
bam-10833	354	12	y	y	PROPN
bam-10833	354	13	,	,	PUNCT
bam-10833	354	14	gedik	gedik	NOUN
bam-10833	354	15	h	h	NOUN
bam-10833	354	16	,	,	PUNCT
bam-10833	354	17	paul	paul	PROPN
bam-10833	354	18	m.	m.	PROPN
bam-10833	354	19	polymyxin	polymyxin	PROPN
bam-10833	354	20	monotherapy	monotherapy	NOUN
bam-10833	354	21	or	or	CCONJ
bam-10833	354	22	in	in	ADP
bam-10833	354	23	combination	combination	NOUN
bam-10833	354	24	against	against	ADP
bam-10833	354	25	carbapenem	carbapenem	NOUN
bam-10833	354	26	-	-	PUNCT
bam-10833	354	27	resistant	resistant	ADJ
bam-10833	354	28	bacteria	bacteria	NOUN
bam-10833	354	29	:	:	PUNCT
bam-10833	354	30	systematic	systematic	ADJ
bam-10833	354	31	review	review	NOUN
bam-10833	354	32	and	and	CCONJ
bam-10833	354	33	meta	meta	ADJ
bam-10833	354	34	-	-	PUNCT
bam-10833	354	35	analysis	analysis	NOUN
bam-10833	354	36	.	.	PUNCT
bam-10833	355	1	j	j	PROPN
bam-10833	355	2	antimicrob	antimicrob	PROPN
bam-10833	355	3	chemother	chemother	PROPN
bam-10833	355	4	.	.	PUNCT
bam-10833	356	1	2017	2017	NUM
bam-10833	356	2	jan;72(1):29	jan;72(1):29	PROPN
bam-10833	356	3	-	-	PUNCT
bam-10833	356	4	39	39	NUM
bam-10833	356	5	.	.	PUNCT
bam-10833	357	1	doi	doi	NOUN
bam-10833	357	2	:	:	PUNCT
bam-10833	357	3	10.1093	10.1093	NUM
bam-10833	357	4	/	/	SYM
bam-10833	357	5	jac	jac	PROPN
bam-10833	357	6	/	/	SYM
bam-10833	357	7	dkw377	dkw377	PROPN
bam-10833	357	8	.	.	PUNCT
bam-10833	358	1	epub	epub	PROPN
bam-10833	358	2	2016	2016	NUM
bam-10833	358	3	sep	sep	PROPN
bam-10833	358	4	13	13	NUM
bam-10833	358	5	.	.	PUNCT
bam-10833	358	6	49	49	NUM
bam-10833	358	7	.	.	PUNCT
bam-10833	359	1	yaghoubi	yaghoubi	NOUN
bam-10833	359	2	s	s	PROPN
bam-10833	359	3	,	,	PUNCT
bam-10833	359	4	zekiy	zekiy	PROPN
bam-10833	359	5	ao	ao	PROPN
bam-10833	359	6	,	,	PUNCT
bam-10833	359	7	krutova	krutova	PROPN
bam-10833	359	8	m	m	PROPN
bam-10833	359	9	,	,	PUNCT
bam-10833	359	10	gholami	gholami	PROPN
bam-10833	359	11	m	m	PROPN
bam-10833	359	12	,	,	PUNCT
bam-10833	359	13	kouhsari	kouhsari	PROPN
bam-10833	359	14	e	e	PROPN
bam-10833	359	15	,	,	PUNCT
bam-10833	359	16	sholeh	sholeh	PROPN
bam-10833	359	17	m	m	PROPN
bam-10833	359	18	,	,	PUNCT
bam-10833	359	19	ghafouri	ghafouri	PROPN
bam-10833	359	20	z	z	PROPN
bam-10833	359	21	,	,	PUNCT
bam-10833	359	22	maleki	maleki	PROPN
bam-10833	359	23	f.	f.	PROPN
bam-10833	359	24	tigecycline	tigecycline	PROPN
bam-10833	359	25	antibacterial	antibacterial	ADJ
bam-10833	359	26	activity	activity	NOUN
bam-10833	359	27	,	,	PUNCT
bam-10833	359	28	clinical	clinical	ADJ
bam-10833	359	29	effectiveness	effectiveness	NOUN
bam-10833	359	30	,	,	PUNCT
bam-10833	359	31	and	and	CCONJ
bam-10833	359	32	mechanisms	mechanism	NOUN
bam-10833	359	33	and	and	CCONJ
bam-10833	359	34	epidemiology	epidemiology	NOUN
bam-10833	359	35	of	of	ADP
bam-10833	359	36	resistance	resistance	NOUN
bam-10833	359	37	:	:	PUNCT
bam-10833	359	38	narrative	narrative	PROPN
bam-10833	359	39	review	review	NOUN
bam-10833	359	40	.	.	PUNCT
bam-10833	360	1	eur	eur	PROPN
bam-10833	360	2	j	j	PROPN
bam-10833	360	3	clin	clin	PROPN
bam-10833	360	4	microbiol	microbiol	PROPN
bam-10833	360	5	infect	infect	VERB
bam-10833	360	6	dis	dis	PROPN
bam-10833	360	7	.	.	PUNCT
bam-10833	361	1	2022	2022	NUM
bam-10833	362	1	jul;41(7):1003	jul;41(7):1003	NOUN
bam-10833	362	2	-	-	PROPN
bam-10833	362	3	1022	1022	NUM
bam-10833	362	4	.	.	PUNCT
bam-10833	363	1	doi	doi	NOUN
bam-10833	363	2	:	:	PUNCT
bam-10833	363	3	10.1007	10.1007	NUM
bam-10833	363	4	/	/	SYM
bam-10833	363	5	s10096	s10096	NOUN
bam-10833	363	6	-	-	PUNCT
bam-10833	363	7	020	020	NUM
bam-10833	363	8	-	-	PUNCT
bam-10833	363	9	04121	04121	NUM
bam-10833	363	10	-	-	SYM
bam-10833	363	11	1	1	NUM
bam-10833	363	12	.	.	NOUN
bam-10833	363	13	50	50	NUM
bam-10833	363	14	.	.	PUNCT
bam-10833	364	1	sato	sato	PROPN
bam-10833	364	2	y	y	PROPN
bam-10833	364	3	,	,	PUNCT
bam-10833	364	4	ubagai	ubagai	PROPN
bam-10833	364	5	t	t	PROPN
bam-10833	364	6	,	,	PUNCT
bam-10833	364	7	tansho	tansho	NOUN
bam-10833	364	8	-	-	PUNCT
bam-10833	364	9	nagakawa	nagakawa	NOUN
bam-10833	364	10	s	s	NOUN
bam-10833	364	11	,	,	PUNCT
bam-10833	364	12	yoshino	yoshino	PROPN
bam-10833	364	13	y	y	PROPN
bam-10833	364	14	,	,	PUNCT
bam-10833	364	15	ono	ono	PROPN
bam-10833	364	16	y.	y.	PROPN
bam-10833	364	17	effects	effect	NOUN
bam-10833	364	18	of	of	ADP
bam-10833	364	19	colistin	colistin	NOUN
bam-10833	364	20	and	and	CCONJ
bam-10833	364	21	tigecycline	tigecycline	VERB
bam-10833	364	22	on	on	ADP
bam-10833	364	23	multidrug	multidrug	NOUN
bam-10833	364	24	-	-	PUNCT
bam-10833	364	25	resistant	resistant	ADJ
bam-10833	364	26	acinetobacter	acinetobacter	ADJ
bam-10833	364	27	baumannii	baumannii	ADJ
bam-10833	364	28	biofilms	biofilm	NOUN
bam-10833	364	29	:	:	PUNCT
bam-10833	364	30	advantages	advantage	NOUN
bam-10833	364	31	and	and	CCONJ
bam-10833	364	32	disadvantages	disadvantage	NOUN
bam-10833	364	33	of	of	ADP
bam-10833	364	34	their	their	PRON
bam-10833	364	35	combination	combination	NOUN
bam-10833	364	36	.	.	PUNCT
bam-10833	365	1	sci	sci	PROPN
bam-10833	365	2	rep	rep	PROPN
bam-10833	365	3	.	.	PROPN
bam-10833	365	4	2021	2021	NUM
bam-10833	365	5	jun	jun	PROPN
bam-10833	365	6	3;11(1):11700	3;11(1):11700	NUM
bam-10833	365	7	.	.	PUNCT
bam-10833	366	1	doi	doi	NOUN
bam-10833	366	2	:	:	PUNCT
bam-10833	366	3	10.1038	10.1038	NUM
bam-10833	366	4	/	/	SYM
bam-10833	366	5	s41598	s41598	NOUN
bam-10833	366	6	-	-	PUNCT
bam-10833	366	7	021	021	NUM
bam-10833	366	8	-	-	PUNCT
bam-10833	366	9	90732	90732	NUM
bam-10833	366	10	-	-	SYM
bam-10833	366	11	3	3	NUM
bam-10833	366	12	..	..	PUNCT
bam-10833	366	13	disclaimer	disclaimer	NOUN
bam-10833	366	14	all	all	DET
bam-10833	366	15	claims	claim	NOUN
bam-10833	366	16	expressed	express	VERB
bam-10833	366	17	in	in	ADP
bam-10833	366	18	this	this	DET
bam-10833	366	19	article	article	NOUN
bam-10833	366	20	are	be	AUX
bam-10833	366	21	solely	solely	ADV
bam-10833	366	22	those	those	PRON
bam-10833	366	23	of	of	ADP
bam-10833	366	24	the	the	DET
bam-10833	366	25	authors	author	NOUN
bam-10833	366	26	and	and	CCONJ
bam-10833	366	27	do	do	AUX
bam-10833	366	28	not	not	PART
bam-10833	366	29	necessarily	necessarily	ADV
bam-10833	366	30	represent	represent	VERB
bam-10833	366	31	those	those	PRON
bam-10833	366	32	of	of	ADP
bam-10833	366	33	their	their	PRON
bam-10833	366	34	affiliated	affiliated	ADJ
bam-10833	366	35	organizations	organization	NOUN
bam-10833	366	36	,	,	PUNCT
bam-10833	366	37	or	or	CCONJ
bam-10833	366	38	those	those	PRON
bam-10833	366	39	of	of	ADP
bam-10833	366	40	the	the	DET
bam-10833	366	41	publisher	publisher	NOUN
bam-10833	366	42	,	,	PUNCT
bam-10833	366	43	the	the	DET
bam-10833	366	44	editors	editor	NOUN
bam-10833	366	45	and	and	CCONJ
bam-10833	366	46	the	the	DET
bam-10833	366	47	reviewers	reviewer	NOUN
bam-10833	366	48	.	.	PUNCT
bam-10833	367	1	any	any	DET
bam-10833	367	2	product	product	NOUN
bam-10833	367	3	that	that	PRON
bam-10833	367	4	may	may	AUX
bam-10833	367	5	be	be	AUX
bam-10833	367	6	evaluated	evaluate	VERB
bam-10833	367	7	in	in	ADP
bam-10833	367	8	this	this	DET
bam-10833	367	9	article	article	NOUN
bam-10833	367	10	or	or	CCONJ
bam-10833	367	11	claim	claim	NOUN
bam-10833	367	12	that	that	PRON
bam-10833	367	13	may	may	AUX
bam-10833	367	14	be	be	AUX
bam-10833	367	15	made	make	VERB
bam-10833	367	16	by	by	ADP
bam-10833	367	17	its	its	PRON
bam-10833	367	18	manufacturer	manufacturer	NOUN
bam-10833	367	19	is	be	AUX
bam-10833	367	20	not	not	PART
bam-10833	367	21	guaranteed	guarantee	VERB
bam-10833	367	22	or	or	CCONJ
bam-10833	367	23	endorsed	endorse	VERB
bam-10833	367	24	by	by	ADP
bam-10833	367	25	the	the	DET
bam-10833	367	26	publisher	publisher	NOUN
bam-10833	367	27	.	.	PUNCT
bam-10833	368	1	submission	submission	NOUN
bam-10833	368	2	:	:	PUNCT
bam-10833	368	3	september	september	PROPN
bam-10833	368	4	3	3	NUM
bam-10833	368	5	,	,	PUNCT
bam-10833	368	6	2022	2022	NUM
bam-10833	368	7	revision	revision	NOUN
bam-10833	368	8	received	receive	VERB
bam-10833	368	9	:	:	PUNCT
bam-10833	368	10	september	september	PROPN
bam-10833	368	11	9	9	NUM
bam-10833	368	12	,	,	PUNCT
bam-10833	368	13	2022	2022	NUM
bam-10833	368	14	accepted	accept	VERB
bam-10833	368	15	for	for	ADP
bam-10833	368	16	publication	publication	NOUN
bam-10833	368	17	:	:	PUNCT
bam-10833	368	18	september	september	PROPN
bam-10833	368	19	9	9	NUM
bam-10833	368	20	,	,	PUNCT
bam-10833	368	21	2022	2022	NUM
bam-10833	368	22	results	result	VERB